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ABSTRACT OF DISSERTATION

STUDIES ON DRUG SOLUBILIZATION MECHANISM
IN SIMPLE MICELLE SYSTEMS
Poor aqueous solubilities of drug candidates limit the biopharmaceutical
usefulness in either oral or parenteral dosage forms. Lipid assemblies, such as
micelles, may provide a means of enhancing solubility. Despite their usefulness,
little is known about the means by which micelles accomplish this result. The goal
of the current dissertation is to provide the molecular level understanding of the
mechanism by which simple micelle systems solubilize drugs. Specifically, the
location, orientation and amount of the drug molecules in micelle systems are the
focuses of the work.
Three series of model drugs, steroids, benzodiazepines and parabens, in three
surfactant systems with anionic, cationic and neutral hydrophilic headgroups were
studied. Solubilization power of each micelle system for each model drug was
determined by equilibrium solubility. The observed strong surface activities of
model drug at hydrocarbon/water interface and the ability of the drugs to compete
with surfactants for the model oil/water interface lend support to the hypothesis
that drug molecules are mainly solubilized in the interfacial region of the micelles.
A surface-localized thermodynamic model that considered the surfactant-drug
competition at micelle surface was successfully applied to predict the
micelle/water partitioning coefficients. The predictions were made without the use
of adjustable parameters in the case of both dilute and concentrated solutions. The
orientation of drug at micelle surface was determined by matching calculated
occupied areas by solutes at oil/water interface using molecular modeling method
to the experimental values. To look into the micro-structure of micelles, twodimensional and diffusion (or PGSE) NMR techniques were employed to detect
the specific drug-surfactant interactions and the micelle sizes influenced by model
drugs and electrolytes.

KEYWORDS: Simple Micelle Systems, Poorly Water-soluble
Drugs, Solubilization, Thermodynamic Model,
Surface Activity

Shaoxin Feng

November 17, 2009

STUDIES ON DRUG SOLUBILIZATION MECHANISM
IN SIMPLE MICELLE SYSTEMS

By
Shaoxin Feng

Dr. Paul M. Bummer
Director of Dissertation
Dr. Robert Yokel
Director of Graduate Studies
November 17, 2009
Date

RULES FOR THE USE OF DISSERTATIONS
Unpublished dissertations submitted for the Doctor's degree and deposited
in the University of Kentucky Library are as a rule open for inspection, but
are to be used only with due regard to the rights of the authors.
Bibliographical references may be noted, but quotations or summaries of
parts may be published only with the permission of the author, and with the
usual scholarly acknowledgments.

Extensive copying or publication of the dissertation in whole or in part also
requires the consent of the Dean of the Graduate School of the University
of Kentucky.

A library that borrows this dissertation for use by its patrons is expected to
secure the signature of each user.
Name

Date

___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________

DISSERTATION

Shaoxin Feng

The Graduate School
University of Kentucky
2009

STUDIES ON DRUG SOLUBILIZATION MECHANISM
IN SIMPLE MICELLE SYSTEMS

DISSERTATION

A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy in the
College of Pharmacy at the University of Kentucky
By
Shaoxin Feng
Lexington, Kentucky
Director: Dr. Paul M. Bummer, Associate Professor of Pharmaceutical
Sciences
Lexington, Kentucky
2009
Copyright © Shaoxin Feng 2009

ACKNOWLEDGEMENTS
I would like to thank all the people who have accompanied and supported me and made
their direct and indirect contributions to this dissertation in the past years.
First and foremost I would like to express my sincere appreciation to my research advisor,
Dr. Paul M. Bummer, for his tremendous support throughout my graduate study. Dr.
Bummer had been not only a scientist, but also a mentor, a great educator and a friend to
me. His expertise and continuous guidance helped me develop skills in designing,
executing and analyzing experiments, given my pure theoretical background. His
approachable character and ever-present enthusiasm led to a lot of discussions with him,
from which I got patient answers and fresh insights that covered various areas, such as
experimental methodologies, instrumental problems, presentation preparations and even
job-hunting strategies.
I would like to thank Dr. Bradley Anderson for his inspiring questions that helped keep
my research in the right track. His preciseness and deep understanding in physical
pharmacy helped me develop critical thinking that is important for a qualified scientist. I
am also grateful for his kindness of letting me use many instruments in his lab. I would
like to thank the members of my dissertation committee: Dr. Barbara Knutson and Dr.
Tonglei Li, as well as Dr. Stefan Stamm, the outside examiner, for their technical
expertise, insights, and knowledge to this work.
Special thanks go to Mr. John Layton and Dr. Anne-Frances Miller who generously
helped me use the Pulsed Gradient Spin Echo NMR in the Department of Chemistry.
I would like to thank my labmates, Lin Song, Salin Gupta, Abebe Mengesha, and Dr.
Anderson’s group members (Vijay Jogoparthi, Michael DeHart, Dhaval Patel) for their
help on my experiments. I also thank my friends, Xue Luo, Liming Zhao, Donghua Zhu,
and Mikolaj Milewski, for their friendship which made the time in the graduate school
unforgettable.
I would like to thank my parents for their love and support during the long years of my
education. I thank my parents-in-law for their support in helping with the family. I also
thank my son, Yihan (Leo), for all the joys he brought to the family which had brightened
my life.
Last but not least, I thank my wife, Lingzhi Liu, for being there for me no matter what
happens. Her love, dedication and persistent confidence in me have taken, and will
always take the load off my shoulder.

iii

TABLE OF CONTENTS
Acknowledgements............................................................................................................iii
List of Tables....................................................................................................................viii
List of Figures.....................................................................................................................xi
Chapter 1. Statement of Problem and Aims.........................................................................1
Chapter 2. Background and Literature Review....................................................................3
2.1. Introduction..........................................................................................................3
2.2. Means of Solubilization.......................................................................................5
2.3. Families of Lipids Assemblies.............................................................................6
2.4. Examples in the Literature of Use of Lipid Assemblies in Drug Delivery..........9
2.5. Micelles as Drug Delivery Systems...................................................................10
2.6. Relevant Properties of Micelles.........................................................................12
2.6.1. Physical and Chemical Properties of Micelles.......................................12
2.6.2. Molecular Organization in Micelles......................................................13
2.6.3. Solubilization Capacity of Micelles.......................................................15
2.6.4. Location of Solutes in Micelles.............................................................18
2.7. Unanswered Questions.......................................................................................23
2.8. Summary............................................................................................................25
Chapter 3. Solubilization Capacity of Simple Micelle Systems and its Relation
to the Partitioning of Model Drugs between Hydrocarbon and Water......................26
3.1. Introduction........................................................................................................26
3.2. Materials and Methods.......................................................................................28
3.2.1. Materials................................................................................................28
3.2.2. Solubility Measurements in Aqueous Solutions....................................32
3.2.3. Solubility Determinations in Hydrocarbon Solutions............................32
3.2.4. Micelle/water Partitioning Coefficient Determinations.........................32
3.2.5. Hydrocarbon/water Partitioning Coefficient Determinations................33
3.2.6. Direct Partitioning Coefficient Determinations.....................................34
3.2.7. HPLC Methods......................................................................................34
3.3. Results and Discussion......................................................................................46
3.3.1. Solubilization of Model Drugs in Three Micelle Systems.....................46
3.3.2. Effect of Salts on the Micelle/water Partitioning Coefficients..............58
3.4. Conclusion.........................................................................................................63
Chapter 4. Oil/water Interface Activities of Hydrophobic Drugs in the
Presence and Absence of Surfactants........................................................................64
4.1. Introduction........................................................................................................64
4.2. Materials and Methods.......................................................................................65
4.2.1. Materials................................................................................................65
4.2.2. Methods.................................................................................................66
4.2.2.1. Surface Tension Measurement...................................................66
iv

4.2.2.2. Purification of Steroids and Surfactants.....................................69
4.3. Results................................................................................................................74
4.3.1. Interfacial Studies in the Absence of Surfactants..................................74
4.3.2. Interfacial Studies in the Presence of Surfactants..................................75
4.3.2.1. Sodium Dodecyl Sulfate (SDS).................................................75
4.3.2.2. Dodecyltrimehylammonium Bromide (DTAB).........................77
4.3.2.3. Dodecyl -D-Maltoside (DM)...................................................77
4.3.3. Thermodynamic Model of Dodecane/water Interfacial Tension
in the Presence of Drug and Surfactant...................................................79
4.3.3.1. Introduction of Two Models for Surface Adsorption
and Model Selection...................................................................79
4.3.3.2. Application of Butler Model to Single Solute Systems.............80
4.3.3.3. Application of Butler Model to Two Solute (Surfactant
and Drug) Systems......................................................................87
4.4. Discussion..........................................................................................................88
4.5. Conclusion.........................................................................................................95
Chapter 5. Surface-localized Thermodynamic Model Used to Predict the
Micelle/water Partitioning Coefficient.....................................................................96
5.1. Introduction........................................................................................................96
5.2. Materials and Methods.......................................................................................98
5.2.1. Materials................................................................................................98
5.2.2. Purification of Dodecane.......................................................................98
5.2.3. Surface-localized Thermodynamic Model.............................................99
5.3. Results and Discussion....................................................................................101
5.3.1. Drug Solute-Specific Parameters of Solubilization in Micelles..........101
5.3.2. Surfactant-Specific Parameters Used in the Thermodynamic
Model....................................................................................................111
5.3.3. Application of surface-localized model to predict the
micelle/water partitioning.....................................................................114
5.3.4. Sensitivity of Parameter Selections to the Prediction of
Micelle/water Partition Coefficient.......................................................120
5.3.4.1. Sensitivity of Predicted Km/w Values to the Radii of Micelles.121
5.3.4.2. Sensitivity of Predicted Km/w Values to Aggregation
Number of Micelles..................................................................125
5.3.4.3. Sensitivity of Predicted Km/w Values to Occupied
Interfacial Areas by Water Molecules......................................130
5.3.4.4. Sensitivity of Predicted Km/w Values to Interfacial Areas
Occupied by Drugs...................................................................131
5.3.5. Effect of Salt on the Micelle/water Partitioning Coefficients..............139
5.3.6. Solubilization Isotherm Simulations by Removing the
Assumption of Dilute Condition for the Solute....................................139
v

5.3.7. Effect of Solute on CMC of Micelles Explained by Laplace
Pressure Effect......................................................................................146
5.4. Conclusion.......................................................................................................148
Chapter 6. Molecular Simulation Studies on the Orientations of Model Drugs at
Oil/water Interface..................................................................................................152
6.1. Introduction......................................................................................................152
6.2. Methods............................................................................................................153
6.2.1. Molecular Structures of Isolated Drug Molecules...............................153
6.2.2. Defining the Boundary of Isolated Molecules.....................................154
6.2.3. Calculation of Cross-section Areas along All Possible Directions......155
6.2.4. Visualizations of the Molecules, Isosurfaces of Electron Densities,
and Cutting Planes................................................................................156
6.3. Results and Discussion....................................................................................157
6.3.1. Molecular Structures of Model Drugs.................................................157
6.3.2. Determination of Molecular Boundaries.............................................157
6.3.3. Determining Orientation of Model Drugs by Matching Calculated
Interfacial Areas Occupied by Model Drugs to Experimental Areas....160
6.4. Conclusion.......................................................................................................174
Chapter 7. NMR Studies on Inter-molecular Interactions in Micelles and Micellar
Diffusivity...............................................................................................................176
7.1. Introduction......................................................................................................176
7.2. Materials and Methods.....................................................................................177
7.2.1. Materials..............................................................................................177
7.2.2. Methods...............................................................................................177
7.2.2.1. 2D NMR (NOESY and ROESY) Methods..............................177
7.2.2.2. 2-D NMR Sample Preparations...............................................180
7.2.2.3. PGSE NMR Method................................................................180
7.2.2.4. PGSE NMR Sample Preparations............................................184
7.3. Results and Discussion....................................................................................186
7.3.1. Two-dimensional NMR.......................................................................186
7.3.1.1. 2-D NMR for Steroids in Micelles...........................................186
7.3.1.2. 2-D NMR for Parabens in Micelles.........................................189
7.3.1.3. 2-D NMR for Benzodiazepines in Micelles.............................199
7.3.2. Pulse Gradient Spin-Echo (PGSE) NMR............................................204
7.3.2.1. Drugs Solubilized in SDS Micelles.........................................205
7.3.2.2. Drugs Solubilized in DTAB Micelles......................................206
7.3.2.3. Drugs Solubilized in DM Micelles..........................................210
7.3.2.4. Support for Competition for the Micelle Surface....................213
7.3.2.5. Possible Self-Association of Drug Molecules.........................214
7.4. Conclusion.......................................................................................................214
Chapter 8. Summary and Conclusions.............................................................................218
vi

Appendices.......................................................................................................................221
Appendix 1. Liquid-liquid Interfacial Adsorption by Two-dimensional
Solution Model..............................................................................................221
Appendix 2. Surface-localized Thermodynamic Model.........................................225
A2.1. Dilute Solute Condition.......................................................................226
A2.2. Non-dilute Solute Condition................................................................229
A2.3. The Effect of Finite Solute Concentration on CMC of Surfactants
Using Laplace Pressure Concept..........................................................233
References........................................................................................................................234
Vita...................................................................................................................................240

vii

List of Tables

Table 3.1, Reverse phase and normal phase HPLC assays for all model drugs................36
Table 3.2, Critical parameters of model steroids: logPoct, aqueous solubility, solubility
in dodecane, hydrocarbon/water partitioning coefficient (Kh/w),
solubilization capacity () and micelle/water partitioning coefficients
(Km/w) in SDS, DTAB and DM micelle systems...........................................47
Table 3.3, Critical parameters of model benzodiazepines: logPoct, aqueous solubility,
solubility in dodecane, hydrocarbon/water partitioning coefficient (Kh/w),
solubilization capacity () and micelle/water partitioning coefficients
(Km/w) in SDS, DTAB and DM micelle systems...........................................48
Table 3.4, Critical parameters of model parabens: logPoct, aqueous solubility,
solubility in dodecane, hydrocarbon/water partitioning coefficient (Kh/w),
solubilization capacity () and micelle/water partitioning coefficients
(Km/w) in SDS, DTAB and DM micelle systems...........................................49
Table 3.5, Aqueous solubility, solubilization capacity () and micelle/water
partitioning coefficient (Km/w) of three model drugs in SDS, DTAB
and DM micelle systems in the absence and presence of 0.15M NaCl.
Experimental data in the absence of salts are from Table 3.2~3.4................62
Table 4.1, Interfacial tension in the absence and presence of model drugs.......................76
Table 4.2, Dodecane/water interfacial tensions in the absence and presence of
saturated model steroids (progesterone, testosterone, 17-estradiol)
and sodium dodecyl sulfate (SDS) solutions. Three concentrations
of SDS were used: 0.1, 1.0 and 10.0mg/mL.................................................76
Table 4.3, Dodecane/water interfacial tensions in the absence and presence of
saturated model steroids (progesterone, testosterone, 17-estradiol)
and dodecyltrimethylammonium bromide (DTAB) solutions. Three
concentrations of DTAB were used: 0.1, 1.0 and 10.0mg/mL......................78
Table 4.4, Dodecane/water interfacial tensions in the absence and presence of
saturated model steroids (progesterone, testosterone, 17-estradiol)
and dodecyl -D-maltoside (DM) solutions. Three concentrations
of DM were used: 0.003, 0.03 and 0.3mg/mL..............................................78
Table 4.5, Critical parameters used in simulations. Those parameters are
fitted from surface tension experiments........................................................84
Table 4.6, Comparison between experimental and predicted dodecane-water
interfacial tensions in the presence of both surfactants and drugs. The
predicted values were obtained using the Eq. (A1.9) and (A1.10).
Experimental data are from Table 4.2 to 4.4.................................................90
Table 5.1, Volumes of each molecules of model drugs based on reported crystal
viii

structures.....................................................................................................102
Table 5.2, Fitted transfer free energy Gwater→interface and occupied area at oil/water
interface for all model drugs.......................................................................107
Table 5.3, Estimated transfer free energy from hydrocarbon to oil/water interface,
Ghydrocarbon→interface, for model drugs..........................................................110
Table 5.4, The parameters of surfactants and the corresponding micelles used in the
surface-localized model. The data with asterisk are independent and
obtained from literatures (detail information is in main text). The
other data are derivative from those independent parameters.....................112
Table 5.5, The predicted micelle/water partitioning coefficients, Km/w(calc.), their
components, exp(-PV/RT), /Xw, A, f, Km/w, core (=Kh/wexp(-PV/RT)),
and experimental micelle/water partitioning coefficients, Km/w(exp.),
for 9 model drugs solubilized in 3 micelle systems....................................117
Table 5.6, The sensitivity of micelle/water partitioning coefficients in SDS and
DTAB micelle systems to the aggregation number of the micelles............128
Table 5.7, The sensitivity of micelle/water partitioning coefficients in DM micelle
systems to the aggregation number of the micelles....................................128
Table 5.8, Fitted transfer free energies Gwater→interface and occupied areas at oil/water
interface for the model drugs using awater=10Å².........................................132
Table 5.9, Calculated micelle/water partitioning coefficients using new parameter
(Table 5.8) set corresponding to awater=10Å² compared to predictions
using old parameters with awater=7.62Å².....................................................133
Table 5.10, The dependence of free energy of transfer for model drugs from water
to oil/water interface on varying interfacial area occupied by the drugs
at oil/water interface. In order to test the sensitivity of calculated Km/w
on adrug, four interfacial areas were chosen: maximum area, minimum
area and ±10% deviations from the experimental area...............................135
Table 5.11, Calculated micelle/water partitioning coefficients using new parameter
set (Table 5.10) corresponding to varying interfacial areas occupied by
drugs at oil/water interface..........................................................................136
Table 5.12, Calculated micelle/water partitioning coefficients under dilute condition
(shown early in section 5.4.3 Table5.4) and non-dilute condition
(saturated solution) compared to experimental micelle/water
partitioning coefficients (mainly under saturated condition). The ratios
of Km/w(saturated solution) and Km/w(dilute condition) are listed...............145
Table 6.1, The calculated occupied volumes of isolated molecules using different
isovalues of the isosurfaces of electron densities compared to
experimental occupied volumes for all model drugs..................................161
Table 6.2, The calculated maximum and minimum cross-section areas occupied
by drug molecules at oil/water interface, amax and amin, compared to
the experimental cross-section areas of molecules at oil/water
ix

interface, aexp, reported in Table 5.1 (section 5.4.1); the estimated
angles between long axes of model drugs and the normal of the
oil/water interface and the calculated time-average interfacial areas
occupied by drug molecules when the molecules are permitted to
rotate freely at oil/water interface, aaverage...................................................170
Table 7.1, List of NMR bands of model drugs and surfactants used in diffusivity
measurements..............................................................................................185

x

List of Figures

Figure 2.1, A schematic of biopharmaceutical classification system (BCS) (Adapted
from Amidon et al. (Amidon et al., 1995). Solubilization could shift
BCS class II drug candidates into the BCS I region.......................................4
Figure 2.2, A schematic of phase diagram of lipid based systems. Adapted from
Bummer (Bummer, 2004)...............................................................................7
Figure 2.3, Conventional representation of a micelle. The circles represent the
hydrophilic head groups of micelles, and the zigzags are the
hydrocarbon chains of micelles....................................................................14
Figure 3.1a, The chemical structures of model steroids....................................................29
Figure 3.1b, The chemical structures of model benzodiazepines......................................30
Figure 3.1c, The chemical structures of model parabens...................................................30
Figure 3.2, The chemical structures of model surfactants.................................................31
Figure 3.3a, Reverse phase HPLC chromatograms of progesterone: the top
chromatogram is the standard solution with drug concentration of
51ug/mL; the bottom curve represents 20 times dilution of the
saturated drug in 10mg/mL DTAB solution..................................................40
Figure 3.3b, Normal phase HPLC chromatograms of progesterone: the top
chromatogram is the standard solution with drug concentration of
105ug/mL; the bottom curve is 40 times dilution of the saturated
drug in dodecane...........................................................................................40
Figure 3.4a, Reverse phase HPLC chromatograms of testosterone: the top
chromatogram is the standard solution with drug concentration of
81ug/mL; the bottom curve represents twice dilution of the
saturated drug in 5mg/mL DTAB solution....................................................40
Figure 3.4b, Normal phase HPLC chromatograms of testosterone: the top
chromatogram is the standard solution with drug concentration of
104ug/mL; the bottom curve is 5 times dilution of the saturated
drug in dodecane...........................................................................................40
Figure 3.5a, Reverse phase HPLC chromatograms of 17-estradiol: the top
chromatogram is the standard solution with drug concentration of
40ug/mL; the bottom curve represents twice dilution of the
saturated drug in 5mg/mL SDS solution.......................................................41
Figure 3.5b, Normal phase HPLC chromatograms of 17-estradiol: the top
chromatogram is the standard solution with drug concentration of
10ug/mL; the bottom curve is the saturated drug in dodecane.....................41
Figure 3.6a, Reverse phase HPLC chromatograms of 11-hydroxyprogesterone:
the top chromatogram is the standard solution with drug
xi

concentration of 84ug/mL; the bottom curve represents the saturated
drug in 1.0mg/mL DM solution....................................................................41
Figure 3.6b, Normal phase HPLC chromatograms of 11-hydroxyprogesterone:
the top chromatogram is the standard solution with drug concentration
of 67ug/mL; the bottom curve is the saturated drug in dodecane.................41
Figure 3.7a, Reverse phase HPLC chromatograms of diazepam: the top
chromatogram is the standard solution with drug concentration of
88ug/mL; the bottom curve represents the saturated drug in
1.0mg/mL DM solution.................................................................................42
Figure 3.7b, Normal phase HPLC chromatograms of diazepam: the top
chromatogram is the standard solution with drug concentration of
119ug/mL; the bottom curve is 10 times dilution of the saturated
drug in dodecane...........................................................................................42
Figure 3.8a, Reverse phase HPLC chromatograms of temazepam: the top
chromatogram is the standard solution with drug concentration of
82ug/mL; the bottom curve represents 20 times dilution of the
saturated drug in 2.5mg/mL SDS solution....................................................42
Figure 3.8b, Normal phase HPLC chromatograms of temazepam: the top
chromatogram is the standard solution with drug concentration of
57ug/mL; the bottom curve is 3 times dilution of the saturated
drug in dodecane...........................................................................................42
Figure 3.9a, Reverse phase HPLC chromatograms of prazepam: the top
chromatogram is the standard solution with drug concentration of
24ug/mL; the bottom curve represents the saturated drug in 5mg/mL
DTAB solution..............................................................................................43
Figure 3.9b, Normal phase HPLC chromatograms of prazepam: the top
chromatogram is the standard solution with drug concentration of
73ug/mL; the bottom curve is 40 times dilution of the saturated
drug in dodecane...........................................................................................43
Figure 3.10a, Reverse phase HPLC chromatograms of oxazepam: the top
chromatogram is the standard solution with drug concentration of
81ug/mL; the bottom curve represents 5 times dilution of the
saturated drug in 2.5mg/mL SDS solution....................................................43
Figure 3.10b, Normal phase HPLC chromatograms of oxazepam: the top
chromatogram is the standard solution with drug concentration of
1.8ug/mL; the bottom curve is the saturated drug in dodecane....................43
Figure 3.11a, Reverse phase HPLC chromatograms of methylparaben: the top
chromatogram is the standard solution with drug concentration of
107ug/mL; the bottom curve represents 40 times dilution of the
saturated drug in 2.5mg/mL SDS solution....................................................44
Figure 3.11b, Normal phase HPLC chromatograms of methylparaben: the top
xii

chromatogram is the standard solution with drug concentration of
86ug/mL; the bottom curve is the saturated drug in dodecane.....................44
Figure 3.12a, Reverse phase HPLC chromatograms of ethylparaben: the top
chromatogram is the standard solution with drug concentration of
91ug/mL; the bottom curve represents 20 times dilution of the
saturated drug in 2.5mg/mL SDS solution....................................................44
Figure 3.12b, Normal phase HPLC chromatograms of ethylparaben: the top
chromatogram is the standard solution with drug concentration of
87ug/mL; the bottom curve is the saturated drug in dodecane.....................44
Figure 3.13a, Reverse phase HPLC chromatograms of butylparaben: the top
chromatogram is the standard solution with drug concentration of
87ug/mL; the bottom curve represents 15 times dilution of the
saturated drug in 2.5mg/mL SDS solution....................................................45
Figure 3.13b, Normal phase HPLC chromatograms of butylparaben: the top
chromatogram is the standard solution with drug concentration of
90ug/mL; the bottom curve is 3 times dilution of the saturated
drug in dodecane...........................................................................................45
Figure 3.14, Solubilities of 4 model steroids as a function of SDS concentration............51
Figure 3.15, Solubilities of 4 model steroids as a function of DTAB concentration.........51
Figure 3.16, Solubilities of four model steroids as a function of DM concentration........52
Figure 3.17, Solubilities of four benzodiazepines as a function of SDS concentration.....52
Figure 3.18, Solubilities of four benzodiazepines as a function of DTAB
concentration.................................................................................................53
Figure 3.19, Solubilities of four benzodiazepines as a function of DM concentration.....53
Figure 3.20, Solubilities of three parabens as a function of SDS concentration...............54
Figure 3.21, Solubilities of two parabens as a function of DTAB concentration..............54
Figure 3.22, Solubilities of two parabens as a function of DM concentration..................55
Figure 3.23, The relationships between hydrocarbon/water partition coefficient, Kh/w,
and micelle/water partition coefficient, Km/w, in aqueous SDS solutions
for three series of drugs, steroids, benzodiazepines and parabens................57
Figure 3.24, Solubilities of progesterone and diazepam as a function of SDS
concentration in the absence and presence of 0.15M NaCl..........................60
Figure 3.25, Solubilities of progesterone and diazepam as a function of DTAB
concentration in the absence and presence of 0.15M NaCl..........................60
Figure 3.26, Solubilities of progesterone and diazepam as a function of DM
concentration in the absence and presence of 0.15M NaCl..........................61
Figure 3.27, Solubilization results of methylparaben in three surfactant systems,
SDS (square), DTAB (triangle) and DM (circle), in the absence and
presence of 0.15N NaCl................................................................................61
Figure 4.1, A schematic of the duNouy ring method. The ring is pulled up through
the oil/water interface with a force F that is proportional to the
xiii

interfacial tension..........................................................................................67
Figure 4.2, Surface tension vs. concentration of SDS in aqueous solutions before
and after purification by solid adsorption method. Some error bars
are smaller than the symbols.........................................................................70
Figure 4.3, Surface tension vs. concentration of DTAB in aqueous solutions
before and after purification by solid extraction method..............................70
Figure 4.4. Surface tension vs. concentration of dodecyl -D-maltoside in aqueous
solutions........................................................................................................71
Figure 4.5, HPLC chromatograms of progesterone before (upper curve) and after
(lower curve) purification. The arrow shows the main progesterone
elution band...................................................................................................73
Figure 4.6, HPLC chromatograms of testosterone before (upper curve) and after
(lower curve) purification. The arrow shows the main testosterone
elution band...................................................................................................73
Figure 4.7, The experimental oil/water interfacial pressure in the presence of sodium
alkyl sulfate surfactants as a function of area per surfactant molecule
by Haydon and Taylor (Haydon and Taylor, 1960). The solid curve
is fitted according to Eq. (A1.13)..................................................................82
Figure 4.8, The experimental oil/water interfacial pressure in the presence of alkyl
trimethylammonium bromide surfactants as a function of area per
surfactant molecule by Haydon and Taylor (Haydon and Taylor, 1960).
The solid curve is fitted according to Eq. (A1.13)........................................82
Figure 4.9, Dodecane/water interfacial tension as a function of dodecyl
-D-maltoside concentration in water. The solid line is the fitted
theoretical curve............................................................................................85
Figure 4.10, Dodecane/water interfacial tension as a function of progesterone
concentration in water. The solid line is the fitted theoretical curve............86
Figure 4.11, Dodecane/water interfacial tension as a function of testosterone
concentration in water. The solid line is the fitted theoretical curve............86
Figure 4.12, Comparison between experimental and theoretical fitted
dodecane/water interfacial tensions in the presence of pure surfactants
(SDS, DTAB or DM) or pure steroids (progesterone or testosterone)..........89
Figure 4.13, Comparison between experimental and predicted dodecane/water
interfacial tensions in the presence of both surfactants (SDS, DTAB
or DM) and model steroids (progesterone or testosterone)..........................91
Figure 5.1. Correlation between logarithm of micelle/water partitioning
coefficient for SDS, Km/w, and logPoctanol/water. The solid line is from
Treiner and Mannebach (Treiner and Mannebach, 1987) and the
dotted line is from Valsaraj and Thibodeaux (Valsaraj and
Thibodeaux, 1990). The plotted points are experimental data taken
from the present work in Tables 3.2~3.4......................................................97
xiv

Figure 5.2, Dodecane/water interfacial tension as a function of time before and
after purification of dodecane.....................................................................100
Figure 5.3, Dodecane/water interfacial tensions as a function of drug concentration
in aqueous phase for 3 model steroids. The markers are experimental
data and the solid lines are fitted curves based on surface adsorption
model, Eq.(A1.8).........................................................................................103
Figure 5.4, Dodecane/water interfacial tensions as a function of drug concentration
in aqueous phase for 3 model benzodiazepines. The markers are
experimental data and the solid lines are fitted curves based on
surface adsorption model, Eq.(A1.8)..........................................................103
Figure 5.5, Dodecane/water interfacial tensions as a function of drug concentration
in aqueous phase for 3 model parabens. The markers are experimental
data and the solid lines are fitted curves based on surface adsorption
model, Eq.(A1.8).........................................................................................104
Figure 5.6, Dodecane/water interfacial tension as a function of drug concentration
in aqueous phase for 17-estradiol and oxazepam. The markers are
experimental data and the solid lines are fitted curves based on
surface adsorption model, Eq.(A1.8)..........................................................104
Figure 5.7, A schematic of relationship between the two key parameters of drug
substances,

G waterinterface a drug
,
and the oil/water interfacial

tension versus drug concentration (a) or logarithm of drug
concentration (b).........................................................................................105
Figure 5.8, Summary of dodecane/water interfacial tensions as a function of
drug concentration in aqueous phase for 9 model drugs. All curves
are experimental data in the absence of fitted theoretical lines..................108
Figure 5.9, Comparison between experimental and predicted micelle/water
partitioning coefficients (Km/w) of 9 model drugs in 3 surfactant
systems........................................................................................................115
Figure 5.10, The sensitivity of calculated micelle/water partitioning coefficient
in SDS micelle systems to the radius of SDS micelles. The arrow
marks the radius employed in the evaluation of the thermodynamic
model, Table 5.3..........................................................................................123
Figure 5.11, The sensitivity of calculated micelle/water partitioning coefficient
in DTAB micelle systems to the radius of DTAB micelles. The
arrow marks the radius employed in the evaluation of the
thermodynamic model, Table 5.3................................................................123
Figure 5.12, The sensitivity of calculated micelle/water partitioning coefficient
in DM micelle systems to the radius of DM micelles. The arrow
marks the radius employed in the evaluation of the thermodynamic
model, Table 5.3..........................................................................................124
xv

Figure 5.13a,b, The ratio of calculated micelle/water partitioning coefficient
(Km/w) using varying parameter, adrug, and the micelle/water
partitioning coefficient (Km/w,0) using experimentally determined
interfacial area occupied by drugs (adrug). Four groups of adrug
values were chosen: the maximum and minimum interfacial areas,
±10% variations from adrug,exp. (a) Another parameter, Gtrans, was
allowed to vary with changing adrug to best fit the oil/water interface
adsorption experiment of drugs (Fig. 5.3~5.5); (b) The parameter
Gtrans was fixed with changing adrug in the calculations of Km/w.............138
Figure 5.14, Experimental and predicted solubilization isotherms for methylparaben
in SDS micelles. Experimental data are from Goto and Endo (Goto
and Endo, 1978)..........................................................................................141
Figure 5.15, Experimental and predicted solubilization isotherms for ethylparaben
in SDS micelles. Experimental data are from Goto and Endo (Goto
and Endo, 1978)..........................................................................................141
Figure 5.16, Experimental and predicted solubilization isotherms for butylparaben
in SDS micelles. Experimental data are from Goto and Endo (Goto
and Endo, 1978)..........................................................................................142
Figure 5.17, Comparison between experimental and predicted micelle/water
partitioning coefficients (Km/w) of 9 model drugs in 3 surfactant
systems under saturated condition of drugs................................................147
Figure 5.18, Predicted and experimental CMCs of SDS as a function of drug
concentration in aqueous solutions. The experimental data are
from Goto and Endo (Goto and Endo, 1978)..............................................149
Figure 6.1, (a) The molecular structure of prazepam extracted from reported
crystal structure (Allen, 2002) without coordinates of hydrogen
atoms; (b) The molecular structure in (a) was added with hydrogen
atoms using Hyperchem® software............................................................158
Figure 6.2, The optimized molecular structure of butylparaben using
Hartree-Fock /6-31G** method with the aid of Gaussian03®
program (Frisch et al., 2003).......................................................................159
Figure 6.3, The comparisons between calculated and experimental occupied
volumes by isolated model drug molecules. The calculated occupied
volumes were based on a cut-off electron density of 0.00065e/bohr3........162
Figure 6.4, The orientations of progesterone when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
is 104.4Å² and the minimum projected area is 39.6 Å².
The scales of axes have a unit of Å.............................................................164
Figure 6.5, The orientations of testosterone when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
xvi

illustrated using a blue color plane. The maximum projected area
is 95.8Å² and the minimum projected area is 39.5Å². The
scales of axes have a unit of Å....................................................................164
Figure 6.6, The orientations of 11-hydroxyprogesterone when it occupies the
maximum (a) and minimum (b) areas at the oil-water interface
which is illustrated using a blue color plane. The maximum
projected area is 104.8Å² and the minimum projected area is
40.2Å². The scales of axes have a unit of Å................................................165
Figure 6.7, The orientations of 17-estradiol when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
is 95.8Å² and the minimum projected area is 38.3Å². The
scales of axes have a unit of Å....................................................................165
Figure 6.8, The orientations of diazepam when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated
using a blue color plane. The maximum projected area is 86.2Å²
and the minimum projected area is 42.7Å². The scales of axes have
a unit of Å...................................................................................................166
Figure 6.9, The orientations of temazepam when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated
using a blue color plane. The maximum projected area is 84.9Å²
and the minimum projected area is 45.5Å². The scales of axes
have a unit of Å...........................................................................................166
Figure 6.10, The orientations of prazepam when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
is 86.4Å² and the minimum projected area is 50.9Å². The scales
of axes have a unit of Å..............................................................................167
Figure 6.11, The orientations of oxazepam when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
is 83.7Å² and the minimum projected area is 44.8Å². The scales
of axes have a unit of Å..............................................................................167
Figure 6.12, The orientations of methylparaben when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
is 62.0Å² and the minimum projected area is 24.5Å². The scales
of axes have a unit of Å..............................................................................168
Figure 6.13, The orientations of ethylparaben when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
xvii

is 70.6Å² and the minimum projected area is 25.6Å². The
scales of axes have a unit of Å....................................................................168
Figure 6.14, The orientations of butylparaben when it occupies the maximum (a)
and minimum (b) areas at the oil-water interface which is
illustrated using a blue color plane. The maximum projected area
is 82.9Å² and the minimum projected area is 25.4Å². The scales
of axes have a unit of Å..............................................................................169
Figure 6.15, A schematic of orientations of three series of model drugs at oil/water
interface. The molecules of model drugs are illustrated using
ellipsoids that have long and short axes reflecting molecular shapes.
The small circles represent the hydrophilic functional groups...................172
Figure 7.1, The schematics of pulse sequences used in NOESY and ROESY
experiments.................................................................................................179
Figure 7.2, Schematics of nonstimulated and stimulated PGSE NMR sequences
used in diffusivity measurements. The shaded bars represent the
magnetic field gradient (along z direction) pulses with duration,
, and intensity, g........................................................................................181
Figure 7.3, ROESY of 3.5mg/mL 11-hydroxyprogesterone in 15mg/mL SDS............187
Figure 7.4, ROESY of 1.9mg/mL 11-hydroxyprogesterone in 20mg/mL DTAB.........187
Figure 7.5, ROESY of 4.9mg/mL methylparaben in 15mg/mL SDS. The
interested cross-peaks are labeled using arrows...’’’...................................190
Figure 7.6, A schematic of inter-molecular interactions between methylparaben
and SDS molecules detected by ROESY experiments (Fig. 7.5)...............190
Figure 7.7, ROESY of 6.7mg/mL methylparaben in 20mg/mL DTAB. The
interested cross-peaks are labeled using arrows.........................................192
Figure 7.8, A schematic of inter-molecular interactions between methylparaben
and DTAB molecules detected by ROESY experiments (Fig. 7.7)............192
Figure 7.9, NOESY of 3.7mg/mL methylparaben in 20mg/mL DM. The
interested cross-peaks are labeled using arrows.........................................193
Figure 7.10, A schematic of inter-molecular interactions between methylparaben
and DM molecules detected by NOESY experiments (Fig. 7.9)................193
Figure 7.11, ROESY of 3.7mg/mL ethylparaben in 15mg/mL SDS. The
interested cross-peaks are labeled using arrows.........................................195
Figure 7.12, A schematic of inter-molecular interactions between ethylparaben
and SDS molecules detected by ROESY experiments (Fig. 7.11).............195
Figure 7.13, ROESY of 5.8mg/mL ethylparaben in 20mg/mL DTAB. The
interested cross-peaks are labeled using arrows.........................................196
Figure 7.14, A schematic of inter-molecular interactions between ethylparaben
and DTAB molecules detected by ROESY experiments (Fig. 7.13)..........196
Figure 7.15, ROESY of 5.0mg/mL butylparaben in 15mg/mL SDS. The
interested cross-peaks are labeled using arrows.........................................198
xviii

Figure 7.16, A schematic of inter-molecular interactions between butylparaben
and SDS molecules detected by ROESY experiments (Fig. 7.15).............198
Figure 7.17, ROESY of 3.8mg/mL diazepam in 15mg/mL SDS. The interested
cross-peaks are labeled using arrows..........................................................200
Figure 7.18, A schematic of inter-molecular interactions between diazepam and
SDS molecules detected by ROESY experiments (Fig. 7.17)....................200
Figure 7.19, ROESY of 4.4mg/mL temazepam in 15mg/mL SDS. The
interested cross-peaks are labeled using arrows.........................................201
Figure 7.20, A schematic of inter-molecular interactions between temazepam
and SDS molecules detected by ROESY experiments (Fig. 7.19).............201
Figure 7.21, ROESY of 1.6mg/mL temazepam in 20mg/mL DTAB. The
interested cross-peaks are labeled using arrows.........................................203
Figure 7.22, A schematic of inter-molecular interactions between temazepam
and DTAB molecules detected by ROESY experiments (Fig. 7.21)..........203
Figure 7.23, Diffusivities of progesterone, diazepam and butylparaben as a
function of drug concentration in 15mg/mL SDS solutions in the
absence and presence of 0.15M NaCl.........................................................207
Figure 7.24, Diffusivities of progesterone and diazepam as a function of drug
concentration in 20mg/mL DTAB solutions in the absence and
presence of 0.15M NaCl.............................................................................207
Figure 7.25, Diffusivities of butylparaben as a function of drug concentration
in 20mg/mL DTAB solutions......................................................................208
Figure 7.26, Diffusivities of DM as a function of drug concentration in 20mg/mL
DM solutions in the absence and presence of 0.15M NaCl. Two
model drugs, progesterone and diazepam, were used.................................211
Figure 7.27, Diffusion coefficients of methylparaben in D2O as a function of
drug concentration......................................................................................215

xix

Chapter 1
Statement of Problem and Aims

Poor water solubility is a major limiting factor to the development of many
pharmacotherapeutic agents.

Micelles are well known to enhance the aqueous solubility

of poorly-water soluble drugs and thus have the potential to enable drug delivery by the
parenteral or oral routes.

At present, fundamental understanding of the solubilization

mechanism by micelles is lacking.

As a consequence, the enhancement of drug delivery

employing micelles has not reached its full potential.

The goal of this dissertation is to provide a molecular-level understanding of the
mechanism by which micelle systems solubilize drug molecules. Specifically, the
location and orientation of the drug molecules in micelle systems will be determined; the
amount of the solute molecules in specific micelle systems could be predicted based on
the interactions between solutes and surfactants in micelles. The mechanistic
understanding of which micelle system could best solubilize a specific drug candidate can
provide a guideline for selecting the optimal solubilizing ingredients and greatly speed up
the drug formulation process.

The major hypothesis to be tested is: It is possible to predict micelle/water partitioning by
accounting for solute-surfactant interactions that lead to localization at the micelle
surface.

The specific aims employed to test this hypothesis are as follows:
1. Demonstrate that solubilization of model drugs in the core of the micelles is
insufficient to predict micelle/water partitioning of the drugs.
1

2. Show experimentally that competition does occur between hydrophobic solutes and
surfactants for a model oil/water interface.
3. Evaluate the ability of a surface-localized thermodynamic model to account for
experimentally-determined micelle/water partitioning.
4. Determine the orientations of model drugs at the micelle surface by matching the
calculated interfacial areas occupied by drugs at the oil/water interface to the
experimental values.
5. Employing NMR spectroscopic techniques, probe the nature of the solute-surfactant
molecular interactions in the micelles with the goal of determining how interactions will
govern molecular location/orientation and thus solubilization of drugs.

Copyright © Shaoxin Feng 2009
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Chapter 2
Background and Literature Review

2.1.

Introduction

It has been estimated that 40 to 60 % of new drug candidates entering drug development
programs possess poorly aqueous solubility. Poor solubility presents a major challenge
for pharmaceutical formulation of both oral and parenteral products. The formulation
scientist is often faced with the difficult task of either increasing the dissolution rates or
enhancing the aqueous solubility of those poorly soluble drug candidates.

The importance of solubility has long been recognized by official compendia, such as the
USP (USP, 2009). There are several ways to express absolute solubility of a solute, such
as the number of parts of solvent required to dissolve one part of solute. For
biopharmaceutical purposes, a solubility descriptor focusing on the clinical dose is
appropriate. Based on biopharmaceutical classification system (BCS) (Amidon et al.,
1995), a drug candidate is considered to have adequate solubility when its highest dose
could be dissolved in 250mL or less of buffer within pH 1~7.5. If more than 250mL is
required the drug candidate is defined as poorly soluble. BCS classifies drug candidates
into 4 categories in terms of their aqueous solubilities and permeabilities through
biological membrane (Figure 2.1). Class I drugs are both highly soluble and highly
permeable and tend to have good oral bioavailabilities, assuming no issues with first-pass
metabolism or chemical stability. Class II drugs have bioavailabilities limited by poor
solubility. Poor solubility is also one characteristic of Class IV drugs as well. Formulation
methods that enhance solubility could “move” class II drug candidates (low solubility,
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High solubility
High permability

Class II
Low solubility
High permability

Permeability

Solubilization

Class III
High solubility
Low permability
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Low solubility
Low permability

Solubility

Figure 2.1 A schematic of biopharmaceutical classification system (BCS) (Adapted from
Amidon et al. (Amidon et al., 1995)). Solubilization could shift BCS class II drug
candidates into the BCS class I region.
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high permeability) into class I (high solubility, high permeability) and enhance the
corresponding bioavailabilities.

2.2.

Means of Solubilization

There are many techniques used to improve aqueous solubility, such as pH adjustment,
salt formation, co-solvents, complexation, amorphous solids and lipid assemblies
(Yalkowsky, 1999). The techniques could be employed individually or in combination to
provide synergistic effect of solubility enhancement (Li et al., 1999a; Li et al., 1999b; Li
et al., 1998; Tongeree et al., 1999; Viernstein et al., 2003; Kawakami et al., 2004). All
these methods are successful to some extent or another, but all do have disadvantages for
oral or parenteral administration. Altering pH or salt formation makes use of higher
solubility of ionic form of solute which could be obtained by decreasing pH for weak
bases or increasing pH for weak acids, but the methods has potential issues of chemical
stability of drugs and biocompatibility of pH extremes. Co-solvents technique uses the
mixture of water and physiologically-acceptable organic solvents, such as propylene
glycol, ethanol, glycerin etc., to improve solubility, but has the issue of pharmacological
effect of organic solvents and possible precipitation of drugs upon dilution. Complexation
could shift monomer forms of drugs into complexes with complexing agents, usually
cyclodextrin, and improve solubility.

The structure of drug must be such so as to

interact strongly with the complexing agent. Slow releasing rate of drugs from the
complexes is another potential limiting issue. Amorphous solids could be applied to
enhance the “solubility”, as defined using free energy difference between amorphous and
crystal form (Hancock and Parks, 2000), because of the higher free energy of the
amorphous state. On the other hand, the high free energy of amorphous solids exhibit
poor long term physical/chemical stability.

Lipid assemblies make use of higher

solubility of hydrophobic drugs in biocompatible lipid assemblies but excipient selection
and drug releasing profiles are not yet well understood.
5

2.3.

Family of Lipid Assemblies

One of the advantageous characteristics of the use of lipids to enhance the solubility of
drugs in dosage forms is the wide variety of lipid assemblies that can be formed in an
aqueous environment. The properties of lipid assemblies are modified by changing the
composition of their components: water, surfactant, oil, and in some cases co-solvent.
Figure 2.2 shows a general schematic phase diagram of lipid assemblies adapted from
Bummer (Bummer, 2004). Lipid assemblies included here are micelles, mixed micelles,
microemulsions, emulsions, liposomes, solid lipid nanoparticles, and self-dispersing
systems. In all cases, the assemblies provide micro-environments that help solubilize
drug molecules of varying properties. For example, micelles, as aggregations of
surfactant molecules, may be treated as a separate phase when the surfactant
concentration was above critical micelle concentration (CMC) in the absence of oil.
Emulsions/microemulsions have oil-in-water or water-in-oil form depending on the
surfactant properties and oil/water ratio. Liposomes use phospholipids bi-layer as the
primary structure and may be classified as small unilamellar vesicles (SUV, size~50nm),
large unilamellar vesicles (LUV, size 100~1000nm), multilamellar vesicles (MLV) and
multivesicular liposomes (MVL) types. The drug molecules could be solubilized or
loaded inside the liposomal vesicles or on lipid bi-layer membranes.

As indicated in Figure 2.2, the surfactant is a critical component of any lipid assemblies.
Surfactant, as an abbreviation of “surface active agent”, is an organic compound that is
amphiphilic comprising both hydrophilic groups (commonly referred to as “heads”) and
hydrophobic groups (“tails”). Based on the electron charges of the hydrophilic head
groups, surfactant are classified into 4 categories: anionic surfactants, such as sodium
dodecyl sulfate (SDS), cationic surfactants, such as cetyl trimethylammonium bromide
(CTAB), nonionic surfactants, such as polysorbate 80, and amphoteric (zwitterionic)
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Figure 2.2 A schematic of phase diagram of lipid based systems. Adapted from Bummer
(Bummer, 2004)
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surfactants, such as phospholipids that contain anionic phosphate groups and cationic
ammonium groups. In pharmaceutical preparations, the surfactants or any other
excipients selected are often limited to be generally regarded as safe (GRAS) materials
by Food and Drug Administration (Smolinske, 1992). Especially the use of the cationic
agents is limited to topical antimicrobial preservatives rather than solubilizing agents
because organic cations can be adsorbed at cell membrane in a nonspecific manner
resulting in cell lysis. Anionic agents generally result in less hemolysis and SDS has been
widely used as wetting agent, emulsifier and solubilizer in oral solid dosage forms.
Zwitterionic surfactants, such as phospholipids, usually exhibit good biocompatibility.
Phospholipids are mainly used to form liposomes that are often effective drug delivery
systems for poorly soluble drugs and have controlled releasing profile and targeting
capability (Joguparthi, 2007). Nonionic surfactants generally have the least toxicity
profile and thus are the major class of surfactants used in pharmaceutical system through
both oral and parenteral routes. Most commonly used nonionic surfactants have
polyethylene glycol (PEG) chains as parts of hydrophilic heads, e.g. trade-marked
products Tween series, Brij series, Cremophor EL and RH, TPGS etc.. Besides the
solubilization function of PEGylated head groups, the PEG brushes on particle surfaces
are believed to prevent the phagocytosis by blocking opsonins binding and increase the
lifetime of the drug delivery vehicles in systemic circulation when administered
parenterally (Allen et al., 1991).

Surfactants may also be classified in terms of technical applications. Each surfactant may
be assigned a hydrophile-lipophile balance (HLB) value indicative of the relative polarity
of parts of the molecules (Griffin, 1949; Griffin, 1954). The HLB value, as originally
defined for nonionic surfactants, is weight percentage of hydrophilic groups (usually refer
to polyethylene glycol) divided by 5 to narrow the range of values. Some ionic
surfactants, such as SDS, could have greater HLB values than the theoretical maximum
8

number (20) because their hydrophilic behavior of the anionic head exceeds the
polyethylene glycol group alone. HLB system is quite useful in assigning the major
functions of surfactants: surfactants with HLB values between 3 and 6 are mainly used as
water-in-oil emulsifiers; agents with HLB 8~18 are good oil-in-water emulsifiers; wetting
agents usually have a HLB from 7 to 9; surfactants having HLB 15~20 can be used as
solubilizers (Ansel et al., 1995).

Again referring to Figure 2.2, the oil is also a critical component of many (but not all)
lipid assembly dosage forms. The oil phase of lipid assemblies is often a glyceride
derived from plant sources, purified and chemically modified, either by PEGylation or
hydrogenation to decrease the degrees of unsaturation for protection from oxidation.
Typically triglycerides could be classified into 3 categories: short chain (<5 carbons),
medium chain (6~12 carbons) and long chain (>12 carbons) for fatty acid portion. In
commercial application of lipid-based delivery systems, the most frequently used oils are
medium-chain (e.g. coconut oil, palm seed oil, etc.) and long-chain (e.g. corn oil, soybean
oil, olive oil, sesame oil etc.) triglycerides because those oils could provide desirable
physical and drug absorption properties (Hauss, 2007). Typically, triglycerides are
employed, but a wide variety of commercially-modifed di- and mono-glycerides are also
available.

2.4.

Examples in the Literature of Use of Lipid Assemblies in Drug Delivery

Lipid-based drug delivery systems have received considerable interest in the recent years
(Hauss, 2007; Pouton, 1997; Grove and Mullertz, 2007) because of their advantages in
enhancing bioavailability of poorly-soluble hydrophobic drugs and possessing good
biocompatibility. Besides the solubility improvement of poorly-soluble drugs by
lipid-based system, there are several other factors that could help further increase the
bioavailability and decrease the variability of absorption of poorly-soluble drugs: (1)
9

Some excipients such as Cremophor may increase absorption of drugs by inhibiting
P-glycoprotein-mediated

drug

efflux

and/or

metabolism

by

GIT

(GI

tract)

membrane-bind-cytochrome enzymes (Dintaman and Silverman, 1999; Chervinsky et al.,
1993; Wandel et al., 2003). (2) Lymphatic transport could be promoted by long chain
triglyceride, which delivers drug into lymph before entering the systemic circulation
while avoiding hepatic first-pass metabolism (Khoo et al., 2003; Holm et al., 2003). (3)
Permeability of drug through GIT membrane can be enhanced by surfactants through
interfering with epithelial cell membrane (Whitehead and Mitragotri, 2008; Kitagawa and
Ikarashi, 2003).

On the pharmaceutical market, there are already some commercially available
formulations applying lipid based drug delivery systems through oral and parenteral
routes (Strickley, 2004). For example, immunosuppressant cyclosporin A/Sandimmune®
(Novartis)

is

formulated

into

oral

soft

gelatin

capsules

with

Labrafil

M-2125CS(surfactants) and corn oil; Anti-HIV drugs lopinavir & ritonavir/Kaletra®
(Abbott) are formulated into oral soft gelatin capsules with oleic acid(oils) and
Cremophor EL(surfactants); Antifungal antibiotics amphotericin B/Abelcet® (Enzon)
employs liposomal formulations through IV injection using two kinds of phospholipids
(dimyristoylphosphatidylcholine

and

dimyristoylphosphatidylglycol).

Based

on

Strickley’s survey on three markets, lipid-based system has occupied 3% (27 out of 839
products) of current drug market in the United States, 2% (21 out of 1254 products) in the
United Kingdom, and 4% (8 out of 200 products) in Japan (Strickley, 2007).

2.5.

Micelles as Drug Delivery Systems

Micelles are among the oldest lipid-based drug delivery systems. The earliest
pharmaceutical application of micelles as solubilization agents was using soap solutions
to solubilize cresols in preparation of Saponated Solutions of Cresol, U.S.P. and Lysol,
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B.P. at the end of 19th century (Sjoblom, 1967). Surfactants, as emulsifying agents, had
been applied in pharmaceuticals even earlier (Fishbein, 1945). It was not until 1950s that
the pharmaceutical applications of micellar solubilization had received systematic
attention (Sjoblom, 1967) and became extensively studied afterwards. In the current
pharmaceutical market, many products use micelles as the drug delivery systems. For
examples: anti-cancer drug paclitaxel/Taxol® (Bristol-Myers Squibb) uses Cremorphor
EL micelles as the major delivery vehicles through IV infusion; Dutasteride/Avodart®
(Glaxo SmithKline) is formulated into gelatin capsule that could form mixed micelles of
mono- and diglycerides of caprylic/capric acid upon oral administration.

There are many advantages of micelles as a practical drug delivery system other than
solubilization of poorly soluble drugs: micelles are thermodynamic stable (McBain and
McBain, 1936); micelles may protect some unstable drugs from chemical degradation
when the vulnerable functional groups of the drug are hided in the core region (Rodriguez
et al., 2008); some polymeric micelles have tumor targeting function through enhanced
permeation and retention (EPR) effect (Rangel-Yagui et al., 2005).

Micelles could also play an important role in other lipid-based delivery systems, such as
self-emulsifying drug delivery system (SEDDS). Emulsions or microemulsions are
formed by diluting SEDDS with aqueous fluids in GI tract. The digestability of the lipid
component is thought to be essential in the drug release and absorption because
indigestible lipids, such as paraffin oil, often actually inhibit the drug absorption by
keeping the drug within the lipophilic reservoir (Palin and Wilson, 1984). The lipid
digestion, mainly through lipolysis, will hydrolyze triglycerides to mono- or diglycerides
and fatty acids that form mixed micelles with phospholipids and bile salts (Zangenberg,
2001a; Zangenberg, 2001b). The drugs solubilized in the mixed micelles are readily
absorbed because of the large surface/volume ratio and fast exchange rate of the
11

monomers in and out of the micelles. The amount of the drug that could be solubilized in
the mixed micelles would be critical in drug absorption.

2.6.
2.6.1.

Relevant Properties of Micelles
Physical and Chemical Properties of Micelles

There are several physicochemical properties of micelles that are critical in understanding
their thermodynamic and kinetic behaviors. Typically, micelles exhibit critical behavior,
that is, they form only when the concentration of the surfactant exceeds a characteristic
value. This critical micelle concentration (CMC) can be modified by temperature and by
the presence of other solutes. Micelles have a small size, normally around 5 to 100 nm
(Rangel-Yagui et al., 2005). Light-scattering (Anacker and Ghose, 1968), small angle
X-ray scattering (SAXS) (Svens and Rosenholm, 1973), small angle neutron scattering
(SANS) (Lin et al., 1990), pulse gradient spin-echo NMR (Soderman et al., 2004) and
other methods have been used to measure the micellar size and shape. Yalkowsky and
Zografi found most micelles likely assume a spherical shape when the aggregation
number, the number of surfactant molecules in the assembly, is below 100 (Yalkowsky
and Zografi, 1972). The aggregation number may be modified by changing surfactant
concentration or by other solutes (Turro and Yekta, 1978). At high surfactant
concentration corresponding to high aggregation number, micelles may be subjected to a
transition from spherical shape to elongated ellipsoidal shape (Imae et al., 1985;
Reiss-Husson and Luzzati, 1964; Lin et al., 1990).

The kinetics of association and disassociation of surfactants forming a micelle are usually
very rapid. The characteristic time for the surfactant monomers moving in and out of
micelle is typically in the range of 10-8 to 10-3s (Lindman and Wennerstrom, 1980). These
bring a practical issue of possible precipitation of solubilizate among dilution of
surfactants to below CMC that could affect drug performance. One exception is some
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polymeric micelle could have much longer lifetime, in the order of hours, in the
circulation system even the surfactant concentration is below CMC (Lavasanifar et al.,
2002; Adams et al., 2003).

The micellar surfaces are found to be highly hydrated based on both experiments
(Lindman and Brun, 1973; Mukerjee, 1964) and theoretical molecular dynamic
simulations (Tieleman et al., 2000). For example, the hydration numbers per surfactant
molecule in micelle are on the order of 9 for SDS, 5 for dodecyl trimethylammonium
chloride (Mukerjee, 1964) and 8.7 for sodium caprylate (Lindman and Brun, 1973).

2.6.2.

Molecular Organization in Micelles

The conventional representation of a micelle assumed the hydrocarbon chain was
all-trans and directed radially inward shown in Figure 2.3. Apparently all the chain
termini were located at the center of micelle which resulted in anomalously high density
that was not physically appropriate. Dill et al. introduced an interphase model to describe
the molecular arrangement in micelles that considered both chain continuity and steric
constraint (Dill and Flory, 1981; Dill, 1982; Dill et al., 1984). The SANS and 13C and 2H
NMR experiments supported the interphase model as opposed to the radial chain or oil
droplet models. The interphase model inferred disordered alkyl chains near the micelle
surface and much more ordered chains near the core of micelle. With rapid development
in computational power, more explicit micellar structure was explored using molecular
dynamic simulations (MacKerel, 1995; Bogusz et al., 2000; Moura and Freitas, 2005).
The radial density distributions from micelle center for hydrocarbon chain, head group
and water were clearly demonstrated. The interior of micelle was found to be less fluidic
for hydrocarbon and be void of water that all agreed with Dill et al. (Dill et al., 1984).
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Figure 2.3 Conventional representation of a micelle. The circles represent the hydrophilic
head groups of micelles, and the zigzags are the hydrocarbon chains of micelles.
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2.6.3.

Solubilization Capacity of Micelles

The surfactant solutions, such as soaps and bile salts, had been observed to be able to
increase the solubility of water insoluble substances in as early as 19th century (Persoz,
1846; Kuehne, 1868; Engler and Dierckhoff, 1892). It was until 1930s when the
solubilization phenomena by surfactants were rationalized using the hypothesis of the
formation of colloidal particles or micelles (Smith, 1932; Blitzinger and Beier, 1933;
McBain and McBain, 1936; Verzar, 1933). Hartley observed that solubilization of
trans-azobenzene in solutions of cetylpyridinium salts only occurred when the
concentration of surfactant was above the CMC (Hartley, 1938). Many studies have been
done on micellar solubilization of pharmaceuticals and there were many review
articles/book chapters covering the subject (Mulley, 1964; Sjoblom, 1967; Elworthy et al.,
1968; Attwood and Florence, 1983; Rosen, 1989; Christian and Scamehorn, 1995;
Yalkowsky, 1999).

Many factors had been found to be able to affect solubilization capacities of micelles,
such as hydrocarbon chain length and headgroup of surfactants, polarity and
hydrophobicity of solubilizates, temperature, pH, ionic strength, etc. Longer hydrocarbon
chain length of surfactant usually produces higher solubilization capacity. The more
nonpolar the solute, the more significant the increase in solubilization. For example, a
series of drugs was solubilized in polysorbate 20, 40, 60 and 80 and the solubilization
powers all increased to some extent with increasing the alkyl chain length of surfactants
(Sjoblom, 1967; Attwood and Florence, 1983; Ong and Tamoukian, 1988). The
solubilization capacity ratio between polysorbate 80 and polysorbate 20 systems had the
following ranking order: vitamin A palmitate (4.5) > estrone (1.9) > timobesome acetate
(1.6) > indomethacin (1.4). Vitamin A palmitate was apparently most nonpolar of the
tested solutes. Timobesome acetate and indomethacin, having more polar functional
groups, were most polar. When the alkyl chain length of surfactants was fixed, the
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hydrophilic head group could also affect the solubilization capacity and the trend
depended on the solute properties. Tokiwa (Tokiwa, 1968) used a series of surfactants
with same hydrocarbon chain length to solubilize hydrocarbon and nonpolar compounds.
Although it was expected that these solutes localized in the core of the miclle, Tokiwa
found the solubilizing powers of the surfactants in the order of anionic < cationic
<nonionic. For polar solutes that were solubilized in the palisade layer of the micelles, the
results were somewhat different. Shihab et al. (Shihab et al., 1979) solubilized
furosemide, a diuretic, in anionic SDS micelles, nonionic polysorbate 80 micelles and
PEG polymers and observed the ranking order of the solubilization capacity to be
SDS>polysorbate 80>PEG. With elevated temperature the micellar solubilization capacity
would usually increase (Lundberg, 1980; Saket, 1996) with some exceptions, e.g.,
benzocaine in polysorbate systems had lower solubilization power at higher temperature
(Hamid and Parrott, 1971). The complicated behavior was due to the two factors of the
solubilization power, intrinsic solubility and micelle-water partitioning, which may have
different trend with rising temperature: intrinsic solubility would increase with increasing
temperature while the micelle-water partitioning coefficient was usually decreased with
elevated temperature (Barry and El Eini, 1976; Saket, 1996). The overall effect depended
on the competition between the two factors.

The above studies, although experimental, mainly observe some qualitative correlation
between solubilization and varieties of micelle factors. Attempts to quantitatively predict
the solubilization capacity are mainly of three approaches: linear free energy relationship
(LFER), deconstruction method and thermodynamic modeling. Most commonly used
LFER based methods utilize a correlation between micelle/water partitioning coefficient,
Km/w, of the solubilizate with its octanol/water partitioning coefficient, Poct, in specific
surfactant systems. The following linear equation is employed:
log K m / w  A  B log Poct

(2.1)
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where A, B are constants and have different values for different surfactants. This
approach was applied to SDS (Valsaraj and Thibodeaux, 1990; Treiner and Mannebach,
1987), DTAB/CTAB (Treiner and Mannebach, 1987), polysorbate 80 (Alvarez-Munez
and Yalkowsky, 2000), bile salt (Wiedmann and Kamel, 2002) and bile salt/egg PC mixed
micelle (Wiedmann and Kamel, 2002) systems. Abraham et al. (Abraham et al., 1995)
extended the method to include the volume term of the solubilizate:
log K m / w  A  B log Poct  C  V x

(2.2)

where A, B, C are constants; Vx is the McGowan characteristic volume (McGowan, 1978)
of the solute. They also extended the LFER-based equation to express micelle/water
partitioning coefficient in SDS using the linear combination of a few molecular
descriptors of the solute, such as excess molar refraction, polarizability, hydrogen-bond
acidity and basicity, in the absence of logPoct parameter. Some other LFER approaches to
predict micelle/water partitioning considered the group contributions (Smith et al., 1987;
Jafvert et al., 1994). Those correlation methods could be employed to predict the
micelle/water partitioning of new compounds using their logP values and/or other solute
properties. As with most LFER methods, the approach is semi-empirical and depends
strongly on the training set of solubilizates.

The second method of predicting solubilization capacity is a deconstruction approach
(Malcolmson and Lawrence, 1993), where the micelle is broken down into component
parts.

Octadecene

was

used

to

simulate

the

inner

core

of

the

micelle;

dimethoxytetraethylene glycol (DMTG) was employed to simulate the poly(ethylene
oxide) mantle region of Brij 96 micelles. Solubilities in the component parts were
combined by weight fraction to predict micelle solubilization. This method could roughly
estimate the relative importance of two micellar regions, core and surface, in
solubilization. The overall prediction was not accurate. In addition, it may be difficult to
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identify suitable solvent counterparts for some micelle hydrophilic head groups, such as
that of SDS and DTAB.

The third method of predicting solubilization capacity is based on thermodynamic models
(Mukerjee and Cardinal, 1978; Mukerjee, 1979; Gumkowski, 1986). In a two-location
model, a micelle is divided into a core region that is hydrocarbon-like and a palisade
region representing the surface of the micelle. The micelle/water partitioning coefficient
of the solute could be expressed as the sum of two contributions from the two locations.
Based on the Mukerjee model on bulk phase and surface adsorption phase, the
micelle/water partitioning coefficient of solute could be expressed as:
K m / w  K m / w,core  K m / w, surface  K h / w exp  PV RT   Af

(2.3)

where Kh/w is the hydrocarbon/water partitioning coefficient; P is the Laplace pressure
(Mukerjee, 1979); V is the molar volume of the solute; R the ideal gas constant; T the
temperature. For the surface solubilization term,  is the surface excess of drugs on
hydrocarbon/water interface; A is the area per surfactant molecular on micellar surface; f
is a competition factor between surfactant and drug at hydrocarbon/water interface.

The method had been applied to many organic molecules with simple structures, such as
alkanols, ketones, amides and aromatics, in SDS and sodium decyl sulfate (SDeS)
micelle systems and the predicted results showed good agreement with experimental
values.

2.6.4.

Location of Solutes in Micelles

Micelles could solubilize water-insoluble drugs in a range of microenvironments, from
the hydrophobic core to the amphiphilic surface (palisade). Certainly then, the micellar
solubilization mechanism must be critically-related to the location of the drug in the
assemblies. The small size of these aggregates results in a very large surface-to-volume
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ratio, therefore, the surface region has to be considered in any mechanistic picture of
micellar solubilization. Many spectroscopic techniques, including fluorescence
quenching (Bromberg and Temchenko, 1999; Lebedeva et al., 2007) UV/visible
spectroscopy (Sabate et al., 2001; Goldenberg et al., 1993; Ramachandran et al., 1982;
Vermathen et al., 2000), small angle X-ray diffraction (Svens and Rosenholm, 1973;)
NMR (Nagaonkar and Bhagwat, 2006; Kim et al., 2001; Suratkar and Mahapatra, 2000;
Vermathen et al., 2000; Bratt et al., 1990), EPR (Yoshioka, 1979; Lebedeva et al., 2007),
and indirect method based on thermodynamic analysis (Mukerjee and Ko, 1992; Croy
and Kwon, 2005; Donbrow et al., 1967), had been employed to probe the locus of drug
solubilization in micelles. The field is too voluminous to review comprehensively and we
cover only some of the more important works below.

Bromberg and Temchenko (Bromberg and Temchenko, 1999) used fluorescence
spectroscopy combined with hydrophilic quenching (using Tl+ as quencher) technique to
probe the location of pyrene and steroids in Pluronic-poly(acrylic acid) micelles. They
concluded that pyrene was mainly solubilized in the micellar core while only 60% of
17-estradiol was located in the core region. Lebedeva et al. (Lebedeva et al., 2007)
applied EPR and time resolved fluorescence quenching techniques (using 5- and
16-doxyl stearic acid methyl esters as quenchers) to study the location of pyrene in
sodium dodecyl sulfate (SDS) micelles. At low aggregation number (N=53) of SDS
micelles 33% of pyrene was found in the core region and the fraction decreased to 25%
when the aggregation number was increased to 130. Sabate et al. (Sabate et al., 2001)
employed UV/visible spectroscopy method to study the solubilization site of pinacyanol
in DTAB, TTAB and HTAB micelles. They first built a correlation between ionization
constant pKa of the solute and dielectric constant  of bulk solvent. By measuring the
pKa of the solute in micelles using UV/vis method the effective dielectric constant of its
microenvironment was determined to be that between water and hydrocarbon, which
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indicated the solubilizate was on average located in an environment with characteristics
between micellar core and outer aqueous solution. Svens and Rosenholm (Svens and
Rosenholm, 1973) utilized small angle X-ray diffraction technique to examine the
locations of N,N’-dimethylaniline, decanol and p-xylene in sodium octanoate micelles by
measuring the radii of the core and polar (palisade) regions of the micelles.
N,N’-dimethylaniline was found at the polar layer because the radius of the polar region
increased in the presence of the solubilizate but the radius of the core was not affected by
the solubilization process. Based on the same principle, p-xylene was mainly solubilized
in the core region while the location of dodecanol was concentration-dependent.

NMR is an important technique in studying the location of solutes in micelles. The
technique includes approaches that focus on chemical shifts, spin-lattice /spin-spin
relaxation times, and intermolecular interactions based on 2D NMR spectra. Nagaonkar
and Bhagwat (Nagaonkar and Bhagwat, 2006) employed proton NMR spectroscopy to
detect the solubilization site of isophorone in SDS micelles. By monitoring the change of
chemical shifts of different protons in isophorone, part of the solute was not affected and
believed to be located in aqueous environment while remainder of the solute was affected
significantly indicating its location close to the micellar core. The NMR approach was
also focused on the chemical shifts of surfactant molecule, which were measured in pure
micelle system compared to those in micelle+solubilizate system. The largest change in
chemical shift of hydrogen atoms of surfactant molecules corresponds to the closest
contact to solute molecule. Using the position of those hydrogen atoms of the carbon
chain, the depth of penetration of the drugs into micelle core could be determined
(Suratkar and Mahapatra, 2000). 1H spin-lattice relaxation time (T1) and spin-spin
relaxation time (T2) could also be used in molecular location determination (Ueno and
Asano, 1997). In general, the relaxation rates depend on the motional behavior of
functional groups in solution where restricting motion corresponds to shorter relaxation
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time.

Ueno and Asano employed the relaxation time approach to study the orientation

of bile salt sodium glycochenodeoxycholate (NaGCDC) at the NaGCDC/octaoxyethylene
glycol mono n-decyl ether (C10E8) mixed micelle systems (Ueno and Asano, 1997). The
increased T1 and T2 values of 19-methyl group at lower mole fraction of NaGCDC
suggested 19-methyl group became free due to the hydrogen-bonding breakage between
two NaGCDC molecules in the mixed micelle. In contrast, the motion of 18-methyl
group was restricted at the lower mole fraction of NaGCDC. Those results suggested that
-plane of the bile salt oriented toward the water phase and the -plane together with
19-methyl group oriented toward the center of the core; the 18-methyl group was located
near the boundary between ethylene oxide and hydrocarbon chain of the C10E8 molecule
in mixed micelles. 2-Dimensional NMR, nuclear Overhauser effect spectroscopy
(NOESY) and rotating-frame Overhauser effect spectroscopy (ROESY) were applied to
detect inter-molecular interactions (Hawrylak and Marangoni, 1999; Matsuoka et al.,
2007; Heins et al., 2007; Bachofer et al., 1991). Hawrylak and Marangoni studied the
solubilization sites of butanol and benzene in SDS and DTAB micelles using NOESY
(Hawrylak and Marangoni, 1999). The cross peaks between -protons of the SDS and the
1-butanol molecule indicated the hydroxyl group of butanol was close to the headgroup
of SDS at the micelle surface. The cross peaks between the methyl protons of the butanol
and the hydrocarbon chain protons of SDS suggested the hydrocarbon chain of butanol
was pointed inwards towards the center of the micelle.

2D NMR method is highly specific on the inter-molecular interactions that provide
molecule level understanding of micellar solubilization. As of yet, the applications of the
technique to micellar solubilization of pharmaceuticals are limited (Matsuoka et al., 2007;
Heins et al., 2007). Applying 2D NOESY and ROESY NMR methods would be a
powerful tool to study the solublization of model drugs in micelle systems in order to
obtain microscopic information of micellar solubilization.
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As shown earlier, the groups of Bromberg (Bromberg and Temchenko, 1999) and
Lebedeva (Lebedeva et al., 2007) used fluorescence quenching method to determine the
pyrene to be in the micellar core or part in hydrocarbon core and part at the surface of
micelles. One reason for the controversies is the location of solutes has a subtle different
definition for different experimental technique. For thermodynamics based technique the
location is for the whole molecule: if one part of the molecule was at surface the whole
molecule is considered to be at surface. But for UV/vis, fluorescence and NMR methods
the location of drug is functional group specific: only the polar part or the fluorescent part
of the molecules is focused in ultraviolet or fluorescence spectroscopy respectively.
Hence, the conclusion about fractions of drug molecules located in different regions of
micelles would be different using different experiments. Thermodynamics based method
usually claim a larger fraction of solubilizates at the micellar surface compared to
spectroscopy based methods.

Mukerjee and Ko (Mukerjee and Ko, 1992) observed a significant discrepancy between
micelle/water and hydrocarbon/water partitioning coefficients of ethyl o-, m- and
p-aminobenzoates in a series of micelles (octyl glucoside, SDS, DM, zwig 3-12 and
HTAC): the micelle/water partitioning coefficients were much higher than the
hydrocarbon/water partitioning constants which indicated the core region was insufficient
to solubilize the drugs, i.e. the first term in Eq. 2.3 was negligible, and micelle surface
should be the major solubilization locus. Croy and Kwon (Croy and Kwon, 2005) studied
the micelle/water partitioning of nystatin in polysorbate 80 and cremophor EL systems as
a function of drug concentrations (solubilization isotherm). The results showed a good fit
with the Langmuir adsorption isotherm indicating the drug was solubilized at the
core-corona interface, in an adsorbed state.
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Based on those studies on solubilization sites in micelles, attempts have been mad to
correlate the locus of the solubilization and the chemical structures of the solubilizates:
Saturated aliphatic and alicyclic hydrocarbons that were nonpolar molecules were
solubilized in the inner core of the micelles (Rosen, 1989; Attwood and Florence, 1983;
Lindblom et al., 1973). Semi-polar or polar solubilizates, such as alkanols, acids, and
amines, were oriented radially in the micelle with the polar group at the micellar surface
(Rosen, 1989; Attwood and Florence, 1983; Lee et al., 1990; Christian and Scamehorn,
1995). For the aromatic hydrocarbons, such as benzene, naphthalene and pyrene, there is
still no general agreement regarding their loci in micelle systems (Mukerjee and Cardinal,
1978; Nakagawa, 1967; Eriksson and Gillberg, 1966; Bromberg and Temchenko, 1999;
Lebedeva et al., 2007). For example, Mukerjee and Cardinal (Mukerjee and Cardinal,
1978) showed a moderate surface activity of benzene at the heptane-water interface
which provided an explanation of its location mainly at the micellar surface (in the
“adsorbed” state). They also pointed out the hydrocarbon core could not provide
sufficient solubilization power based on the micelle-water and hydrocarbon-water
partitioning properties.

2.7.

Unanswered Questions

Controversy continues to surround the question s to the nature of the properties that
promote solute localization in the core. The weaker argument (covering narrow range
of solubilizate) is that only nonpolar molecules reside in the core region (Rosen, 1989;
Attwood and Florence, 1983). The stronger argument (covering a broader range of
solubilizates) suggests that hydrophobic molecules have a tendency to reside in the core,
in addition to other locations (Rangel-Yagui et al., 2005; Suratkar and Mahapatra, 2000).
Hydrophobic molecules often possess larger nonpolar regions with fewer polar functional
groups. Whether those small polar contributions would affect drug location in micelles
would be important to rational application of the dosage form.
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Mukerjee’s group have shown many organic molecules with simple chemical structures
exhibit some surface activities at oil-water interface. It is unclear whether hydrophobic
drug molecules with complicated chemical structures are surface active at oil/water
interface although they do not possess surface activity at water-/air interface. If so, further
studies of the strength of the surface activity, its correlation with chemical structures and
the interaction/competition between the drugs and surfactants at the oil-water interface as
a model micelle surface would provide deeper mechanistic understanding of micellar
solubilization process.

Mukerjee et al. had laid a solid foundation of applying thermodynamic model, especially
the surface adsorption model, to micellar solubilization mechanism studies. There are still
some questions to be clarified:

1) Most of the test solutes were organic molecules with simple chemical structures. One
exception was the solubilization studies on imaging probe molecules, OTEMPO and
TEMPO in SDS micelles (Pyter et al., 1982). The surfactants chosen were limited to SDS
and SDeS. It will be valuable to systematically study several series of drug molecules
with complicated structures in micelle systems with different electron charges.
2) One of the major assumptions in derivation of two-state model was the dilute condition
of solute. In many of the solubilization isotherm studies, the micelle/water partitioning
coefficient is significantly dependent upon solute concentration (Christian et al., 1986;
Lee et al., 1990; Goto and Endo, 1978). To remove the assumption, the micelle/water
partitioning at saturated concentration of drug would be important in pharmaceutical
applications where solute concentration is often high.
3) In the early two-state model studies, some controversial values for occupied areas at
the oil/water interface by solute molecules were employed, e.g. 17.4Å² was used for both
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benzene and pyrene molecules (Gumkowski, 1986). The area term is critical to predicting
the amount and the orientation of solute at oil/water interface. As we illustrate in Chapter
5, inaccuracies in the value of the occupied area can result in misinterpretation of the
solubilization data and weaken the strength of the model.

2.8.

Summary

Micelle solution is a practical means of enhancing the solubility of poorly-soluble drugs
and facilitating both administration and bioavailability.

While several general rules have been developed, at present the mechanism of
solubilization of poorly-soluble drugs by micelles is not understood. This lack of
fundamental knowledge forces formulators to adopt an inefficient and labor-intensive
search for the optimal combination of solubilizing ingredients. A mechanistic
understanding of which micelle system could best solubilize a specific drug candidate
would greatly speed up the drug formulation process.

Copyright © Shaoxin Feng 2009
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Chapter 3
Solubilization Capacity of Simple Micelle Systems and its Relation to the
Partitioning of Model Drugs between Hydrocarbon and Water.

3.1.

INTRODUCTION

The application of micelles as drug delivery vehicles has become increasingly popular
with growing number of commercially available products utilizing micelles in the
formulations. Even for conventional oral delivery vehicles, such as tablets and capsules,
when the formulations reach the gastrointestinal tract the bile salts/phospholipids mixed
micelles produced by the human body serve as a natural delivery system to help carry and
transport the drug molecules into systemic circulation. One of the important advantages
of micelles as drug delivery vehicles is their ability to enhance the solubility of poorly
water-soluble drugs which account for a significant fraction (>40%) of drug candidates.
Although micellar solubilization of drug substances has been studied for some time, and
many factors that influence the solubilization power of micelles have been identified, the
mechanism of the solubilization by micelles is not fully understood. The most notable
gap in our knowledge is the inability to predicting the amount of a drug solubilized in a
specific micelle system. This current work is designed to probe the solubilization
mechanism at the molecular level and in a quantitative manner.

To understand the mechanism by which micelles solubilize poorly water-soluble drugs,
one of the critical factors is the location of the drugs in micelles. It has been
well-recognized that micelles present at least two regions for drug solubilization, a
lipophilic “core” and an anisotropic “surface” region. The core is nonpolar and
hydrocarbon-like. The surface, called palisade region, may be likened to an interface
between oil (hydrocarbon) and aqueous phases. Many techniques, such as UV, NMR,
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fluorescence, etc., had been employed to study the location of drug substances in
difference micelle systems. In this study, a thermodynamics based model was employed
so as to evaluate the location of the drug and to provide quantitative partitioning
information of the drug in different regions.

We started with an assumption that poorly-water soluble drug molecules were mainly
solubilized in the core region of the micelle. The distribution of solutes between
hydrocarbon and water could then serve as a simulation of partitioning between micellar
core and aqueous phase. Experimentally, the hydrocarbon/water and the micelle/water
partitioning coefficients were measured and compared to each other. If the assumption
about micellar core as the solubilization region is true, the above two partitioning
coefficient would be comparable.

Related to the assumption of drugs solubilized in the core, another factor should be
considered: the Laplace pressure effect (Mukerjee, 1979; Gumkowski, 1986). As a result
of the presence of surface tension at the micelle surface and the small size of the micelle,
the micellar interior is subject to a Laplace pressure which is expressed as following:
P  2 r

(3.1)

where P is the Laplace pressure;  is the surface tension at micelle surface and r is the
micelle size. This equation is based on an assumption that the micelle has a spherical
shape. Since the solute molecule has to create a spatial vacancy at micelle core, it must
overcome a larger energy barrier under higher pressure. Therefore the presence of
Laplace pressure will lower the solubilization capacity of micelle core region. To quantify
the Laplace pressure effect, the following equation is applied:
K m / w  K h / w exp  PV RT 

(3.2)
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where Km/w is the micelle/water partitioning coefficient; Kh/w is the hydrocarbon/water
partitioning coefficient; V is the molar volume of the solute; R is the ideal gas constant
and T is the temperature.

Experiments on micelle/water and hydrocarbon/water partitioning were carried out to test
the accuracy of Eq. (3.2) in order to clarify whether the core region is the major locus of
the solubilization in micelles. In these studies, three independent series of drugs were
chosen as model solutes. In each series, 3 or 4 compounds were selected in order to probe
the effect of functional groups on solubilization phenomena. In sum total there were 11
compounds:

4

steroids

(progesterone,

testosterone,

17-estradiol

and

11-hydroxyprogesterone), 4 benzodiazepines (diazepam, temazepam, oxazepam and
prazepam) and 3 parabens (methylparaben, ethylparaben and butylparaben). The
chemical structures of those molecules are shown in Figure 3.1.

So as to cover a broad

range of micelle/water partitioning coefficient two series exhibit poor aqueous solubility
and the third series exhibits relatively higher solubility were employed. Three micelle
systems were employed as model simple micelle system: anonic sodium dodecyl sulfate
(SDS), cationic dodecyltrimethylammonium bromide (DTAB) and nonionic dodecyl
-D-maltoside (DM). All three surfactants have the same hydrocarbon chain length (12
carbons) and differ only by the charge on the headgroups. The chemical structures of the
surfactants are shown in Figure 3.2. An n-alkane, dodecane, was employed as a good
model of hydrocarbon as a simulation of micellar core since dodecane have the same
alkyl chain length with the hydrophobic tails of three model surfactants.

3.2.
3.2.1.

MATERIALS AND METHODS
Materials:

Progesterone (>99%), testosterone (>98%), 17-estradiol (>98%), diazepam, temazepam,
oxazepam, prazepam, methylparaben (>99%), ethylparaben (>99%), butylparaben
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Progesterone

Testosterone

17-estradiol
11-hydroxyprogesterone
Figure 3.1a The chemical structures of model steroids.
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Diazepam

Temazepam

Prazepam
Oxazepam
Figure 3.1b The chemical structures of model benzodiazepines.

Methylparaben
Ethylparaben
Butylparaben
Figure 3.1c The chemical structures of model parabens.
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Sodium dodecyl sulfate

Dodecyltrimethylammonium bromide

Dodecyl -D-maltoside

Figure 3.2 The chemical structures of model surfactants.
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(>99%), sodium dodecyl sulfate (>99%), dodecyltrimethylammonium bromide (>99%)
and dodecyle -D-maltoside (>98%) were obtained from Sigma-Aldrich (St. Louis, MO).
11-hydroxyprogesterone (>95%) was from Janssen Chimica (New Brunswick, NJ).

3.2.2.

Solubility Measurements in Aqueous Solutions:

The conventional shake-flask method was applied to measure the solubility of all model
drugs in aqueous solutions in the presence and absence of surfactant: An extra amount of
drugs was placed into aqueous solution with known concentration of surfactants and the
system was rotated for 3~5 days at room temperature (24±1oC) to reach equilibrium.
Solutions were filtered using 0.2m hydrophilic PTFE filter (Millipore Inc.) and the
filtrates were diluted appropriately and assayed for drug concentration determinations by
reverse phase HPLC methods (assays shown later in the chapter).

3.2.3.

Solubility Determinations in Hydrocarbon Solutions:

Dodecane was chosen as a model hydrocarbon medium. The conventional shake-flask
method was employed to measure the solubility of model drugs in dodecane: An excess
amount of drug was placed into dodecane and the system was rotated for 3~5 days at
room temperature (24±1oC) to reach equilibrium. Solutions were filtered using 0.2m
hydrophobic PTFE filter (Pall corp.) and the filtrates were diluted appropriately and
assayed for drug concentrations by normal phase HPLC methods (assays shown later in
the chapter).

3.2.4.

Micelle/water Partitioning Coefficient Determinations:

In a micelle-containing solution, drugs are dissolved both in the aqueous phase and in the
micelle solutions. If it is assumed that solubility in the aqueous phase is independent of
the presence of micelles, the total solubility of drug as a function of surfactant
concentration has the following relationship:
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S tot  S w  (Csurfactant  CMC ) * 

(3.3)

where Stot and Sw are total and aqueous solubilities of drug (mole fraction based);
Csurfactant and CMC are surfactant concentration and critical micelle concentration (CMC,
mole fraction based);  is the slope of the ascending line and is defined as solubilization
capacity (or solubilization power), in unit of moles of drug per mole of surfactant.

Under the condition where the surfactant concentration is much greater than the CMC, Eq.
(3.3) becomes:
S tot  S w  Csurfactant * 

(3.4)

If the micelle is considered as a “pseudo-phase”, a micelle/water partitioning coefficient,
Km/w, can be defined as mole fraction of drugs in micelles divided by the mole fraction of
drugs in aqueous phase. The relationship can be expressed as:
Km/w 

3.2.5.

   1

(3.5)

Sw

Hydrocarbon/water Partitioning Coefficient Determination:

In the literature, there are two methods that were used to determine the Kh/w, solubility
ratio and direct partitioning.

The solubility ratio (in mole fraction units) can be described by following equation:
Kh/w 

Sh
Sw

(3.6)

where Sh is the solubility of drugs in model hydrocarbon, dodecane. The solubility ratio
method assumes that both the aqueous phase and the oil phase act as near-ideal solutions
of the drug. For instance, the drug is assumed not to self associate in either phase. The
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method is also based on the assumption that saturated drugs have the same activities at
different media. This assumption may not be true when the drug molecule could form
different solvates in different media. One example is the testosterone crystal which has
anhydrous form in dodecane but forms a hydrate in aqueous media. In those cases where
the assumptions are not met, the direct partitioning method will be employed.

3.2.6.

Direct Partitioning Coefficient Determinations

A known amount of drug was placed into 1:1 (v/v) mixture of dodecane and water. The
system was rotated for 2 days and all the solid material was dissolved. The drug
concentrations in aqueous solutions and dodecane solutions were analyzed using reverse
phase HPLC and normal phase HPLC methods respectively. In some instances it was
necessary to dilute the sample prior to HPLC analysis.

The partition coefficient (direct) would be determined:

Kh w 

3.2.7.

conc. in hydrocarbo n
conc. in water

(3.7)

HPLC Methods

Waters HPLC system including 717plus autosampler, 610 pump and 486 UV detector
was employed in the reverse phase experiments. Waters LCMod1 HPLC system was
employed to run the normal phase measurements. SRI PeakSimple V3.21 software was
utilized to analyze the collected chromatograms. Column and samples were all held at
room temperature (24±1oC). All mobile phases were pre-mixed and degassed before use.
The assay protocols used in reverse phase and normal phase HPLC for all model drugs
are listed in Table 3.1. In the table, the retention times and the response factors of the
drugs are shown as well. All the assays were validated for precision and linearity test by
standard protocols. The measured drug concentrations were all within the linear range of
the respective calibration curves. No carry over was observed in any assays.
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The HPLC chromatograms for all the assays are shown in Figure 3.3~3.13. In a majority
of the chromatograms the peaks of the interested compounds exhibit symmetric shapes.
Only the normal phase HPLC assays for temazepam and oxazepam result in significant
tailing. These assays were not optimized in terms of the peak shape because there was
only one interested compound and no peak overlaps from other components.
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Table 3.1 Reverse phase and normal phase HPLC assays for all model drugs
Progesterone:
Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
95% hexane/ 5% 2-propanol

Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.5mL/min
11.1min
37.9±0.7

240nm
1.5mL/min
7.2min
50.0±0.7

Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
95% hexane/ 5% 2-propanol

Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.5mL/min
6.2min
43.6±0.2

240nm
1.5mL/min
9.1min
37.3±0.8

Column
Mobile phase

Reverse phase
Alltech® Alltima C18 5u
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
95% hexane/ 5% 2-propanol

Injection volume

20L

40L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

280nm
1.0mL/min
12.0min
7.56±0.14

280nm
1.5mL/min
3.4min
15.1±0.2

Testosterone:

17 -estradiol:
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Table 3.1 (continued) Reverse phase and normal phase HPLC assays for all model drugs
11-hydroxyprogesterone:
Reverse phase
Normal phase
Column
Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u
Mobile phase
50% acetonitrile/ 50% H2O 80% hexane/ 20% 2-propanol
Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.0mL/min
6.2min
53.8±0.6

240nm
1.5mL/min
6.4min
31.3±0.2

Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
90% hexane/ 10% 2-propanol

Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.0mL/min
8.1min
91.7±0.4

240nm
1.5mL/min
3.9min
52.0±0.6

Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
80% hexane/ 20% 2-propanol

Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.0mL/min
6.4min
88.7±0.1

240nm
1.5mL/min
4.2min
46.1±0.2

Diazepam:

Temazepam:
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Table 3.1 (continued) Reverse phase and normal phase HPLC assays for all model drugs
Prazepam:
Reverse phase
Normal phase
Column
Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u
Mobile phase
50% acetonitrile/ 50% H2O 90% hexane/ 10% 2-propanol
Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.0mL/min
12.8min
77.7±0.9

240nm
1.5mL/min
2.8min
44.6±0.5

Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
80% hexane/ 20% 2-propanol

Injection volume

20L

200L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

240nm
1.0mL/min
5.8min
89.7±1.1

240nm
1.5mL/min
3.3min
511±9

Oxazepam:

Methylparaben:
Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
97.5% hexane/2.5% 2-propanol

Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

254nm
1.5mL/min
3.4min
78.1±0.3

254nm
1.5mL/min
5.0min
68.9±1.0
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Table 3.1 (continued) Reverse phase and normal phase HPLC assays for all model drugs
Ethylparaben:
Reverse phase
Normal phase
Column
Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u
Mobile phase
50% acetonitrile/ 50% H2O 97.5% hexane/2.5% 2-propanol
Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

254nm
1.5mL/min
4.3min
72.8±0.4

254nm
1.5mL/min
4.5min
63.2±1.3

Column
Mobile phase

Reverse phase
Supelcosil ABZ+plus C18
50% acetonitrile/ 50% H2O

Normal phase
Alltech® Allsphere Silica 5u
97.5% hexane/2.5% 2-propanol

Injection volume

20L

20L

Detection wavelength
Flow rate
Retention time
Response factor
(mV×min×mL/g)

254nm
1.5mL/min
8.8min
63.4±0.3

254nm
1.5mL/min
4.0min
54.8±0.7

Butylparaben:
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Figure 3.3a, Reverse phase HPLC
chromatograms of progesterone: the top
chromatogram is the standard solution
with drug concentration of 51ug/mL; the
bottom curve represents 20-fold dilution
of the saturated drug in 10mg/mL DTAB
solution.

Figure 3.3b, Normal phase HPLC
chromatograms of progesterone: the top
chromatogram is the standard solution
with drug concentration of 105ug/mL;
the bottom curve is 40-fold dilution of
the saturated drug in dodecane.

Figure 3.4a, Reverse phase HPLC
chromatograms of testosterone: the top
chromatogram is the standard solution
with drug concentration of 81ug/mL; the
bottom curve represents two-fold dilution
of the saturated drug in 5mg/mL DTAB
solution.

Figure 3.4b, Normal phase HPLC
chromatograms of testosterone: the top
chromatogram is the standard solution
with drug concentration of 104ug/mL;
the bottom curve is 5-fold dilution of the
saturated drug in dodecane.
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Figure 3.5a, Reverse phase HPLC
chromatograms of 17-estradiol: the top
chromatogram is the standard solution
with drug concentration of 40ug/mL; the
bottom curve represents two-fold dilution
of the saturated drug in 5mg/mL SDS
solution.

Figure 3.5b, Normal phase HPLC
chromatograms of 17-estradiol: the top
chromatogram is the standard solution
with drug concentration of 10ug/mL; the
bottom curve is the saturated drug in
dodecane.

Figure 3.6a, Reverse phase HPLC
chromatograms
of
11-hydroxyprogesterone: the top chromatogram is
the standard solution with drug
concentration of 84ug/mL; the bottom
curve represents the saturated drug in
1.0mg/mL DM solution.

Figure 3.6b, Normal phase HPLC
chromatograms
of
11-hydroxyprogesterone: the top chromatogram is
the standard solution with drug
concentration of 67ug/mL; the bottom
curve is the saturated drug in dodecane.
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Figure 3.7a, Reverse phase HPLC
chromatograms of diazepam: the top
chromatogram is the standard solution
with drug concentration of 88ug/mL; the
bottom curve represents the saturated
drug in 1.0mg/mL DM solution.

Figure 3.7b, Normal phase HPLC
chromatograms of diazepam: the top
chromatogram is the standard solution
with drug concentration of 119ug/mL;
the bottom curve is 10-fold dilution of
the saturated drug in dodecane.

Figure 3.8a, Reverse phase HPLC
chromatograms of temazepam: the top
chromatogram is the standard solution
with drug concentration of 82ug/mL; the
bottom curve represents 20-fold dilution
of the saturated drug in 2.5mg/mL SDS
solution.

Figure 3.8b, Normal phase HPLC
chromatograms of temazepam: the top
chromatogram is the standard solution
with drug concentration of 57ug/mL; the
bottom curve is 3-fold dilution of the
saturated drug in dodecane.
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Figure 3.9a, Reverse phase HPLC
chromatograms of prazepam: the top
chromatogram is the standard solution
with drug concentration of 24ug/mL; the
bottom curve represents the saturated
drug in 5mg/mL DTAB solution.

Figure 3.9b, Normal phase HPLC
chromatograms of prazepam: the top
chromatogram is the standard solution
with drug concentration of 73ug/mL; the
bottom curve is 40-fold dilution of the
saturated drug in dodecane.

Figure 3.10a, Reverse phase HPLC
chromatograms of oxazepam: the top
chromatogram is the standard solution
with drug concentration of 81ug/mL; the
bottom curve represents 5-fold dilution
of the saturated drug in 2.5mg/mL SDS
solution.

Figure 3.10b, Normal phase HPLC
chromatograms of oxazepam: the top
chromatogram is the standard solution
with drug concentration of 1.8ug/mL; the
bottom curve is the saturated drug in
dodecane.
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Figure 3.11a, Reverse phase HPLC
chromatograms of methylparaben: the
top chromatogram is the standard
solution with drug concentration of
107ug/mL; the bottom curve represents
40-fold dilution of the saturated drug in
2.5mg/mL SDS solution.

Figure 3.11b, Normal phase HPLC
chromatograms of methylparaben: the
top chromatogram is the standard
solution with drug concentration of
86ug/mL; the bottom curve is the
saturated drug in dodecane.

Figure 3.12a, Reverse phase HPLC
chromatograms of ethylparaben: the top
chromatogram is the standard solution
with drug concentration of 91ug/mL; the
bottom curve represents 20-fold dilution
of the saturated drug in 2.5mg/mL SDS
solution.

Figure 3.12b, Normal phase HPLC
chromatograms of ethylparaben: the top
chromatogram is the standard solution
with drug concentration of 87ug/mL; the
bottom curve is the saturated drug in
dodecane.
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Figure 3.13a, Reverse phase HPLC
chromatograms of butylparaben: the top
chromatogram is the standard solution
with drug concentration of 87ug/mL; the
bottom curve represents 15-fold dilution
of the saturated drug in 2.5mg/mL SDS
solution.

Figure 3.13b, Normal phase HPLC
chromatograms of butylparaben: the top
chromatogram is the standard solution
with drug concentration of 90ug/mL; the
bottom curve is 3-fold dilution of the
saturated drug in dodecane.
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3.3.
3.3.1.

RESULTS AND DISCUSSION
Solubilization of Model Drugs in Three Micelle Systems

The aqueous solubility results for the steroids, benzodiazepines and parabens are shown
in Tables 3.2~3.4. In all cases, the aqueous solubility results were in good agreement with
those found in the literature (Yalkowski and He, 2003). The most water-soluble solute
was methylparaben and the least soluble was 17-estradiol.

The solubility results in dodecane for the three solute sets are also shown in Tables
3.2~3.4. Dodecane solubility results in the literature are rare, so comparisons to results in
Table 3.2 to 3.4 are difficult. None the less, the data presented in Tables 3.2 to 3.4 may be
evaluated directly. For progesterone, testosterone, diazepam, prazepam and butylparaben
solubility in dodecane is greater than in water. 17-estradiol and temazepam show
approximately equal solubility in water and dodecane. All other compounds are less
soluble in dodecane compared to water. The dodecane/water partitioning coefficients of
model drugs are listed in Table 3.2~3.4.

The solubilization capacities and associated micelle/water partitioning coefficients
(calculated by Eq. (3.3) and (3.5), respectively) are also listed in Tables 3.2~3.4. For
butylparaben,  and Km/w values in DTAB and DM were not determined because the
solutions became cloudy that suggested there may be a phase transition.

The experimental octanol/water partitioning property logPoct values from literatures
(Johnson et al., 1995; Kamlet et al., 1988; Hansch et al., 1995) are also shown in those
tables. From the logPoct values, most of the model compounds are quite hydrophobic.
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Table 3.2, Critical parameters of model steroids: logPoct, aqueous solubility, solubility in
dodecane, hydrocarbon/water partitioning coefficient (Kh/w), solubilization capacity ()
and micelle/water partitioning coefficients (Km/w) in SDS, DTAB and DM micelle
systems.
Progesterone

Testosterone

17-estradiol

11-hydroxyprogesterone

logPoct (exp.)

3.77

3.31

3.86

2.36

Aqueous
solubility
(M)

(2.79±0.14)×10-5

(8.42±0.28)×10-5

(6.23±0.33)×10-6

(1.77±0.09)×10-4

Solubility in
dodecane
(M)

(9.13±0.51)×10-3

(1.06±0.06)×10-3

(8.9±1.7)×10-6

(5.08±0.48)×10-5

Kh/w

(3.80±0.10)×103

51.2±2.9

10.6±0.6

3.62±0.39

 (SDS)

0.227±0.008

0.209±0.006

0.0245±0.0003

0.276±0.010

Km/w (SDS)

(3.69±0.21)×105

(1.14±0.05)×105

(2.13±0.12)×105

(6.75±0.39)×104

 (DTAB)

0.099±0.007

0.089±0.005

0.0479±0.0016

0.129±0.003

Km/w (DTAB)

(1.79±0.15)×105

(5.40±0.31)×104

(4.07±0.25)×105

(3.57±0.19)×104

 (DM)

0.0501±0.006

0.0491±0.0078

0.0157±0.0014

0.0441±0.0018

Km/w (DM)

(9.49±1.23)×104

(3.09±0.48)×104

(1.37±0.14)×105

(1.32±0.09)×104

Errors are based on 95% confidence intervals.
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Table 3.3, Critical parameters of model benzodiazepines: logPoct, aqueous solubility,
solubility in dodecane, hydrocarbon/water partitioning coefficient (Kh/w), solubilization
capacity () and micelle/water partitioning coefficients (Km/w) in SDS, DTAB and DM
micelle systems.
Diazepam

Temazepam

Oxazepam

Prazepam

logP (exp.)

2.99

2.19

2.24

3.73

Aqueous
solubility (M)

(1.60±0.05)×10-4

(3.46±0.02)×10-4

(7.34±0.15)×10-5

(1.83±0.09)×10-5

Solubility
in
dodecane (M)

(3.91±0.18)×10-3

(4.16±0.10)×10-4

(2.06±0.63)×10-7

(4.27±0.17)×10-3

Kh/w

308±17

15.1±0.4

0.0353±0.0108

(2.94±0.19)×103

 (SDS)

0.349±0.014

0.416±0.014

0.166±0.003

0.154±0.007

Km/w (SDS)

(8.93±0.39)×104

(4.70±0.11)×104

(1.08±0.03)×105

(4.03±0.26)×105

 (DTAB)

0.0928±0.0016

0.116±0.003

0.0499±0.0023

0.0298±0.0013

Km/w (DTAB)

(2.94±0.10)×104

(1.67±0.04)×104

(3.58±0.18)×104

(8.76±0.57)×104

 (DM)

0.0647±0.0012

0.0640±0.0024

0.0267±0.0010

0.0220±0.0002

Km/w (DM)

(2.10±0.07)×104

(9.63±0.35)×103

(1.96±0.08)×104

(6.51±0.33)×104

Errors are based on 95% confidence intervals.
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Table 3.4, Critical parameters of model parabens: logPoct, aqueous solubility, solubility in
dodecane, hydrocarbon/water partitioning coefficient (Kh/w), solubilization capacity ()
and micelle/water partitioning coefficients (Km/w) in SDS, DTAB and DM micelle
systems.
Methylparaben

Ethylparaben

Butylparaben

logP (exp.)

1.96

2.47

3.57

Aqueous
solubility (M)

(1.39±0.01)×10-2

(5.13±0.07)×10-3

(1.06±0.03)×10-3

Solubility
in
dodecane (M)

(4.00±0.16)×10-4

(5.47±0.37)×10-4

(2.45±0.09)×10-3

Kh/w

0.362±0.015

1.34±0.09

29.0±1.3

 (SDS)

0.559±0.035

0.475±0.015

0.643±0.009

Km/w (SDS)

(1.42±0.06)×103

(3.48±0.09)×103

(2.04±0.06)×104

 (DTAB)

0.771±0.027

0.656±0.035

n.d.

Km/w (DTAB)

(1.73±0.04)×103

(4.28±0.15)×103

n.d.

 (DM)

0.412±0.052

0.359±0.006

n.d.

Km/w (DM)

(1.16±0.10)×103

(2.85±0.05)×103

n.d.

Errors are based on 95% confidence intervals.
n.d.=not determined.
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The detailed solubilization results of 11 model drugs in SDS, DTAB and DM surfactant
systems at room temperature are shown in Figures 3.14~3.22. The typical solubilization
profiles expected in the presence of surfactants were obtained: at low surfactant
concentration the drug solubility was constant and equal to the aqueous solubility. At
surfactant concentrations above the CMC (critical micelle concentration) the solubility
increased linearly as a function of surfactant concentration. From the solubilization
profiles, two critical parameters could be extracted: the aqueous solubility and the
solublization capacity by the slope of the ascending line. Then the micelle/water
partitioning coefficient could be calculated from the solubilization capacity and aqueous
solubility based on Eq. (3.5).

During the measurements of the hydrocarbon/water partitioning coefficients, two
different techniques had been employed: solubility ratio and direct partitioning methods.
For some compounds, such as testosterone and 17-estradiol, there was statistically
significant discrepancy between the results from different methods. The likely reason for
this difference is that both of the drugs can form different crystals in dodecane and
aqueous media: they exhibit an anhydrous form in dodecane and hydrated (testosterone)
or hemi-hydrated (17-estradiol) form in water. Therefore the saturated solutions in the
two media are in equilibrium with different crystalline forms and the solubility ratio
method becomes inappropriate. Other model compounds, such as progesterone, diazepam,
temazepam, etc., have no reported solvate form and are expected to keep the same
polymorph at the two media.

To evaluate the micelle core as the locus of solubilization of model drugs, the
hydrocarbon/water partitioning coefficients were compared to micelle/water partitioning
coefficients. The data in Tables 3.2~3.4 clearly show that in all cases micelle/water
partitioning coefficients, K m/w, are much larger than hydrocarbon/water partitioning
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Figure 3.14, Solubilities of 4 model steroids as a function of SDS concentration.
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Figure 3.15, Solubilities of 4 model steroids as a function of DTAB concentration.
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Figure 3.16, Solubilities of four model steroids as a function of DM concentration.
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Figure 3.17, Solubilities of four benzodiazepines as a function of SDS concentration.
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Figure 3.18, Solubilities of four benzodiazepines as a function of DTAB concentration.
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Figure 3.19, Solubilities of four benzodiazepines as a function of DM concentration.
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Figure 3.20, Solubilities of three parabens as a function of SDS concentration.
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Figure 3.21, Solubilities of two parabens as a function of DTAB concentration.
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Figure 3.22, Solubilities of two parabens as a function of DM concentration.
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coefficients, Kh/w. In most cases, Km/w is at least 2 orders of magnitude larger than Kh/w,
which suggests there is less than 1% of the solutes are exclusively solubilized in the
micellar core. The closest agreement between Kh/w and Km/w is when progesterone is
solubilized in DM micelles with the ratio Km/w/Kh/w=25. When the Laplace pressure
effect is taken into account the differences between Kh/w and Km/w are even greater. The
factor exp  PV RT  in Eq. (3.2) is always less than 1 and ranges from 0.01 to 0.3 in
our systems.

Detailed information on Laplace pressure is presented in Chapter 5. After

considering the Laplace pressure effect, the ratio

K h / w exp  PV RT 
has a maximum
K micelle / water

of 0.4% for progesterone solubilized in DM micelles. The Eq. (3.2) will not hold in any
of our studied systems, which indicates the assumption of micelle core as major
solubilization locus is not true.

If we relax the requirement that the Eq. (3.2) holds, the possible correlations between
micelle/water partitioning coefficients and hydrocarbon/water partitioning constants can
be examined. Using SDS micelle system as an example, the relationships between Kh/w
and Km/w of 11 model drugs are shown in Figure 3.23. From the scattered pattern, there is
no identifiable correlation between the two properties. The hydrocarbon/water
partitioning coefficients cover 5 orders of magnitude from 0.04 (oxazepam) to 3.8×103
(progesterone) while micelle/water partitioning constants span only 2.5 orders of
magnitude from 1.4×103 (methylparaben) to 4.0×105 (prazepam).

Our results are consistent with reports that only completely nonpolar molecule may reside
in the micellar core (Rosen, 1989; Attwood and Florence, 1983). High hydrophobicity is
not the sufficient condition that makes hydrophobic solutes stay in the core region of the
micelles. Although many hydrophobic molecules have the major part of the structure
nonpolar and have only very small fraction of polar groups, those small polar fraction
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Figure 3.23, The relationships between hydrocarbon/water partition coefficient, Kh/w, and
micelle/water partition coefficient, Km/w, in aqueous SDS solutions for three series of
drugs, steroids, benzodiazepines and parabens.
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would affect the location of the molecules and drive them away from the
hydrocarbon-like core.

This analysis had been applied to simple alkanols, ketones, amides and aromatics by
Gumkowski (Gumkowski, 1986). Relatively complicated molecules, ethyl p- o- and maminobenzoates were also studied (Mukerjee and Ko, 1992). They found the micelle core
is not the major locus of those compounds solubilized in the micelles. Our studies
extended the objects to more pharmaceutical important molecules with complicated
chemical structures and drew a similar conclusion: all of the model drugs are not mainly
located at the micellar core region.

Different methods may have different definition when they were applied to determine the
location of solutes in the micelle systems. In the thermodynamics based method, a
molecule that has part of it at the micelle surface will be defined as staying at surface.
Our conclusion that majority of drug molecules are not in the micellar core does not
mean any part of the drug molecules cannot be at the micelle core. The hydrophobic part
of the solute is still likely buried in the core region. From this viewpoint there is actually
no qualitative conflict between thermodynamics based method and spectroscopy
methods.

3.3.2.

Effect of Salts on the Micelle/water Partitioning Coefficients

Three model drugs, progesterone, diazepam and methylparaben, each representing a
series of solutes, were solubilized in SDS, DTAB and DM micelle systems in the
presence of 0.15M NaCl to study the effect of the salts on the micelle/water partitioning
coefficients. In Figures 3.24~3.27, the drug solubilities as a function of surfactant
concentration in the presence and absence of 0.15M NaCl are shown. The quantitative
results of aqueous solubility, solubilization power of micelles, and micelle/water
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partitioning coefficient for three model drugs are summarized in Table 3.5. The statistical
analyses were carried out using Scientist® software to provide the 95% confidence
intervals. For comparison, the results corresponding to the solubilization of the three
model drugs in the absence of salts from Table 3.2~3.4 are included.

In anionic SDS solutions, for all three model drugs, the solubilization power shows a
significant decrease in the presence of salt compared to that in the absence of salt. The
aqueous solubilities of progesterone and diazepam in 0.15M NaCl solutions were not
significantly different from the measured solubilities in the absence of salt. On the other
hand the aqueous solubility of methylparaben in 0.15M NaCl was decreased to
13.0±0.1mM compared to the intrinsic aqueous solubility of 13.9±0.1mM without salts.
The decreasing solubility could be attributed to salting out effect. The calculated
micelle/water partitioning coefficients based on the solubilization power and aqueous
solubility through Eq. (3.5) exhibited a significant decrease by 36% (progesterone), 19%
(diazepam) and 24% (methylparaben) with the introduction of 0.15M NaCl.

In cationic DTAB solutions, the solubilization power toward all three model drugs was
significantly decreased by adding 0.15M NaCl. The micelle/water partition coefficients
of progesterone and diazepam were reduced by 22% and 12% respectively in the
presence of salts. The Km/w of methylparaben showed no statistically significant
difference in the presence and absence of salt. This observation may be due to the
nearly-saturated adsorption of methylparaben at DTAB micelle surface. The
solubilization power of DTAB toward methylparaben was so large (>0.7) that the
micelles consisted of a mole fraction of drugs nearly as much as that of surfactant. The
effect of drug concentration on the solubilization isotherm will be further discussed in a
later chapter.
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Figure 3.24, Solubilities of progesterone and diazepam as a function of SDS
concentration in the absence and presence of 0.15M NaCl.
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Figure 3.25, Solubilities of progesterone and diazepam as a function of DTAB
concentration in the absence and presence of 0.15M NaCl.
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Figure 3.26, Solubilities of progesterone and diazepam as a function of DM concentration
in the absence and presence of 0.15M NaCl.
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Figure 3.27, Solubilization results of methylparaben in three surfactant systems, SDS
(square), DTAB (triangle) and DM (circle), in the absence and presence of 0.15M NaCl.
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Table 3.5, Aqueous solubility, solubilization capacity () and micelle/water partitioning
coefficient (Km/w) of three model drugs in SDS, DTAB and DM micelle systems in the
absence and presence of 0.15M NaCl. Experimental data in the absence of salts are from
Table 3.2~3.4.
Progesterone

Diazepam

Methylparaben

Aqueous solubility (M)

(2.79±0.14)×10-5

(1.60±0.05)×10-4

(1.39±0.01)×10-2

Aqueous solubility
w/0.15N NaCl (M)

(3.09±0.22)×10-5

(1.59±0.03)×10-4

(1.30±0.01)×10-2

 (SDS)

0.227±0.008

0.349±0.014

0.559±0.035

 (SDS) w/0.15N NaCl

0.151±0.002

0.261±0.003

0.341±0.008

Km/w (SDS)

(3.69±0.21)×105

(8.93±0.39)×104

(1.42±0.06)×103

Km/w (SDS) w/0.15N NaCl

(2.35±0.17)×105

(7.21±0.15)×104

(1.08±0.02)×103

 (DTAB)

0.099±0.007

0.093±0.002

0.771±0.027

 (DTAB) w/0.15N NaCl

0.084±0.003

0.080±0.002

0.714±0.023

Km/w (DTAB)

(1.79±0.15)×105

(2.94±0.10)×104

(1.73±0.04)×103

Km/w (DTAB) w/0.15N NaCl

(1.39±0.11)×105

(2.59±0.08)×104

(1.78±0.04)×103

 (DM)

0.050±0.006

0.065±0.001

0.412±0.052

 (DM) w/0.15N NaCl

0.046±0.001

0.067±0.001

0.340±0.009

Km/w (DM)

(9.49±1.23)×104

(2.10±0.07)×104

(1.16±0.10)×103

Km/w (DM) w/0.15N NaCl

(7.95±0.59)×104

(2.19±0.05)×104

(1.08±0.02)×103

Errors are based on 95% confidence intervals.
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In nonionic DM solutions, the presence of salts had no statistically-significant effect on
the micelle/water partition coefficients of all three model drugs. The results suggest that
moderate concentrations of electrolytes have negligible influence on the solubilization
behavior of nonionic micelles.

To determine the location of model drugs in micelles in the presence of salts, the same
approach introduced in section 3.3.1 was employed: the micelle/water partitioning
coefficients, Km/w, was compared to hydrocarbon/water partitioning coefficient multiplied
by a factor representing Laplace pressure effect, Kh/wexp(-PV/RT). The results in the
absence of salts showed the term Km/w was at least 2 orders of magnitude greater than
term Kh/wexp(-PV/RT) in all studied micelle systems. The minimum ratio between these
two terms was 250 (when progesterone was solubilized in DM micelles). In the presence
of salts, the greatest influence on Km/w was a 36% decrease. After taking salt effect into
account, the micelle/water partitioning coefficient was still at least 2 orders of magnitude
greater than term K h/wexp(-PV/RT) in all studied drug-surfactant systems. Therefore, the
micelle surface or palisade region was the major location of model drugs when
solubilized in the three micelle systems in the absence and presence of salts.

3.4.

CONCLUSION

The measured micelle/water partitioning coefficients were much larger than
hydrocarbon/water partitioning constants, which indicated the core region of micelle was
insufficient to solubilize the model hydrophobic drugs based on the thermodynamic
model (Eq.(2.3)). This conclusion holds for 3 series of model drugs in 3 micelle systems
in the absence and presence of salts. The model drugs have broad range in terms of
hydrophobicity, as measured by logP, and aqueous solubility. In all the cases, partitioning
solely into the micelle core seems insufficient to explain partitioning into a micelle.
Copyright © Shaoxin Feng 2009
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Chapter 4
Oil/water Interface Activities of Hydrophobic Drugs in the Presence and Absence of
Surfactants

4.1.

INTRODUCTION

Micellar solubilization has been shown to be important both in considering micelles as
drug delivery vehicles of poorly water-soluble drugs and in understanding in vivo
absorption of hydrophobic drug molecules. Currently, the physicochemical factors
controlling the solubilization capacity of micelles are poorly understood. This work is
designed to probe the mechanism of solubilization by micelle systems with the goal of
quantitative prediction of the micellar solubilization for specific drug-surfactant mixtures.

Location of the drugs in micelles is likely to be a critical factor in understanding the
micellar solubilization phenomena. As a result of the small size of micelles, and the
accompanying large surface/volume ratio, many studies have considered the surface
region of micelles to be the major location of some solutes (Lebedeva et al., 2007; Sabate
et al., 2001; Svens and Rosenholm, 1973; Nagaonkar and Bhagwat, 2006; Yoshioka,
1979); Malcolmson and Lawrence, 1993; Mukerjee and Ko, 1992; Croy and Kwon, 2005;
Donbrow et al., 1967). In the previous chapter, we employed a thermodynamics-based
solubility method to show that solubilization in the micellar core alone is insufficient to
explain our experimental data. The conclusion, drawn from 11 model drugs solubilized in
3 micelle systems, indirectly suggests the micelle surface is the major location of the
drugs solubilized in micelles.

In this chapter, the characteristics of adsorption of model drugs to model interface are
probed.

Here, we view the micelle surface as a hydrocarbon/water interface populated
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by the surfactant molecules. For a drug to be solubilized at the micellar surface, it is
expected to be surface active at the hydrocarbon/water interface even in the presence of
surfactants. The surface activity of the model drugs will be measured at the water/air,
oil/air and oil/water interfaces. The introduction of surfactants to the system will be used
to observe the extent to which drugs and surfactants modulate the oil/water interfacial
tension. Later a thermodynamic model will be utilized to quantitatively simulate the
observed phenomena.

Dodecane/water was chosen as the model hydrocarbon/water interface to mimic the
hydrocarbon chain of the model surfactants. Poorly-soluble steroids were chosen to
demonstrate the ability of drugs to adsorb to the model oil/water interface. Three
surfactants, anionic sodium dodecyl sulfate (SDS), cationic dodecyl trimethyl ammonium
bromide (DTAB) and nonionic dodceyl maltoside (DM), were used to detect their
interactions with the drug molecules at oil/water interface.

It should be kept in mind that many differences exist between a micelle surface and a flat
hydrocarbon/water interface. Among the most obvious differences between the two is that
the micelle surface is highly curved. In the current chapter, The curvature effect will be
explored in the following chapter by invoking the Laplace pressure concept.

4.2.
4.2.1.

MATERIALS AND METHODS
Materials

Progesterone (>99%), testosterone (>98%), 17-estradiol (>98%), sodium dodecyl
sulfate (>99%), dodecyltrimethylammonium bromide (>99%) and dodecyl -D-maltoside
(>98%) were obtained from Sigma-Aldrich (St. Louis, MO). Progesterone, testosterone,
SDS and DTAB were purified before use while 17-estradiol and dodecyl -D-maltoside
were used as received.
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4.2.2.
4.2.2.1.

Methods
Surface Tension Measurement

DuNouy ring method was used to measure the liquid/air and liquid/liquid interfacial
tension. The method was first developed by duNouy in 1919 (duNouy, 1919). In this
method, the interfacial tension is measured with the aid of platinum-iridium ring pulled
through the interface (Figure 4.1). The force necessary to detach the ring at the interface
is proportional to the interfacial tension.

The relationship between the interfacial tension and the applied force could be expressed
using the formula:



F

4  R

(4.1)

F is the applied force pulling the ring; R is the radius of the metal ring and  is the
correction factor that could be calculated using Zuidema and Waters‟s empirical equation
(Zuidema and Waters, 1941):
 0.01452 F 
1.679 r 
  0.04534 
  0.725   2

R 
 C 1   2  

0.5

(4.2)

Here, r is the radius of metal wire; C is the circumference of the metal ring which is equal
to 2R ; 1 and 2 are the densities of lower and upper layers of liquid. The parameters
of the above equation were obtained by fitting the formula to experimentally determined
correction factors by Harkins and Jordan (Harkins and Jordan, 1930).

Our experiments were carried out in a water-jacketed beaker where the temperature was
controlled at 25.0±0.1oC. The parameters used were: circumference C=6.005cm; the ratio
r R =0.01859; 1  0.997 g cm 3 (water at 25oC) and  2  0.748 g cm 3 for dodecane

or 0.001 g cm 3 for air.
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Figure 4.1, A schematic of the duNouy ring method. The ring is pulled up through the
oil/water interface with a force F that is proportional to the interfacial tension.

67

When the drugs were present, an excess amount of drugs was added to water and
hydrocarbon solvents (dodecane or octane) separately. Both systems were rotated for 3~5
days at room temperature (24±1oC) to reach equilibrium. Aqueous solutions were filtered
using 0.2m hydrophilic PTFE filter (Millipore Inc.) and the hydrocarbon solutions were
filtered using 0.2m hydrophobic PTFE filter (Pall corp.). The filtrates were employed in
water/air and hydrocarbon/air interfacial tension measurements respectively. The
mixtures of the two filtered solutions (hydrocarbons at top layer and aqueous solutions at
bottom layer) were used in hydrocarbon/water interfacial tension measurements.

The surfactants were dissolved in aqueous phase to make solutions with known
concentrations, e.g. 0.1, 1.0 and 10 mg/mL SDS solutions. Because of negligible
solubility in hydrocarbons, the surfactants were not prepared in oil phase. The aqueous
solutions containing surfactants were mixed with dodecane for dodecane/water interfacial
tension determinations. When also present, an excess amount of the drug solid was placed
into aqueous solutions with known concentration of surfactants. The aqueous solutions
were rotated for 3~5 days to reach equilibrium before being filtered using 0.2m
hydrophilic PTFE filter. The filtrate was mixed with drug-saturated dodecane prepared as
shown above to measure the dodecane/water interfacial tensions.

Since testosterone can form different crystal forms, an anhydrous form in oil and a
hydrate in water, the saturated aqueous and dodecane solutions prepared separately could
not keep the same activity of the drug in the two media. Therefore the oil/water
interfacial tension measurement would have a starting point where the oil/water
partitioning of the drug was far from equilibrium and the kinetics of partitioning could
affect the interfacial tension determinations. To avoid the complexity, a direct partitioning
method was used in sample preparations: the dodecane and aqueous solutions in the
presence or absence of surfactants were pre-mixed and excess testosterone was placed
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into the mixture. The system was rotated for 3~5 days at room temperature to reach
equilibrium. The two liquid layers were filtered using 0.2m hydrophilic (for aqueous
layer) and hydrophobic (for oil layer) PTFE filters separately and were mixed again for
dodecane/water interfacial tension measurements.

4.2.2.2.

Purification of Steroids and Surfactants:

Solid state adsorption method reported by Rosen to purify SDS (Rosen, 1981) was
employed. This method was also applied to the purification of DTAB and two model
drugs (progesterone and testosterone).

Purification of SDS and DTAB: About 1g SDS or DTAB was combined with 100mL
deionized water and the solution was passed through a Sep-Pak® Plus C18 column
(wetted with methanol and double distilled water before use). The first 15mL solution
was discarded and the next 70 mL eluted solution was collected and freeze-dried using
the following lyophilization cycle:
1. Freeze to -40oC and maintain for 4h
2. Apply vacuum (100mT)
3. Increase temperature to -20oC and maintain for 2h
4. Increase temperature to 0oC and maintain for 8h
5. Increase temperature to 20oC and maintain for 10h
After the purification, the surface tensions as a function of surfactant concentration were
measured with the results shown in Figure 4.2 ad 4.3. For the purified surfactants, the
figures clearly show the elimination of the local minimum near the CMC compared to the
curves from unpurified surfactants.

Surface tension versus surfactant concentration curve was also measured for dodecyl
-D-maltoside with the results shown in Figure 4.4. The absence of local minimum in the
69

75

Surface tension (mN/m)

70

After purification
(adsorption)

65

Before purification

60
55
50
45
40
35
30
0.1

1

10

Conc. of SDS (mg/mL)

Figure 4.2, Surface tension vs. concentration of SDS in aqueous solutions before and
after purification by solid adsorption method. Some error bars are smaller than the
symbols.
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Figure 4.3, Surface tension vs. concentration of DTAB in aqueous solutions before and
after purification by solid adsorption method.
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Figure 4.4. Surface tension vs. concentration of dodecyl -D-maltoside in aqueous
solutions
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curve indicates high purity of the materials received from the vendor. The purification
step for DM was deemed unnecessary.

Purification of progesterone and testosterone: The drugs were dissolved in hexane (20mL
1.5mg/mL for progesterone and 200mL 0.125mg/mL for testosterone) and the solutions
were passed through Sep-Pak® Plus C18 columns (wetted with methanol before use).
The eluent solutions were dried under a stream of nitrogen gas. After the purification, the
HPLC chromatograms (Figure 4.5 and 4.6) showed significant suppressions of two
impurity peaks for progesterone and one impurity peak for testosterone. The putative
impurities were found to exhibit be less than 0.1% of main peaks (based on AUC ratio).
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Figure 4.5, HPLC chromatograms of progesterone before (upper curve) and after (lower
curve) purification. The arrow shows the main progesterone elution band.

Figure 4.6, HPLC chromatograms of testosterone before (upper curve) and after (lower
curve) purification. The arrow shows the main testosterone elution band.
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4.3.
4.3.1.

RESULTS
Interfacial Studies in the Absence of Surfactants

The surface tensions of the water/air, oil/air and oil/water interfaces were measured in the
presence and absence of steroids. Saturated solutions of the drugs were employed for
water and oil phases. The results are summarized in Table 4.1. At the air/water interface
and at the air/oil interface, the presence of 17-estradiol showed no statistically
significant effect on the surface tension. The presence of progesterone or testosterone
showed only a weak effect on the surface tension at air/water interface and no effect at
the air/oil interface. These results indicate that the model drugs are not significantly
surface active at the water/air and oil/air interfaces. However, there was a dramatic
change in the oil/water interfacial tension upon the addition of the drugs. In the absence
of model drugs, the tension of the dodecane/water interface was 51.2 mN/m, a value
close to that reported previously (Zeppieri et al., 2001; Gillap et al., 1968). In the
presence of saturated solutions of progesterone (P), testosterone (T) or 17-estradiol (E)
the oil/water interfacial tensions were reduced to 28.9, 33.5, and 44.6 mN/m, respectively.
Clearly, the progesterone showed the greatest influence on the interfacial tension by
almost a factor of 2 compared to that in the absence of the drug. Thus it seems that these
steroids do possess an ability to accumulate at the oil/water interface. Shown in the last
column of Table 4.1 are the effects of hydrocarbon chain length on the hydrocarbon/water
interface properties. A similar trend was observed in octane/water interface system
compared to dodecane/water interface. All model steroids show a strong surface activity
at the octane/water interface.

During the measurement of dodecane/water interfacial tension in the presence of the
steroids, the direct partitioning was employed. The reason for this approach was that both
testosterone and 17-estradiol form different crystalline forms in aqueous and dodecane
environments (see Chapter 3, Section 3.3.1).
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The direct partitioning method could

guarantee the same activity of the drugs in contacted phases. Despite the surface activity
expressed by the steroids, no evidence of emulsification was observed.

4.3.2.
4.3.2.1

Interfacial Studies in the Presence of Surfactants
Sodium Dodecyl Sulfate (SDS)

In Table 4.2, the interfacial tensions of the dodecane-water system in the presence of both
SDS and steroids are listed. Addition of 0.1 mg/mL SDS to the control system (no drug)
resulted in an interfacial tension of 40.1 mN/m. On the other hand, addition of 0.1 mg/mL
SDS to the steroid-oil-water systems reduced the interfacial tensions to 24.2 (P), 30.4 (T)
and 36.6 mN/m (E), respectively. The ability of the drugs to lower the interfacial tension,
even in the presence of SDS, suggests that all three model drugs have some ability to
compete with the surfactant for this interface. At the 1.0 mg/mL concentration of SDS,
the interfacial tensions of the progesterone (12.9 mN/m) and testosterone (16.3 mN/m)
systems were less than those of the SDS-oil-water system (19.4 mN/m) by about 6.5 and
3.1 mN/m, respectively. The 17-estradiol exhibited no ability to make a statistically
significant change in dodecane/water interfacial tension in the presence of 1mg/mL SDS.
When the concentration of SDS was increased to 10 mg/mL, a value higher than the
CMC of SDS (2.2mg/mL), the oil/water interfacial tension in the presence of
17-estradiol was no different from control, indicating that the ability of the drug to
effect interfacial tension was overwhelmed by higher surfactant concentration. On the
other hand, saturated progesterone and testosterone were still able to compete with SDS
for oil/water interface and further lower the interfacial tension from 7.86 (control, no
drug) to 6.29 (P) and 7.68 mN/m (T). The surface tension of the air/water interface was
only slightly decreased by progesterone or testosterone and unchanged by the presence of
17-estradiol (shown in Table 4.1). The lack of effect at the air/water interface suggests
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Table 4.1, Interfacial tensions in the absence and presence of model drugs
Interfacial tension (mN/m)*
Water/air

Dodecane/air

Dodecane/water

Octane/water

No drug

71.2±0.6

24.2±0.5

51.2±1.0

47.5

Progesterone

65.2±1.8

23.8±1.1

28.9±0.8

23.7

Testosterone

66.8±0.7

23.6±0.9

33.5±0.5

27.8

-estradiol

69.9±1.3

24.8±0.2

44.6±0.4

42.7

*

n=3, except for octane/water interface n=1.

Table 4.2, Dodecane/water interfacial tensions in the absence and presence of saturated
model steroids (progesterone, testosterone, 17-estradiol) and sodium dodecyl sulfate
(SDS) solutions. Three concentrations of SDS were used: 0.1, 1.0 and 10.0mg/mL.
Dodecane/water
0.1mg/mL
1.0mg/mL
10mg/mL
interfacial tension No surfactant
SDS
SDS
SDS
(mN/m)*
No drug

51.2±0.7

40.1±1.3

19.4±0.6

7.86±0.03

Progesterone

28.9±0.8

24.2±0.2

12.9±0.3

6.29±0.03

Testosterone

33.5±0.5

30.4±0.1

16.3±0.1

7.68±0.13

-estradiol

44.6±0.4

36.6±2.0

18.8±0.6

7.84±0.19

*

n=3.
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that the surface tension decrease observed at the oil/water interface is not due to highly
surface-active impurities in the systems.

4.3.2.2.

Dodecyltrimethylammonium Bromide (DTAB)

In Table 4.3, the interfacial tensions of the dodecane-water system in the presence of both
DTAB and steroids are listed. Addition of 0.1 mg/mL DTAB to the control system (no
drug) resulted in an interfacial tension of 41.1 mN/m. On the other hand, addition of 0.1
mg/mL DTAB to the steroid-oil-water system reduced the interfacial tensions to 21.1 (P),
22.7 (T) and 32.2 mN/m (E), respectively. The ability of the drugs to lower the interfacial
tension, even in the presence of DTAB, suggests that all three model drugs have some
ability to compete with the surfactant for this interface. At the 1.0 mg/mL concentration
of DTAB, the interfacial tensions of the progesterone (15.1 mN/m), testosterone (19.0
mN/m) and 17-estradiol systems (20.9 mN/m) were less than those of the
DTAB-oil-water system (25.8 mN/m) by about 10.7, 6.8 and 4.9 mN/m, respectively.
When the concentration of DTAB was increased to 10 mg/mL, a value higher than the
CMC of DTAB (4.9mg/mL), the ability of model drugs to compete for the interface was
further weakened: the interfacial tensions of the steroid-DTAB-oil-water system dropped
to 6.59 (P), 7.35 (T) and 7.43 mN/m (E) from 8.11 mN/m for control DTAB-oil-water
system.

4.3.2.3.

Dodecyl -D-Maltoside (DM)

In Table 4.4, the interfacial tensions of the dodecane-water system in the presence of both
DM and steroids are listed. Addition of 0.003mg/mL DM to the control system (no drug)
resulted in an interfacial tension of 31.2 mN/m. On the other hand, addition of
0.003mg/mL DM to the steroid-oil-water system reduced the interfacial tensions to 24.2
(P), 26.9 (T), and 30.0 mN/m (E), respectively. The ability of the drugs to lower the
interfacial tension, even in the presence of DM, suggests that all three model drugs have
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Table 4.3, Dodecane/water interfacial tensions in the absence and presence of saturated
model
steroids
(progesterone,
testosterone,
17-estradiol)
and
dodecyl
trimethylammonium bromide (DTAB) solutions. Three concentrations of DTAB were
used: 0.1, 1.0 and 10.0mg/mL.
Dodecane/water
0.1mg/mL
1.0mg/mL
10mg/mL
interfacial tension No surfactant
DTAB
DTAB
DTAB
(mN/m)*
No drug

51.2±0.7

41.1±1.7

25.8±0.5

8.11±0.02

Progesterone

28.9±0.8

21.1±0.5

15.1±0.4

6.59±0.17

Testosterone

33.5±0.5

22.7±0.2

19.0±0.9

7.35±0.07

-estradiol

44.6±0.4

32.2±1.7

20.9±0.9

7.43±0.03

*

n=3

Table 4.4, Dodecane/water interfacial tensions in the absence and presence of saturated
model steroids (progesterone, testosterone, 17-estradiol) and dodecyl -D-maltoside
(DM) solutions. Three concentrations of DM were used: 0.003, 0.03 and 0.3mg/mL.
Dodecane/water
0.003mg/mL
0.03mg/mL
0.3mg/mL
interfacial tension No surfactant
DM
DM
DM
(mN/m)*
No drug

51.2±0.7

31.2±0.4

12.7±0.2

4.92±0.06

Progesterone

28.9±0.8

24.2±0.6

11.3±0.3

4.22±0.16

Testosterone

33.5±0.5

26.9±1.0

11.8±0.4

4.59±0.11

-estradiol

44.6±0.4

30.0±0.4

12.7±0.2

4.89±0.06

*

n=3
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some ability to compete with the surfactant for this interface. At the 0.03mg/mL
concentration of DM, the interfacial tensions of the progesterone (11.3 mN/m) and
testosterone (11.8 mN/m) systems were less than those of the SDS-oil-water system (12.7
mN/m) by about 1.4 and 0.9 mN/m. The 17-estradiol system exhibited no statistically
significant change in dodecane/water interfacial tension in the presence of either
0.03mg/mL or 0.3 mg/mL DM, indicating that the ability of the drugs to compete for the
interface was overwhelmed by higher surfactant concentration. On the other hand,
saturated progesterone and testosterone were still able to compete with DM for oil/water
interface and further lower the interfacial tension from 4.92 (control, no drug) to 4.22 (P)
and 4.59 mN/m (T).

4.3.3.

Thermodynamic Model of Dodecane/water Interfacial Tension in the

Presence of Drug and Surfactant
The above experimental results clearly show competition between surfactants and model
drugs in a concentration-dependent manner at the oil/water interface. As of yet, the
molecular basis for this proposed competition is not known. In this section, we will
subject interfacial tension data to a thermodynamic analysis to probe the energetics of the
putative competition. We will focus attention on the free energy of transfer to the
interface of the surfactants and of the model solutes and will attempt to predict interfacial
tension of mixtures based on the Gtrans of the component members.

4.3.3.1.

Introduction-Models for Surface Adsorption

There are two main theoretical approaches to build the equilibrium relationship between
adsorption and surface tension (Lucassen-Reynders, 1981). The two-dimensional gas
model was first introduced by Langmuir (Langmuir, 1917) while a two-dimensional
solution model was proposed by Butler (Butler, 1932). Both of the models employ a
monolayer assumption for treatment of the interface. The 2-D gas model considers only
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the surfactant at the interface, while the 2-D solution model explicitly includes the
surfactants and the solvents at the interface. The 2-D gas approach works best for
insoluble surfactants while the 2-D solution approach has advantages for soluble
surface-active compounds (Lucassen-Reynders, 1981). In our studied systems, clearly the
2-D solution approach would be more appropriate because the surfactants employed are
quite soluble in the aqueous phase.

Shown in Appendix 1 is the derivation, proposed by Butler, for relating bulk
concentration, interfacial tension and surface transfer free energy.

4.3.3.2.

Application of Butler Model to Single Solute Systems

The goal of this section is to employ interfacial tension data to calculate both the free
energy of transfer to interface from the bulk and the partial molar interfacial area
occupied by solute (surfactant or drug).

To determine the transfer free energies to interface for ionic surfactants (SDS and DTAB),
the experimental dodecane-water interfacial tensions at three surfactant concentrations in
Tables 4.2 and 4.3 were fitted to Eq. (A1.7). Several parameters required by the model
could be obtained from the literature. The value employed for the occupied interfacial
area of water was 7.62Å²/molecule taken from Gumkowski (Gumkowski, 1986) which
was based on average hard sphere diameter of water ranging from 2.50~2.93 Å (Pierotti,
1965). The area occupied per molecule by SDS and DTAB, two extensively studied
surfactant systems, at oil/water interface were determined by fitting the experimental -A
curves (Haydon and Taylor, 1960) using the -A relationship, Eq. (A1.13), derived from
2-D solution model.



2a water
RT 
ln 1 
a water 
A  a surfact






(A1.13)
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where  is the surface pressure; A is the interfacial area per surfactant; awater is surface
area occupied by water. Figures 4.7 and 4.8 show the experimental -A curves for three
sodium alkyl sulfates and three alkyl trimethylammonium bromides in decane/water or
petroleum ether/water interfacial systems from literatures (Haydon and Taylor, 1960).
The SDS and DTAB data were collected employing petroleum ether whereas other
systems,

sodium

octylsulfate

(SOS),

sodium

decylsulfate

(SDeS),

octyltrimethylammonium bromide (OTAB) and decyltrimethylammonium bromide
(DeTAB), were collected employing decane. Surprisingly the -A curves for three alkyl
sulfate surfactants in two different oil/water interfaces were essentially indistinguishable
indicating that the occupied areas of the surfactants were not sensitive to the chain length
of the hydrophobic tail and the type of oil phase. For this reason, we extrapolated the
results to SDS in dodecane/water interface. In Figure 4.7, the fitted -A curve using Eq.
(A1.13) is also shown. Clearly the fitting was very good and the fitted occupied area by
each SDS molecule was 32.0±0.6 Å². Similarly, in Figure 4.8, the -A curves for three
alkyl trimethylammonium bromide surfactants in two different oil/water interfaces were
overlapped with each other. The fitted -A curve applying Eq. (A1.13) is in good
agreements with experiments. The estimated occupied area by DTAB at oil/water
interface was 37.1±0.6 Å²/molecule.

l
The activity coefficient f surfact
for ionized surfactants (SDS and DTAB) in Eq. (A1.7)

could be calculated in terms of the ionic strength, I, using Debye-Huckel equation:
l
 log f surfact


0.509 I

(4.3)

I 1
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Figure 4.7, The experimental oil/water interfacial pressure in the presence of sodium
alkyl sulfate surfactants as a function of area per surfactant molecule by Haydon and
Taylor (Haydon and Taylor, 1960). The solid curve is fitted according to Eq. (A1.13).
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Figure 4.8, The experimental oil/water interfacial pressure in the presence of alkyl
trimethylammonium bromide surfactants as a function of area per surfactant molecule by
Haydon and Taylor (Haydon and Taylor, 1960). The solid curve is fitted according to Eq.
(A1.13).
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At concentrations greater than CMC, the CMC was employed in the simulations because
the concentration of surfactant monomers was critical in determining the surface
properties. In addition, it is know that inclusion of hydrophobic solutes, such as dodecane,
can significantly lower the CMC. To account for this effect, the CMCs of SDS and DTAB
micelles in the presence of saturated dodecane (6.9mM for SDS, Bonfillon et al., 1994
and 12.5mM for DTAB, Medrzycka and Zwierzykowski, 2000) were employed in the
calculations.

The fitted Gtrans values using Eq. (A1.7) and the parameters mentioned above were
-23.5±0.8 for SDS and -22.8±1.2 kJ/mol for DTAB. These surfactants have the same free
energy of transfer to the oil/water interface.

For nonionic surfactant DM and neutral drugs, Eq. (A1.8) was employed to fit the
experimental dodecane/water interfacial tension versus surfactant/drug concentration
curves.

The experimental and fitted dodecane/water ~ C (concentration of either drug or

surfactant) curves for DM, progesterone and testosterone are shown in Figures 4.9~4.11.
The fitted parameters are listed in Table 4.5. Apparently the fitted curves coincide with
the experimental data very well. Statistical analysis was applied using Scientist®
software to provide the 95% confidence intervals for the fitted two parameters that are
also shown in Table 4.5. When applied to 17-estradiol in dodecane/water interface
system the fitting to the model was poor.

The lack of fit is likely the result of poor

reproducibility in measuring interfacial tensions especially when the drug concentrations
were very low (<1g/mL) (the results will be shown in Section 5.3.1, Figure 5.6).
Therefore, in our simulation, the 17-estradiol results were not considered.
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Table 4.5, Critical parameters used in simulations. The parameters are the results of
fitting interfacial tension data to the Butler model.
a (Å2)

Gtrans(kJ/mol)

SDS

32.0±0.6a

-23.45±0.84b

DTAB

37.1±0.6a

-22.83±1.22b

DM

41.41±2.75c

-42.07±0.58c

Progesterone

61.3±4.8c

-42.12±0.48c

Testosterone

59.6±5.1c

-36.17±0.37c

a

Values from fitting Eq. (A1.13)
Values from fitting Eq. (A1.7)
c
Values from fitting Eq. (A1.8)
b
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Dodecyl maltoside in dodecane-water interface

Dodecane-water interfacial tension (mN/m)
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Figure 4.9, Dodecane/water interfacial tension as a function of dodecyl -D-maltoside
concentration in water. The solid line is the fitted theoretical curve.
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Progesterone in dodecane-water interface
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Figure 4.10, Dodecane/water interfacial tension as a function of progesterone
concentration in water. The solid line is the fitted theoretical curve.
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Figure 4.11, Dodecane/water interfacial tension as a function of testosterone
concentration in water. The solid line is the fitted theoretical curve.
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4.3.3.3.

Application of Butler Model to Two Solute (Surfactant and Drug)

Systems
The goal of the section is to predict surface tension by employing Gtrans and area
occupied by each solute at the interface in the 2D solution model in the presence of drug
and surfactant. These predicted values are then compared to experimental values (Tables
4.2~4.4).

For systems containing ionic surfactants SDS and DTAB and neutral molecules (steroids),
Eq. (A1.9) was applied. For systems containing nonionic surfactant DM and steroids, Eq.
(A1.10) was applied. Once the surface pressure, , at any given drug and surfactant
concentrations was solved, the surface tension could be simply calculated using

   0   . As mentioned in the previous section, the CMC of surfactant was employed
in the simulations when the concentration of surfactant was higher than its CMC. The
CMCs of SDS and DTAB in the presence of dodecane were taken from the literature
(Bonfillon et al., 1994; Medrzycka and Zwierzykowski, 2000) with values shown in
section 4.3.3.2. The CMC of DM in the presence of dodecane was determined by the
point of intersection between the two segments of ~C curve (Fig. 4.9) above and below
CMC. The determined CMC using this method was 0.14mM. The computation was
divided into two groups. In the first group only three components, water, dodecane and
either surfactant or drug were considered. The experimental data were used in fitting the
parameters, Gtrans,drug/surfact and adrug/surfact, much like a training set. Eq. (A1.7) and (A1.8)
were fitted with appropriate data to determine free energy of transfer and area occupied
per molecule for the surfactant or the drug at the doecane/water interface.

The second group of calculations considered all four components, water, dodecane,
surfactant and drug. Eq. (A1.9) and (A1.10) were employed to predict the surface
tensions for mixtures of surfactant and drug. The comparisons between calculated and
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experimental surface tensions are shown in Figure 4.10 for part I and in Figure 4.11 for
part II.

It is not surprising that the prediction of surface tension in the first is very close to
experimental results (see Figure 4.12). For the second group of calculations, where the
surfactant and drug are both present, the overall predictions are overall good but with a
few points that exhibited somewhat greater deviations (see Figure 4.13). To better
illustrate the results, the quantitative data and their corresponding conditions are listed in
Table 4.6. From the table, the calculated values for SDS and DM systems are quite close
to measured surface tensions. Significant deviations of the model from experimental
results are observed for DTAB at low concentration. The greatest differences between
experiments and predictions are 10.2 mN/m for saturated testosterone in 0.1mg/mL
DTAB. The other three data points that had large deviations are progesterone in
0.1mg/mL DTAB (5.7 mN/m), progesterone (6.1 mN/m) and testosterone (5.1 mN/m) in
1.0mg/mL DTAB. One possible reason for the deviations is the assumption used in the
surface adsorption model, that there is no specific interactions between the drug and
surfactant and the two solutes are ideally competing with each other for the oil/water
interface.

In following chapters it will be shown that the assumption of no interaction

between drug and surfactant may not hold.

4.4.

DISCUSSION

The experiments clearly showed, in all three surfactant systems differing in electronic
charge, model steroids can successfully compete for the oil/water interface.

In our studies, the ability of model drugs from saturated solution to compete with
surfactants has the rank order: progesterone > testosterone > 17-estradiol. Therefore the
progesterone has the greatest surface activity and 17-estradiol has the least surface
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Figure 4.12, Comparison between experimental and theoretical fitted dodecane/water
interfacial tensions in the presence of pure surfactants (SDS, DTAB or DM) or pure
steroids (progesterone or testosterone).

89

Table 4.6, Comparison between experimental and predicted dodecane/water interfacial
tensions in the presence of both surfactants and drugs. The predicted values were
obtained using the Eq. (A1.9) and (A1.10). Experimental data are from Table 4.2 to 4.4.
Interfacial tension Progesterone
(mN/m)
Experimental

Testosterone
Predicted

Experimental

Predicted

0.1mg/mL
SDS-dodecane
1.0mg/mL
SDS-dodecane
10mg/mL
SDS-dodecane
0.1mg/mL
DTAB-dodecane

24.2±0.2

26.5

30.4±0.1

32.4

12.9±0.3

16.8

16.3±0.1

18.5

6.29±0.03

7.13

7.68±0.13

7.51

21.1±0.5

26.8

22.7±0.2

32.9

1.0mg/mL
DTAB-dodecane
10.0mg/mL
DTAB-dodecane
0.003mg/mL
DM-dodecane
0.03mg/mL
DM-dodecane
0.3mg/mL
DM-dodecane

15.1±0.4

21.2

19.0±0.9

24.1

6.59±0.17

6.61

7.35±0.07

6.93

24.2±0.6

24.3

26.9±1.0

27.8

11.3±0.3

11.9

11.8±0.4

12.3

4.22±0.16

4.75

4.59±0.11

4.87
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Figure 4.13, Comparison between experimental and predicted dodecane/water interfacial
tensions in the presence of both surfactants (SDS, DTAB or DM) and model steroids
(progesterone or testosterone).
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activity at oil/water interface. This rank order correlates well with the solubilization
capacity of the model drugs in all three micelle systems. In those micelle systems,
progesterone always has the greatest solubilization power and 17-estradiol has the least
solubilization capacity. The correlation is consistent with the conclusion of Chapter 3 that
the micellar solubilization is mainly localized to the micelle surface.

When the three different surfactants are compared, the surface tensions at dodecane/water
interface at concentrations near their CMCs are 7.86 (SDS), 8.11 (DTAB) and 4.92 (DM)
mN/m. Therefore the surface activities of surfactants at their CMC have the following
ranking order: DM > SDS  DTAB. This order has an inverse correlation with the
solublization capacity of the micelle. DM micelle system always has the lowest
solubilization power in the three micelle systems. For progesterone and testosterone, the
solubilization power has the order SDS > DTAB > DM. For 17-estradiol, the ranking
order of solubilization capacity becomes DTAB > SDS > DM. The correlation also
supports the hypothesis that these drugs are mainly solubilized in the hydrocarbon/water
interface of the micelle.

The above correlations between solubilization in micelles and surface activity are only
qualitative. There is significant difference between flat oil/water interface we studied in
this chapter and highly curved micelle surface. The high surface curvature could change
the surface packing density of both surfactants and drugs. The Laplace pressure, which
likely offers molecule a greater energy barrier for entry onto the micelle surface as
compared to a flat interface, may be the physical basis of the effect of curvature. In the
next chapter we will consider the curvature effect and apply the surfactant-drug
co-adsorption model to predict the micelle/water partitioning properties.
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It is likely that results obtained on flat oil/water interface will more closely correlate to
real lipid assembly systems when the particle size of oil or water droplets is large. If so,
the present work could be applicable to other lipid-based drug delivery system, such as
emulsions and liposomes. The modification of oil/water interface properties can influence
the emulsification efficiency or particle size of oil droplets in emulsions. In turn, it will
affect the performance of lipid-based drug delivery systems (Malcolmson and Lawrence,
1993; Craig et al., 1993). The studies on the behavior of drugs and surfactants on flat
surface are important to provide intrinsic interface properties of drugs and surfactants and
their interactions as a means of understanding lipid-based drug delivery systems. The
larger the surface/volume ratio, the greater influences the drug-surfactant competition
will make on solubilization.

Besides the experimental studies of competition of drug-surfactant for the model
oil/water interface, a thermodynamic model (2-D solution model) was applied to simulate
the interface adsorption phenomena. The parameters used were obtained by fitting to
dodecane/water interface properties in the presence of only one type of molecules, either
the surfactants or the model drugs. When the surfactants and drugs were mixed together,
the interfacial tension was calculated under an assumption that there is no specific
interaction between drug and surfactant molecules. In another word, the drug and
surfactant are ideally competing with each other at the oil/water interface without any
synergistic or antagonistic effect. Overall the predictions were good with a few
exceptions when the steroids were mixed with low concentration of DTAB. This
suggested the simulation method and the assumption used are valid in most cases. For
DTAB-drug mixtures, the measured surface tensions were lower than predicted values
which indicated the steroids may have attractive interactions with DTAB molecules that
make synergistic effect in lowering the surface tensions.
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From the negative sign of the transfer free energies of surfactants and model steroids, the
oil/water interface is always more energetically favorable than the bulk aqueous phase.
The transfer free energy from water to interface and the partitioning coefficient between
interface and water have the following relationship under dilute solution condition.
K interface/water  exp  G water interface RT 

(4.4)

The lower the G value the more surface active the molecule (with constant low
concentration). From Table 4.5, progesterone and dodecyl -D-maltoside have the largest
surface activity, testosterone is the next, while SDS and DTAB have the lowest surface
activity. The results are quite surprising because they show some hydrophobic molecules
are very surface active at oil/water interface and are even more surface active than
conventional surfactants. The total surface activity of the model drugs is probably limited
by low aqueous solubility while the surfactants have much higher solubility and
monomer concentrations.

The study of 17-estradiol at dodecane/water interface was plagued by large variations in
the surface tension results. The problem may be due to the slow adsorption to the
oil/water interface when the drug concentrations in both oil and aqueous phases are quite
low (<1g/mL). This slow adsorption kinetics may interfere with the effect of even small
amount of impurities that could gradually lower the interfacial tension over long period
of time up to hours (Mysels, 1986).

The success of employing a thermodynamic model in simulating the competing
adsorption at oil/water interface will encourage us to apply the model to micelle surface
where the curvature effect is considered using Laplace pressure concept.
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4.5.

CONCLUSION

Hydrocarbon/water interfacial tension can be significantly decreased in the presence of
hydrophobic drugs, while the model steroids exhibit little or no surface activity in
hydrocarbon/air or water/air interface. The hydrophobic drugs can compete with
surfactant molecules for the oil/water interface. The ability of saturated drugs to compete
for oil/water interface depends on the concentrations of the surfactant. The competition
phenomena can be quantitatively simulated using a thermodynamic model.

Copyright © Shaoxin Feng 2009
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Chapter 5
Surface-localized Thermodynamic Model Used to Predict the Micelle/water
Partitioning Coefficient

5.1.

INTRODUCTION

The capacity of micelle systems to solubilize poorly water-soluble drugs is one of the
most important parameters when considering these lipid assemblies as drug delivery
vehicles. The ability to quantitatively predict the micelle/water partitioning coefficients
based on physicochemical properties of drug and surfactant would guide formulators to
choose effective solubilizer and speed up the formulation process.

Currently, the majority of the predictions of micelle/water partitioning coefficients are
based on empirical linear free energy relationship (LFER). The most frequently used
method is the linear relationship between logarithm of micelle/water partitioning
constants and the logPoctanol/water values for a specific micelle system

(Valsaraj and

Thibodeaux, 1990; Treiner and Mannebach, 1987; Alvarez-Munez and Yalkowsky, 2000;
Wiedmann and Kamel, 2002). While LFERs are successful in correlating solubility
with molecular descriptors, the method is strongly dependent on the members of the
“training set”. Both Valsaraj et al. (Valsaraj and Thibodeaux, 1990) and Treiner et al.
(Treiner and Mannebach, 1987) have published successful correlation for solubilization
of solutes in SDS micelles based on training sets of molecules of simple structure. If the
Km/w data in Table 3.2~3.4 for steroids, benzodiazepines and parabens are plotted on
those very same graphs, (Fig. 5.1), the correlation is much less successful, most likely
because the structures of the drugs are significantly different than those of solutes of the
training sets.
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Figure 5.1. Correlation between logarithm of micelle/water partitioning coefficient for
SDS, Km/w, and logPoctanol/water. The solid line is from Treiner and Mannebach (Treiner and
Mannebach, 1987) and the dotted line is from Valsaraj and Thibodeaux (Valsaraj and
Thibodeaux, 1990). The plotted points are experimental data taken from the present work
in Tables 3.2~3.4.
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Mukerjee et al. (Mukerjee and Cardinal, 1978; Mukerjee, 1979) first applied a two-state
thermodynamic model to simulate the micelle/water partitioning by considering both
surface and core regions as solubilization loci. The results showed the micelle surface
played an important role in solubilization and the agreement between predictions and
theory are quite good in the model anionic micelle systems. The limitations of the work
include the simple molecular structures of model compounds, such as alkanols, ketones,
amides and aromatics, as well as surfactant selection (only anionic). In this Chapter, we
will use a surface-localized thermodynamic model adapted from Mukerjee‟s two-state
model to predict the micelle/water partitioning coefficients of three series of model drugs
in three micelle systems with different charges. Then we will extend the model beyond
the dilute condition to simulate the micellar solubilization at high drug concentration, a
condition of critical importance in pharmaceutical formulation work.

5.2.
5.2.1.

MATERIALS AND METHODS
Materials

Progesterone (>99%), testosterone (>98%), 17 -estradiol (>98%), diazepam, temazepam,
oxazepam, prazepam, methylparaben (>99%), ethylparaben (>99%), butylparaben
(>99%), sodium dodecyl sulfate (>99%), dodecyltrimethylammonium bromide (>99%),
dodecyle -D-maltoside (>98%) and dodecane (>99%) were obtained from
Sigma-Aldrich (St. Louis, MO). 11-hydroxyprogesterone (>95%) was from Janssen
Chimica (New Brunswick, NJ).

5.2.2.

Purification of Dodecane:

In order to remove surface active impurities dodecane was purified using a
double-washing method. The dodecane was washed using methanol: about 40mL
dodecane was mixed with 40mL methanol in separating funnel. The system was shaken
for 1 minute and permitted to rest for 5 minutes. The liquid separated to form two layers.
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The bottom layer containing methanol was removed. The top dodecane-rich layer was
further washed 4 times with fresh methanol. The second washing step was carried out
with deionized water. The washing was designed to remove impurities in dodecane that
were soluble in methanol and the second step could remove methanol any water-soluble
impurities.

The dodecane/water interfacial tension was measured for unpurified and purified solvent
as a function of time. The results are shown in Figure 5.2. Generally, with unpurified
dodecane, the oil/water interfacial tension tended to decrease markedly as a function of
time (Mysels, 1986). For purified dodecane, the drop of dodecane/water interfacial
tension over 40 hours was only about 0.5 mN/m.

5.2.3.

Surface-localized Thermodynamic Model

A detailed derivation of the surface-localized thermodynamic model is included in
Appendix 2.
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Figure 5.2, Dodecane/water interfacial tension as a function of time before and after
purification of dodecane.
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5.3.
5.3.1.

RESULTS AND DISCUSSION
Drug Solute-Specific Parameters of Solubilization in Micelles

The molar volumes of the model drugs are required in evaluating the effect of Laplace
pressure, e.g. Eq.(A2.4). The volumes were estimated based on the occupied volumes of
the molecules in crystalline phases from the crystal structures found in Cambridge
Structure Database (Allen, 2002). The volume of each model drugs is listed in Table 5.1.
Based on the model there are two other key parameters related to the drug substances
solubilized in micelles: the first is the transfer free energy from aqueous solution to
hydrocarbon/water interface, G waterinterface ; and the second is the area occupied by drug
molecule at the oil/water interface, adrug. To determine these key parameters
independently the dodecane/water interfacial tensions were measured as a function of
drug concentration.

The ratio of drug concentrations between hydrocarbon and water

phases were set to be equal to hydrocarbon/water partitioning coefficient determined in
Chapter 3. From these data, adrug and G waterinterface could be determined by fitting the
results to Eq. (A1.8) using Scientist® software.

The measured dodecane/water interfacial tensions as a function of drug concentration in
aqueous phase are shown in Figures 5.3 (for steroids), 5.4 (for benzodiazepines), 5.5 (for
parabens) and 5.6 (17-estradiol and oxazepam). In those figures, the fitted curves based
on surface adsorption model, Eq. (A1.8), are also shown as solid lines. The results in
Figure 5.7 demonstrate the relationship between the ~C curve and the fitted parameters,
G waterinterface and adrug. The initial slope of interfacial tension as a function of drug

concentration (Fig. 5.7a) is related to the transfer free energy term (Eq. (A2.6)):

slope  

RT
 Gwaterinterface 
exp
.
a water
RT
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Table 5.1, Volumes of each molecules of model drugs based on reported crystal
structures.
Drug
Progesterone
Testosterone
11-hydroxyprogesterone
Diazepam
Temazepam
Prazepam
Methylparaben
Ethylparaben
Butylparaben
17-estradiol
Oxazepam

V(Å³)
441.3
406.9
450.7
344.3
356.7
417.7
182.7
213.8
259.2
370.2
330.5
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Dodec ane-water interfac ial tens ion (mN/m)
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Figure 5.3, Dodecane/water interfacial tensions as a function of drug concentration in
aqueous phase for 3 model steroids. The markers are experimental data and the solid lines
are fitted curves based on surface adsorption model, Eq.(A1.8).
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Figure 5.4, Dodecane/water interfacial tensions as a function of drug concentration in
aqueous phase for 3 model benzodiazepines. The markers are experimental data and the
solid lines are fitted curves based on surface adsorption model, Eq.(A1.8).
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Figure 5.5, Dodecane/water interfacial tensions as a function of drug concentration in
aqueous phase for 3 model parabens. The markers are experimental data and the solid
lines are fitted curves based on surface adsorption model, Eq.(A1.8).
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Figure 5.6, Dodecane/water interfacial tensions as a function of drug concentration in
aqueous phase for 17-estradiol and oxazepam. The markers are experimental data and
the solid lines are fitted curves based on surface adsorption model, Eq.(A1.8).
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exp  waterinterface 
RT



a


b

RT
 Gwaterinterface 
exp 

awater
RT





RT
a drug

Figure 5.7, A schematic of relationship between the two key parameters of drug
substances, G waterinterface , a drug and the oil/water interfacial tension versus drug
concentration (a) or logarithm of drug concentration (b).
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In the ~logC plot (Fig. 5.7b), the linear limit is approached at high concentration. The
slope of the line is related to the area occupied by the drug at the interface:
slope  

RT
. The linear region will intersect the x-axis at a surface tension equal to 0.
a drug

 G

The intercept of the x-axis is equal to exp waterinterface  . It should be kept in mind that
RT


the concentration of the drug must be mole fraction which is unitless. From the
relationship, the transfer free energy value depends on the position of the ~logC curve: a
shift to the right of the curve corresponds to a larger transfer free energy.

The fitting results in Fig 5.3~5.6 are very satisfactory for all cases except for
17-estradiol and oxazepam. For these latter two drugs the measured interfacial tensions
exhibited poor reproducibility which we believe contributed to the unsatisfactory nature
of the fit. The fitted parameters are shown in Table 5.2. Scientist® software package was
employed to carry out the statistical analysis and provide the 95% confidence intervals
for those parameters. Not surprisingly, in all cases, the transfer free energies were
negative. From the results in the table, progesterone has the largest negative transfer free
energy from water to dodecane/water interface which indicates that the drug is
energetically favored to reside at the interface. To further illustrate the comparison, the
~C curves for 9 drugs are shown in Figure 5.8. In the figure, the curves have the rank
order, from left to right, progesterone, prazepam, 11-hydroxyprogesterone, testosterone,
diazepam, temazepam  butylparaben, ethylparaben and methylparaben. This rank order
is the same as that of transfer free energies from low to high, as indicated in Fig. 5.7.
Based on physical picture, the higher the surface activity, the lower transfer free energy
and the smaller the concentration necessary to lower the dodecane/water interfacial
tensions by the same amount.

106

Table 5.2, Fitted transfer free energy Gwater→interface and occupied area at oil/water
interface for all model drugs. Listed are average values +/- 95% confidence intervals.
Drug
Progesterone
Testosterone
11-hydroxyprogesterone
Diazepam
Temazepam
Prazepam
Methylparaben
Ethylparaben
Butylparaben
17-estradiol
Oxazepam

Gwater→interface(kJ/mol)
-41.78±0.45
-36.18±0.34
-37.05±0.17
-34.41±0.32
-31.94±0.33
-39.38±0.40
-21.27±0.33
-24.21±0.43
-31.41±0.16
-36.31±2.91
-31.34±0.74
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a(Å²)
58.0±4.4
59.8±4.9
64.8±1.9
46.2±3.7
41.3±3.7
54.0±5.7
31.9±4.0
31.8±4.6
34.1±1.2
57.4±105.3
42.1±17.5

Surface activities of model drug in oil-water interface
Dodecane-water interfacial tension .
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Figure 5.8, Summary of dodecane/water interfacial tensions as a function of drug
concentration in aqueous phase for 9 model drugs. All curves are experimental data in the
absence of fitted theoretical lines.
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If we compare the surface activities of the members of the same series of the model drugs
(structures are shown in Chapter 3), the effect of some functional groups could be
hypothesized. The addition of hydroxyl group to a molecule can significantly decrease its
oil/water

interfacial

activities:

For

example,

the

transfer

free

energy

of

11-hydroxyprogesterone is less negative than that of progesterone and the interfacial
activity of temazepam is much lower than that of diazepam. When testosterone is
compared to progesterone the hydroxyl group appears to lower the interfacial activity to a
greater extent than the acetyl group. The addition of hydrocarbon moiety to the molecule
appears to increase the interfacial activity: For example, by adding a cyclopropyl group to
diazepam, prazepam exhibits greater interfacial activity. Similarly, by lengthening the
alkyl group, the surface activity of parabens exhibits the rank order methylparaben <
ethylparaben < butylparaben.

The negative sign of the transfer free energies listed in Table 5.2 suggests the
dodecane/water interface is more energetically favorable than bulk aqueous phase for all
the model drugs. The transfer free energy from hydrocarbon to oil/water interface can
also be estimated from the following equation:
Ghy drocarbon interface  G waterinterface  RT ln K h / w

(5.1)

The values of G hy drocarbon interface are shown in Table 5.3. When the structure ~
G hy drocarbon interface relationships are examined, it appears that the hydroxyl group has

significant influence on decreasing the transfer free energy from oil to interface. On the
other hand, the addition of hydrocarbon group surprisingly makes very small changes to
the oil to interface transfer free energy. For example, G hy drocarbon interface of
11-hydroxyprogesterone and temazepam are significantly lower than those of
progesterone and diazepam, respectively. The G hy drocarbon interface values are relatively
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Table 5.3, Estimated transfer free energy from hydrocarbon to oil/water interface,
Ghydrocarbon→interface, for model drugs
Drug
Progesterone
Testosterone
11-hydroxyprogesterone
Diazepam
Temazepam
Prazepam
Methylparaben
Ethylparaben
Butylparaben
17-estradiol
Oxazepam

Gdodecane→interface(kJ/mol)
-21.36±0.46
-26.43±0.37
-33.86±0.32
-20.22±0.35
-25.21±0.34
-19.59±0.43
-23.79±0.35
-23.48±0.46
-23.07±0.19
-30.46±2.91
-39.62±1.06
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constant when comparing diazepam with prazepam, or among the methyl-, ethyl- and
butylparabens. Unsurprisingly, these results suggest the hydrocarbon regions of the model
drugs likely remain in the hydrocarbon phase when the molecules are located at the
hydrocarbon/water interface.

5.3.2.

Surfactant-Specific Parameters Used in the Thermodynamic Model

In this section, we discuss the rational behind the choice of surfactant-specific parameters
employed in Equations (A2.13) and (A2.14). The parameters used for surfactants and
micelles included minimum occupied area by surfactant molecules (a), radius (r) and
aggregation number (Naggre) of the micelles, area per surfactant molecule (A) and surface
pressure () at micelle surface, and Laplace pressure acting on the micelles (P). The first
three parameters (a, r, and Naggre) are summarized in Table 5.4. Parameters, A,  and P,
can be calculated from a, r, and Naggre.

The areas occupied by SDS or DTAB at the hydrocarbon/water interface were reported in
Chapter 4 to be 32.0 (for SDS) and 37.1Å² (for DTAB) by fitting Eq. (A1.13) to
experimental -A curves from literatures (Haydon and Taylor, 1960). The occupied area
by DM at dodecane/water interface was determined by fitting Eq. (A1.8) to experimental
~C curve, Fig. 4.9, with the fitted value of 41.4 Å².

The aggregation number of SDS micelles was 51 from Thevenot et al. (Thevenot et al.,
2005) employing time-dependent static light scattering method. For cationic surfactant
DTAB, the aggregation number was 56 from Rafati et al. (Rafati et al., 2003) using
potentiometric technique. The aggregation number of nonionic surfactant DM was 113 by
Bucci et al. (Bucci et al., 1991) using small angle neutron scattering method.
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Table 5.4, The parameters of surfactants and the corresponding micelles used in the
surface-localized model. The data with asterisk are independent and obtained from
literatures (detail information is in main text). The other data are derivative from those
independent parameters.

SDS

DTAB

DM

asurfact (Å²)

32.0±0.6

37.1±0.6

41.4±2.7

r (Å)

19.7*

18.4*

22.4*

Naggr

51*

56*

113*

A=4r2/Naggr (Å²)

95.6

76

55.8

 (mN/m)

11.6

17.9

22.9

P=2(0-)/r (atm)

405

366

257
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The radii of the micelles were estimated as being equal to the length of single surfactant
molecule. The radii of SDS, DTAB and DM micelles were 19.7, 18.4 and 22.4Å
respectively. The molecular structures of SDS and DTAB were obtained from the
corresponding crystal structure from Cambridge Structure Database (Allen, 2002).
Unfortunately, there is no reported crystal structure for dodecyl -D-maltoside, but the
molecular structure of methyl -maltoside was available and served as an analogue of
head group of DM. The maximum inter-atomic distance of dodecyl sulfate molecule was
18.4Å between one oxygen atom in sulfate group and one hydrogen atom in terminal
methyl group. By considering the atomic radii of those atoms, the total length of the
molecule was about 19.7Å. Using the same principle, the length of DTAB molecule was
close to 18.4Å based on the maximum inter-atomic distance of 17.9Å between two
hydrogen atoms in methyl group of head group and in terminal methyl group of
hydrocarbon tail. For dodecyl -D-maltoside, the length of hydrocarbon chain was 14.6Å
and the maximum inter-atomic distance of maltoside head group was 11.3Å. The head
group and the alkyl tail were connected with each other through a carbon-oxygen bond
that could rotate easily and the angle between the long axes of the head group and
hydrocarbon chain varied from 95o to 147o. The average angle was 119o and the average
value of the maximum inter-atomic distances of the DM molecule for different
configurations was 22.4Å. The distance was chosen as the radius of DM micelles without
considering the atomic radii because the DM micelles had a large hydrophilic head group
that let us choose a slightly smaller length compared to the total length of the molecule
without lose of accuracy.

The areas occupied per surfactant molecule at the micelle surface were calculated based
on geometry, A=4r2/Naggre. The surface pressure, =0-, at the micelle surface was
determined by the -A relationship, Eq.(A1.13) for anionic surfactants (SDS or DTAB) or
113

Eq.(A1.15) for nonionic surfactants (DM). The parameters used in these equations were
determined in Section 4.3.3.2.

The Laplace pressure was calculated using equation: P=2/r=2(0-)/r based on
assumption that the micelle has spherical shape.

5.3.3.

Application of Surface-localized Model to Predict the Micelle/water

Partitioning
The micelle/water partitioning coefficients of dilute solutes can be predicted based on the
surface-localized model described in Appendix 2. The model describes micellar
solubilization as the co-localization of drug and surfactant at highly curved interface. The
calculated micelle/water partitioning coefficients of 9 model drugs in 3 micelle systems
are compared to experimental data (Chapter 3) with the results shown in Figure 5.9.
Oxazepam and 17-estradiol were not included because there were poor estimations of
their interfacial activities at hydrocarbon-water interface. When butylparaben was
solubilized in DTAB and DM solutions, the solutions became cloudy, suggesting that the
Krafft point had been exceeded. Therefore there is no experimental micelle/water
partitioning coefficient for butylparaben in the two surfactant systems. It is clear that the
predictions for the remaining 25 surfactant/drug combinations are in good agreement
with the experimental result. It should be noted a broad range of the micelle/water
partitioning constants that cover three orders of magnitude are included. There is no
result that has a deviation greater than a factor of 2, and a majority of the data points (19
out of 25) have deviations within a factor of 1.5. The R-square is equal to 0.959.

Although the surface-localized model has a complicated final expression, e.g. Eq. (A2.13)
or (A2.14), the calculated micelle/water partitioning coefficient can be analyzed by
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Figure 5.9, Comparison between experimental and predicted micelle/water partitioning
coefficients (Km/w) of 9 model drugs in 3 surfactant systems.
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separating the expression into several components in terms of the basic relationship
Eq.(A2.4):
Km/ w 


 A  f  exp[  PV RT ]  K h / w exp[  PV RT ]
Xw

The values for terms,


, A, f , exp[  PV RT ] and
Xw

(5.2)

K h / w exp[  PV RT ] (also

labeled as Km/w,core), are explicitly listed in Table 5.5 along with the predicted and
experimental Km/w values. P=2/r.

Firstly, the contributions of the core region to the

solubilization, K h / w exp[  PV RT ] , are compared to the total micelle/water partitioning
constants. The fraction of solubilization by micellar core (as determined by dividing
K h / w exp[  PV RT ]

by

Km/w(calc.))

has

a

range

from

6.9x10-7

(11-hydroxyprogesterone in SDS micelles) to 2.6x10-3 (prazepam in DM micelles). The
results clearly show that core-localized solubilization is insufficient to explain
experimental results and that the micelle surface is likely the dominant solubilization site.

The contributions of Laplace pressure on solubilization capacity, exp[  PV RT ] , vary
from 0.011 (11-hydroxyprogesterone in SDS) to 0.32 (methylparaben in DM).
Apparently the term exerts a significant influence on the total partitioning properties and
can not be ignored. The Laplace pressure in the three micelle systems has the rank order:
SDS > DTAB > DM, and correlates well with the differences in surface pressure at the
micelle surface and the size of micelles. DM micelle has the greatest diameter and the
largest surface pressure resulting in the lowest interfacial tension at micelle surface.
Those two factors result in DM exhibiting the lowest Laplace pressure. For drug
substances, the larger the molar volume, the more significant influence the Laplace
pressure makes on solubilization capacity. Accordingly, 11-hydroxyprogesterone was
most affected and methylparaben was least influenced by Laplace pressure.
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Table 5.5, The predicted micelle/water partitioning coefficients, Km/w(calc.), their components, exp(-PV/RT), /Xw, A, f, Km/w, core
(=Kh/wexp(-PV/RT)), and experimental micelle/water partitioning coefficients, Km/w(exp.), for 9 model drugs solubilized in 3 micelle
systems.
exp(-PV/RT)

-1

/Xw (Å )

A (Å)

f

Km/w, core

Km/w(calc.)

Km/w(exp.)

Progesterone

SDS

0.01225

2.79E+06

95.6

0.1609

46.50

5.25E+05

(3.69±0.13)E+05

Testosterone

SDS

0.01726

2.90E+05

95.6

0.1529

0.88

7.33E+04

(1.14±0.05)E+05

11OH-prog*

SDS

0.01115

4.13E+05

95.6

0.1328

0.04

5.84E+04

(6.75±0.39)E+04

Diazepam

SDS

0.03224

1.42E+05

95.6

0.2245

9.92

9.84E+04

(8.93±0.39)E+04

Prazepam

SDS

0.0155

1.06E+06

95.6

0.1801

45.53

2.82E+05

(4.03±0.26)E+05

Temazepam

SDS

0.02849

5.24E+04

95.6

0.2575

0.43

3.68E+04

(4.70±0.11)E+04

Methylparaben

SDS

0.16159

7.05E+02

95.6

0.3357

0.06

3.66E+03

3.24E+03

Ethylparaben

SDS

0.11849

2.31E+03

95.6

0.3366

0.16

8.82E+03

8.51E+03

Butylparaben

SDS

0.07533

4.23E+04

95.6

0.3155

2.19

9.62E+04

7.24E+04

Progesterone

DTAB

0.01863

2.79E+06

76

0.0574

70.73

2.27E+05

(1.79±0.13)E+05

Testosterone

DTAB

0.02541

2.90E+05

76

0.0531

1.30

2.98E+04

(5.40±0.31)E+04

11OH-prog*

DTAB

0.01711

4.13E+05

76

0.0428

0.06

2.29E+04

(3.57±0.19)E+04

Diazepam

DTAB

0.04472

1.42E+05

76

0.096

13.76

4.64E+04

(2.94±0.10)E+04

Prazepam

DTAB

0.02305

1.06E+06

76

0.0683

67.72

1.27E+05

(8.76±0.57)E+04

Temazepam

DTAB

0.03999

5.24E+04

76

0.1185

0.61

1.89E+04

(1.67±0.04)E+04

Methylparaben

DTAB

0.19224

7.05E+02

76

0.1783

0.07

1.84E+03

(1.73±0.04)E+03

Ethylparaben

DTAB

0.14519

2.31E+03

76

0.1791

0.19

4.57E+03

(4.28±0.15)E+03

*Abbreviation of 11-hydroxyprogesterone
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Table 5.5 (cont.), The predicted micelle/water partitioning coefficients, Km/w(calc.), their components, exp(-PV/RT), /Xw, A, f, Km/w,
core (=Kh/wexp(-PV/RT)), and experimental micelle/water partitioning coefficients, Km/w(exp.), for 9 model drugs solubilized in 3
micelle systems.
-1
exp(-PV/RT)
A (Å)
f
Km/w, core
Km/w
Km/w(exp.)
/Xw (Å )
Progesterone

DM

0.06167

2.79E+06

55.8

0.0156

234.2

1.50E+05

(9.49±1.18)E+04

Testosterone

DM

0.07663

2.90E+05

55.8

0.0141

3.92

1.75E+04

(3.09±0.48)E+04

11OH-prog*

DM

0.05812

4.13E+05

55.8

0.0107

0.21

1.43E+04

(1.32±0.09)E+04

Diazepam

DM

0.1138

1.42E+05

55.8

0.0301

35.02

2.72E+04

(2.10±0.07)E+04

Prazepam

DM

0.07158

1.06E+06

55.8

0.0195

210.3

8.24E+04

(6.51±0.33)E+04

Temazepam

DM

0.10524

5.24E+04

55.8

0.0395

1.59

1.21E+04

(9.63±0.35)E+03

Methylparaben

DM

0.31556

7.05E+02

55.8

0.0667

0.11

8.28E+02

(1.16±0.10)E+03

Ethylparaben

DM

0.25931

2.31E+03

55.8

0.067

0.35

2.24E+03

(2.85±0.05)E+03

*Abbreviation of 11-hydroxyprogesterone
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The area per molecule term “A” can be best envisioned as the inverse of the density of
surfactant molecules at the micelle surface. A larger value for “A” corresponds to a lower
density of surfactants at the micellar surface. Since the drug is hypothesized to co-adsorb
with surfactant for the oil/water interface, the lower surfactant density of surfactant will
permit drug molecules to more easily adsorb to the micelle surface and thus increase the
micelle/water partitioning coefficient.

The term, /Xw, represents the surface activities of the solutes at an oil/water interface in
the absence of surfactants. This term reflects the transfer free energy of the solute from
water to hydrocarbon/water interface (Eq.(A2.7)). A broad range for the model drugs
from 7x102 (methylparaben) to 3x106 Å-1 (progesterone) is evident.

The relative adsorption potential, f, is defined as a ratio between surface density of drugs
in the presence and absence of surfactant. The factor reflects the ability of the drug to
co-adsorb with surfactants at the oil/water interface. Since the ability of the drug to get
into oil/water interface in the absence of surfactants has been included in the /Xw term,
the f factor takes into account the effect of the presence of the surfactants. The magnitude
of the f factor is between 0.011 (11-hydroxyprogesterone in DM) and 0.34 (methyl- and
ethylparabens in SDS). From Eq. (A2.11) and (A2.12), the f factor is affected mainly by
two parameters: surface pressure of the surfactant at micelle surface and minimum
occupied area by the drug. High surface pressure, due to the stronger surface activity of
the surfactant, will make adsorption of drug molecules onto the oil/water interface more
difficult. When we compare the three surfactants, the f factor has the order of SDS >
DTAB > DM because of the surface pressure has the reverse ranking order.
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The second component of the adsorption potential is the occupied surface area by the
drug molecule. When the drug must clear a larger area in order to move onto the oil/water
interface, it has a weaker ability to compete with surface active agents for the interface.
The rank order of relative adsorption factors in the same micelle system is reversely
correlated to the occupied areas by the drug molecules: methylparaben ≈ ethylparaben >
butylparaben > temazepam > diazepam > prazepam > progesterone > testosterone >
11-hydroxyprogesterone.

To assess the relative importance of those terms, the units must be identical. The /Xw
term is combined with “A” term to form a unitless term /Xw to compare to the other
two unitless terms, exp[  PV RT ] and f. The /Xw term ranges from 3.9x104 to
2.7x108 and thus makes the greatest contribution to total micelle/water partitioning
coefficients. The Laplace pressure effect and the relative adsorption factor are within two
orders of magnitude and make significant, but not the dominant, contributions to the
micellar solubilization.

5.3.4.

Sensitivity of Parameter Selections to the Prediction of Micelle/water

Partition Coefficient
As is evident in Table 5.4, there are a number of physical parameters that are critical to
the application of the thermodynamic model outlined in Equation (A2.13) and (A2.14).
Most notable of these critical parameters are size of the micelle, as defined by radius,
aggregation number, and the interfacial areas occupied by water and drugs. In this section,
the sensitivity of the thermodynamic model to the values selected for these critical
parameters is evaluated. The strategy is to vary each parameter individually over a range
of physically-relevant values and to observe the extent to which Km/w is influenced by the
variation. It is important here to realize that the values of the parameters are not being
“floated” to fit an optimal result, but rather are being systemically-varied to illustrate the
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ultimate effect on Km/w by a range of possible values. The following table lists the
“independent” parameters to be tested, parameters depending on the choice of those
independents, and the corresponding section number.

Independent
parameter to be tested

Parameters dependent on choice of Section
independents
number

r (radius of micelle)

A (micelle surface area per surfactant)
 (surface pressure)
P (Laplace pressure)
Naggre
(aggregation r (radius of micelle)
number of micelle)
A (micelle surface area per surfactant)
 (surface pressure)
P (Laplace pressure)
awater (interfacial area asurfact (interfacial area occupied by
occupied by water)
surfactant)
adrug (area occupied by drug)
Gtrans (free energy of transfer for drug
from water to oil/water interface)
adrug (interfacial area Gtrans (free energy of transfer for drug
occupied by drug)
from water to oil/water interface)

5.3.4.1.

5.3.4.1

5.3.4.2

5.3.4.3

5.3.4.4

Sensitivity of Predicted Km/w Values to the Radii of Micelles

In evaluating the surface-localized model (see results in Table 5.4), radii of the micelles
were based on the dividing oil/water interface at the micelle surface and were calculated
from the lengths of those surfactant molecules including head groups (see Section 5.3.2).
Although experimentally-determined micellar radii are available in the literature, these
values were not employed in the model simulations. The experimental values are
obtained by different detecting techniques, such as dynamic light scattering, small-angle
X-ray diffraction, small-angel neutron scattering, gel filtration and diffusivity
measurements (Anacker and Ghose, 1968; Svens and Rosenholm, 1973; Lin et al., 1990;
Soderman et al., 2004). Typically, the results exhibit a broad range of values. More
importantly, the experimental radii tend to include effects of bound water and electrolytes
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and are not defined solely at the dividing oil/water interface, as is defined in the
thermodynamic model.

The sensitivity of the thermodynamic model to the radii of micelles was tested by varying
the parameter „r‟ without changing any other independent parameters. Some dependent
parameter would surely be modified due to the changing micellar size, such as Laplace
pressure, area per surfactant molecule at micelle surface and the surface pressure. The
radii of SDS micelles were varied from 17 to 20.7Å. A small radius would correspond to
more efficient packing of surfactant molecules in the micelles and a large radius would
indicate looser structures of the micelles. Three model drugs, progesterone, diazepam and
methylparaben, were chosen to run the sensitivity test with the results shown in Figure
5.10. Here, the ratios of Km/w at the test radius to the Km/w at the radius of 19.7Å (Table
5.4) were calculated. Clearly the Km/w value increases with larger micellar size because
the looser micellar structure is expected to provide larger interfacial volume with which
to solubilize drugs. The micelle/water partitioning constants are quite sensitive to the
choice of the micellar radius. The calculated Km/w increases 28~50% with each 1Å
increment of micellar radius. Solubilization of progesterone is most sensitive to the radii
and methylparaben is the least sensitive among the three model drugs. Progesterone
occupies the largest area at the micelle surface and has the largest molecular volume
among the model drugs and it seems likely that progesterone is more sensitive to the
available space in the micelle surface as compared to the other two drugs.

Figures 5.11 and 5.12 show the sensitivities of predicted Km/w in DTAB and DM micelles
to the radii of those micelles. The size ranges for DTAB and DM are 17~20Å and
20.7~24Å respectively. Again, the micelle/water partitioning coefficient is sensitive to the
choice of the micellar radius. For DTAB micelles, one angstrom increment could produce
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Km/w /Km/w (r=19.7Å) in SDS micelles

1.6
progesterone

1.4

diazepam
1.2

methylparaben
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19

20
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r (Å)

Figure 5.10, The sensitivity of calculated micelle/water partitioning coefficient in SDS
micelle systems to the radius of SDS micelles. The arrow marks the radius employed in
the evaluation of the thermodynamic model, Table 5.4.

Km/w /Km/w (r=18.4Å) in DTAB micelles

2.5
progesterone
2

diazepam
methylparaben

1.5
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Figure 5.11, The sensitivity of calculated micelle/water partitioning coefficient in DTAB
micelle systems to the radius of DTAB micelles. The arrow marks the radius employed in
the evaluation of the thermodynamic model, Table 5.4.
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Km/w /Km/w,0 (r=22.4Å) in DM micelles
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Figure 5.12, The sensitivity of calculated micelle/water partitioning coefficient in DM
micelle systems to the radius of DM micelles. The arrow marks the radius employed in
the evaluation of the thermodynamic model, Table 5.4.
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40~56% enhancement in Km/w value. For nonionic DM micelles, increasing 1Å of „r‟
would raise Km/w by 67~88%.

When we compare the three micelle systems, the solubilization by DM micelle is the
most sensitive to the micellar size and SDS micelle system is the least sensitive. One
possible reason is the different packing efficiency of those micelles: The packing of
nonionic surfactant is more compact than ionic surfactants due to the absence of
repulsion forces due to the uncharged headgroup. When the two charged micelles are
compared to each other, the positive charge of DTAB between head groups is screened to
some extent by the methyl groups in the head, while the negative charges of SDS are on
the surface of the head group and the repulsive interactions between head groups would
be stronger. Therefore the DTAB micelles are more efficiently packed than SDS micelles.
The more tightly packed micelles would be more sensitive to the space available for
solubilization of model drugs.

It is clear from the sensitivity analysis that the predicted Km/w is strongly dependent on
the value of the „r‟ term and that the dividing oil/water interface of the micelles has to be
selected carefully.

5.3.4.2.

Sensitivity of Predicted Km/w Values to Aggregation Number of Micelles

Many experimental studies on micelles have shown an increase in the aggregation
number with increasing surfactant concentrations (Rafati et al., 2003; Bucci et al., 1991).
There is experimental evidence for a relation between aggregation number and
concentration of surfactant in our studied systems. For examples, SDS micelles have a
aggregation number of 76 at 50mM and the number increases to 88 at 150mM (Bucci et
al., 1991); the aggregation number of DTAB micelles is 56 at 15mM and rises to 62 at
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92mM (Rafati et al., 2003); DM micelles have values of N=113 at 50mM and N=129 at
150mM (Bucci et al., 1991).

To test the sensitivity of Km/w on the aggregation number „N‟, an appropriate relationship
between the radius of micelles and the „N‟ must be written. There are two approaches to
deal with the effect of increasing surfactant concentration. One approach is to assume that
micelles grow larger, while maintaining a spherical shape, as the total surfactant
concentration in the system is increased. This approach assumes that the density of
surfactant molecules in a micelle remains constant with increasing micelle size. The
second approach assumes that the micelles take on the shape of a prolate ellipsoid. In this
case, curvature restricts the size of the micelle. With a restriction on the size of the
micelle, increasing the aggregation number of micelles must result in greater density of
surfactant molecules in a micelle.

Based on the growing-sphere approach, the r~N relationship can be simply expressed as:

r r0  N N 0 

13

(5.3)

For an ellipsoidal shaped micelle, the additional surfactant molecules have more efficient
packing as compared to spherical shaped micelle. One surfactant molecule in spherical
micelles mainly occupies a cone shape with the volume equal to

1
Sr , where the S is the
3

occupied surface area by each molecule and r is the length of the molecule. On the other
hand, an additional surfactant molecule in an ellipsoid shaped micelle occupies a
pie-shaped wedge with the volume equal to

1
Sr . Since the core region is limited by the
2

packing of the hydrocarbon chain and had a constant density, the cone shape is not able to
pack as efficiently on the surface compared with the pie-shape. The additional molecules
were assumed to have a density of 1.5 times of the original density. The length of the
three principle axes of the prolate ellipsoid is
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a  r0

N 0  2 3  N  N 0 
N0

(5.4)

b  c  r0
The total surface area of a prolate ellipsoid is
b

a 2 b arccos 

a
S  2  b 2 
2
2

a  b 




(5.5)

The average curvature could use the following approximation:
1  N  2 3  N  N 0 
average curvature  0

r0 
N0


1 3

(5.6)

The approximation had an error of <1.7% when the axial ratio of the ellipsoid was below
2. The curvature was employed in estimating the Laplace pressure in prolate
ellipsoid-shaped micelle.

Listed in Table 5.6 are the predicted micelle/water partitioning constants as a function of
aggregation number for SDS and DTAB and Table 5.7 for DM. Aggregation numbers 75
and 100 were tested for ionic surfactants and N=120 and 130 were used for DM micelles.
For purpose of comparison, the values of the Km/w calculated with the parameters listed in
Table 5.4 are included. In the case of SDS micelles, the calculated Km/w of three steroids
and three benzodiazepines increase significantly with large aggregation number under
spherical shape condition. On the other hand, only a small variation in partition
coefficients is observed with increasing aggregation number when the micelle assumes a
prolate shape. The biggest deviations are 45% for spherical-shape micelles and 14% for
prolate-shape micelles. When parabens are solubilized in SDS micelles, spherical shape
micelles would produce smaller changes of Km/w with large aggregation number
compared to those from ellipsoidal shape micelles. The deviations based on sphere shape
are <12% compared to <30% based on prolate shape.
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Table 5.6, Sensitivity of micelle/water partitioning coefficients in SDS and DTAB micelle
systems to the aggregation number of the micelles
Km/w
Original

Km/w spherical

Km/w ellipsoidal

Naggre=75

Naggre=75

Naggre=100

Naggre=100

Progesterone

SDS

5.25E+05

6.88E+05

7.62E+05

5.25E+05

5.12E+05

Testosterone

SDS

7.33E+04

8.97E+04

9.46E+04

6.81E+04

6.30E+04

11OH-prog*

SDS

5.84E+04

7.49E+04

8.11E+04

5.60E+04

5.27E+04

Diazepam

SDS

9.84E+04

1.17E+05

1.23E+05

9.27E+04

8.74E+04

Prazepam

SDS

2.82E+05

3.63E+05

3.99E+05

2.81E+05

2.74E+05

Temazepam

SDS

3.68E+04

4.58E+04

5.00E+04

3.69E+04

3.65E+04

Methylparaben

SDS

3.66E+03

3.57E+03

3.33E+03

2.97E+03

2.56E+03

Ethylparaben

SDS

8.82E+03

9.07E+03

8.79E+03

7.56E+03

6.75E+03

Butylparaben

SDS

9.62E+04

1.06E+05

1.07E+05

8.72E+04

8.09E+04

Progesterone

DTAB

2.27E+05

2.54E+05

2.46E+05

1.99E+05

1.61E+05

Testosterone

DTAB

2.98E+04

3.11E+04

2.80E+04

2.39E+04

1.75E+04

11OH-prog*

DTAB

2.29E+04

2.47E+04

2.27E+04

1.88E+04

1.39E+04

Diazepam

DTAB

4.64E+04

4.88E+04

4.57E+04

3.95E+04

3.16E+04

Prazepam

DTAB

1.27E+05

1.41E+05

1.37E+05

1.12E+05

9.19E+04

Temazepam

DTAB

1.89E+04

2.11E+04

2.11E+04

1.76E+04

1.55E+04

Methylparaben

DTAB

1.84E+03

1.67E+03

1.40E+03

1.38E+03

1.00E+03

Ethylparaben

DTAB

4.57E+03

4.36E+03

3.84E+03

3.65E+03

2.82E+03

*Abbreviation of 11-hydroxyprogesterone

Table 5.7, The sensitivity of micelle/water partitioning coefficients in DM micelle
systems to the aggregation number of the micelles
Km/w

Km/w spherical

Km/w ellipsoidal

Original

Naggre=120

Naggre=130

Naggre=120

Naggre=130

Progesterone

DM

1.50E+05

1.39E+05

1.24E+05

1.26E+05

9.68E+04

Testosterone

DM

1.75E+04

1.59E+04

1.37E+04

1.42E+04

1.04E+04

11OH-prog*

DM

1.43E+04

1.30E+04

1.12E+04

1.16E+04

8.36E+03

Diazepam

DM

2.72E+04

2.54E+04

2.27E+04

2.32E+04

1.82E+04

Prazepam

DM

8.24E+04

7.71E+04

6.92E+04

7.02E+04

5.49E+04

Temazepam

DM

1.21E+04

1.16E+04

1.07E+04

1.08E+04

8.99E+03

Methylparaben

DM

8.28E+02

7.57E+02

6.61E+02

6.97E+02

5.40E+02

Ethylparaben

DM

2.24E+03

2.08E+03

1.85E+03

1.93E+03

1.54E+03

*Abbreviation of 11-hydroxyprogesterone
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In DTAB micelle systems, for all model drugs, the effect of increasing aggregation
number on predicted Km/w values is less under spherical-shape micelle condition
compared to those from the ellipsoid shape. With spherical micelle shape, the deviations
of Km/w are within 10% for steroids and benzodiazepines and are 24% and 16% for two
parabens when aggregation number changed from 56 to 100. When the micelles are
assumed to be in the prolate shape, the greatest deviations of Km/w are 41% for steroids
and benzodiazepines and 46% for parabens.

In DM micelle systems, the predicted Km/w decrease with increasing aggregation number
no matter what the shape of the micelles. The spherical-shape micelles do exhibit smaller
changes of Km/w compared to ellipsoidal micellar shape. The greatest deviations from
original values are 22% for spherical shape and 42% for prolate shape.

As has been seen in Figures 3.14~3.22, the experimental partition coefficients are
insensitive to surfactant concentration and therefore the aggregation number. Under these
conditions, it is likely the DTAB and DM micelles will maintain a sphere shape while
SDS micelles will transform to prolate shape with increasing aggregation number. As an
example, almost doubling the size of the micelles of SDS and DTAB only produces
<30% change in Km/w values. For DM micelles, the sensitivity of Km/w to Naggre is a
slightly larger: a 15% increase in aggregation number resulted in 22% decrease in
micelle/water partition constants. For nonionic surfactant, the increasing of aggregation
number with increasing surfactant concentration is less than that observed in ionic
surfactant systems. Therefore, the sensitivity of Km/w to the surfactant concentration is
small.
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5.3.4.3.

Sensitivity of Predicted Km/w Values to Occupied Interfacial Areas by

Water Molecules
In the thermodynamic model being tested, the occupied areas by water molecules, awater,
and by surfactant molecules, asurfact, are correlated. This can be seen by examining
Figures 4.7 and 4.8 where Eq. (A1.13) was used to fit the two parameters to the
experimental -A curves of SDS and DTAB. When two parameters are directly correlated
to each other, testing one parameter is sufficient in evaluating model sensitivity. Here we
have chosen to test the effect of the occupied area by water molecules. As with other
studies, the choice of the parameter must be physically realistic and not be freely
adjustable. The size of the water molecule was well known. The commonly employed
value is about 10Å² (Lucassen-Reynders, 1981). Gumkowski‟s value, awater=7.62Å²,
(Gumkowski, 1986) had been used in our early studies. In this section, an area of 10Å² is
employed to test the sensitivity of the predicted Km/w to the area occupied by water.

Due

to the correlation between awater and asurfact, Eq. (A1.13) was fit to experimental -A
curves for SDS and DTAB shown in Figures 4.7 and 4.8 using awater=10Å². The fitted
values of asurfact were 33.8±0.6Å² for SDS and 38.9±0.6Å² for DTAB. For nonionic
surfactant DM, Eq. (A1.8) was employed to fit to experimental -C curve for DM, Fig.
4.9, using the test awater value and the fitted asurfact became 42.3±2.1Å². Compared to
original values in Table 5.4, the changes were less than 2Å² indicating the parameter
asurfact is not very sensitive to the occupied interfacial area of water molecules.

The areas occupied by surfactants are not the only parameters that correlate with the area
of water. The transfer free energy and interfacial area occupied by model drugs also
correlate with awater. As mentioned in Section 5.3.1, these two parameters were
determined by fitting to the experimental ~C curves, Fig.5.3~5.6, using Eq.(A1.8) where
parameter awater was present. Table 5.8 shows the fitted transfer free energies and
occupied interfacial areas of 9 model drugs using awater=10Å². Compared to parameter set
130

with awater=7.62Å², Table 5.2, the Gtrans drops by ~0.67kJ/mol while adrug increases by
about 1.1Å². Applying the new parameter set corresponding to relatively large area of
water molecules (10Å²), the predicted micelle/water partitioning coefficients for 9 model
drugs in 3 surfactant systems are listed in Table 5.9. In the table, the calculated Km/w
values using the initial parameter set with awater=7.62Å² are also listed for comparison.
The last column of the table shows the ratios between the predictions using two different
parameters sets. Clearly the ratios are very close to 1. The greatest deviation of these
ratios from a value of 1 is only 1.1% indicating the model predictions of Km/w are not
very sensitive to the choice of occupied interfacial areas by water molecules or surfactant
molecules.

5.3.4.4.

Sensitivity of Predicted Km/w Values to Interfacial Areas Occupied by

Solubilized Drugs
Once the awater term is fixed, the occupied interfacial area of drugs, adrug, and the transfer
free energy of the model drugs, Gwater→interface, become a directly correlated parameter
pair. In this section, only adrug will be adjusted to test the sensitivity of Km/w predictions.
Just like the water molecules, molecular structures of drug substances limit their range of
possible occupied areas at oil/water interface. In the following chapter, a molecular
simulation technique will be used to calculate the theoretical maximum and minimum
areas occupied by the drug molecules assuming the molecule could assume any
orientation. The results are listed in Table 6.2. In the model sensitivity test, four areas
were chosen for each model drug: the theoretical maximum area, the theoretical
minimum area, an area 10% larger than experimental fitted value, and an area 10%
smaller than experimental area. Using these areas, the transfer free energies,
Gwater→interface, were fitted using Eq.(A1.8). A Scientist® software was employed to run
the statistical analysis.
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Table 5.8, Fitted transfer free energies Gwater→interface and occupied areas at oil/water
interface for the model drugs using awater=10Å²
Drug
Progesterone
Testosterone
11-hydroxyprogesterone
Diazepam
Temazepam
Prazepam
Methylparaben
Ethylparaben
Butylparaben

Gwater→interface(kJ/mol)
-42.45±0.45
-36.85±0.34
-37.72±0.17
-35.08±0.32
-32.61±0.33
-40.05±0.40
-21.94±0.33
-24.88±0.43
-32.08±0.16
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adrug(Å²)
59.1±4.4
60.9±4.9
65.9±1.9
47.2±3.7
42.4±3.7
55.1±5.7
33.0±4.0
32.9±4.6
35.1±1.2

Table 5.9, Calculated micelle/water partitioning coefficients using new parameter set
(Table 5.8) corresponding to awater=10Å² compared to predictions using old parameters
with awater=7.62Å².

*

Km/w

Km/w

a=7.62Å²

a=10Å²

Ratio*

Progesterone

SDS

5.25E+05

5.29E+05

1.007

Testosterone

SDS

7.33E+04

7.39E+04

1.008

11OH-prog^

SDS

5.84E+04

5.89E+04

1.008

Diazepam

SDS

9.84E+04

9.92E+04

1.008

Prazepam

SDS

2.82E+05

2.84E+05

1.007

Temazepam

SDS

3.68E+04

3.70E+04

1.006

Methylparaben

SDS

3.66E+03

3.68E+03

1.007

Ethylparaben

SDS

8.82E+03

8.87E+03

1.006

Butylparaben

SDS

9.62E+04

9.70E+04

1.009

Progesterone

DTAB

2.27E+05

2.28E+05

1.004

Testosterone

DTAB

2.99E+04

3.00E+04

1.005

11OH-prog^

DTAB

2.30E+04

2.31E+04

1.005

Diazepam

DTAB

4.65E+04

4.68E+04

1.007

Prazepam

DTAB

1.27E+05

1.27E+05

1.004

Temazepam

DTAB

1.89E+04

1.90E+04

1.004

Methylparaben

DTAB

1.84E+03

1.85E+03

1.005

Ethylparaben

DTAB

4.58E+03

4.60E+03

1.004

Progesterone

DM

1.50E+05

1.51E+05

1.009

Testosterone

DM

1.75E+04

1.77E+04

1.010

11OH-prog^

DM

1.43E+04

1.44E+04

1.010

Diazepam

DM

2.72E+04

2.75E+04

1.011

Prazepam

DM

8.24E+04

8.30E+04

1.008

Temazepam

DM

1.21E+04

1.22E+04

1.006

Methylparaben

DM

8.28E+02

8.34E+02

1.008

Ethylparaben

DM

2.24E+03

2.26E+03

1.007

Equal to Km.w at 10Å² divided by Km/w at 7.62Å²

^ Abbreviation of 11-hydroxyprogesterone
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The chosen occupied areas by drugs and the corresponding transfer free energies are
shown in Table 5.10. The 95% confidence intervals of Gwater→interface are also listed. It is
not surprising that the error of Gwater→interface becomes larger when the chosen area
deviates from the fitted areas. For example, the errors of the transfer free energies are
about 0.20kJ/mol for progesterone areas within ±10% of fitted areas. The error increases
to 1.02kJ/mol when the maximum area of progesterone molecules is chosen. Open cells
Table 5.10 represent those physically-impossible conditions were the test areas are less
than the theoretical lower limits.

The micelle/water partition coefficients were calculated using the parameters in Table
5.10 with the results shown in Table 5.11. When the areas of the drugs are within 10% of
the fitted optimal areas, the calculated micelle/water partition coefficients exhibit small
deviations, between -17% and 19%, from the original values. When the minimum areas
of the drugs are employed, the calculated Km/w values have greater deviations, between
-22% and 74%, from the original results. If the maximum areas of model drugs are
chosen, the predicted Km/w values have the greatest deviations, between -70% and 106%,
from the original values. Because the maximum areas of all model drugs are further away
from the fitted values than are the minimum areas, it is not surprising that the Km/w
predictions using maximum areas of the drugs result in greater deviations from the values
based on fitted occupied areas of the drugs compared to the predictions using minimum
areas. To demonstrate the effect of adrug term on the calculated Km/w, Figure 5.13a shows
the distributions of the ratios Km/w/Km/w(adrug,exp) for four groups of interfacial areas
occupied by drug substances. Clearly, employing maximum occupied areas of model
drugs results in a broad distribution of results. In log units, the deviations range from -0.5
log unit (factor of 3) to 0.3 log unit (factor of 2). The average of the ratios also shifts to
-0.15 log unit corresponding to 30% decrease of the micelle/water partition coefficient.
Both groups with ±10% from the experimental areas have very tight distribution and the
134

Table 5.10, The dependence of free energy of transfer for model drugs from water to
oil/water interface on varying interfacial area occupied by the drugs at oil/water interface.
In order to test the sensitivity of calculated Km/w on adrug, four interfacial areas were
chosen: maximum area, minimum area and ±10% deviations from the experimental area.
Drug

Parameters

amax

Progesterone

a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)
a(Å²)
Gwater→interface
(kJ/mol)

104.4
-45.87
±1.02
95.8
-38.16
±0.50
104.8
-39.95
±1.06
86.2
-37.22
±1.17
84.9
-34.94
±1.22
86.4
-41.36
±0.75
62.0
-23.28
±0.98
70.6
-27.09
±1.38
82.9
-36.60
±2.35

Testosterone

11-hydroxy
progesterone
Diazepam

Temazepam

Prazepam

Methylparaben

Ethylparaben

Butylparaben

Errors are based on 95% confidence intervals.
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aexp.
+10%
63.8
-42.33
±0.20
65.8
-36.55
±0.17
71.3
-37.57
±0.18
50.8
-34.78
±0.18
45.5
-32.28
±0.17
59.4
-39.73
±0.18
35.1
-21.51
±0.15
35.0
-24.49
±0.18
37.5
-31.82
±0.17

aexp.
-10%
52.2
-41.22
±0.19
53.8
-35.79
±0.15
58.3
-36.52
±0.18
28.7
-21.02
±0.14
28.6
-23.93
±0.16
30.7
-30.99
±0.16

amin
39.6
-39.89
±0.38
39.5
-34.75
±0.28
40.2
-34.86
±0.59
42.7
-34.13
±0.15
50.9
-39.17
±0.14
24.5
-20.67
±0.24
25.6
-23.65
±0.23
25.4
-30.30
±0.39

Table 5.11, Calculated micelle/water partitioning coefficients using new parameter set
(Table 5.10) corresponding to varying interfacial areas occupied by drugs at oil/water
interface.
Km/w

Km/w

Km/w

Km/w

Km/w

Original

adrug,max

adrug+10%

adrug-10%

adrug,min

Progesterone

SDS

5.25E+05

7.41E+05

5.57E+05

4.93E+05

4.11E+05

Testosterone

SDS

7.33E+04

5.91E+04

7.19E+04

7.42E+04

7.29E+04

11OH-prog*

SDS

5.84E+04

6.11E+04

6.00E+04

5.67E+04

4.83E+04

Diazepam

SDS

9.84E+04

9.91E+04

1.00E+05

-

9.69E+04

Prazepam

SDS

2.82E+05

2.52E+05

2.79E+05

-

2.83E+05

Temazepam

SDS

3.68E+04

3.62E+04

3.75E+04

-

-

Methylparaben

SDS

3.66E+03

3.53E+03

3.68E+03

3.62E+03

3.54E+03

Ethylparaben

SDS

8.82E+03

9.45E+03

9.02E+03

8.62E+03

8.37E+03

Butylparaben

SDS

9.62E+04

1.98E+05

1.03E+05

8.93E+04

7.85E+04

Progesterone

DTAB

2.27E+05

1.58E+05

2.20E+05

2.33E+05

2.35E+05

Testosterone

DTAB

2.98E+04

1.39E+04

2.67E+04

3.30E+04

4.04E+04

11OH-prog*

DTAB

2.29E+04

1.30E+04

2.13E+04

2.46E+04

2.76E+04

Diazepam

DTAB

4.64E+04

2.54E+04

4.40E+04

-

4.81E+04

Prazepam

DTAB

1.27E+05

6.90E+04

1.15E+05

-

1.33E+05

Temazepam

DTAB

1.89E+04

9.56E+03

1.81E+04

-

-

Methylparaben

DTAB

1.84E+03

1.12E+03

1.76E+03

1.91E+03

1.99E+03

Ethylparaben

DTAB

4.57E+03

2.71E+03

4.45E+03

4.69E+03

4.77E+03

Progesterone

DM

1.50E+05

5.89E+04

1.35E+05

1.65E+05

1.94E+05

Testosterone

DM

1.75E+04

5.23E+03

1.45E+04

2.09E+04

3.04E+04

11OH-prog*

DM

1.43E+04

4.95E+03

1.22E+04

1.65E+04

2.32E+04

Diazepam

DM

2.72E+04

9.11E+03

2.44E+04

-

2.95E+04

Prazepam

DM

8.24E+04

3.02E+04

7.02E+04

-

8.99E+04

Temazepam

DM

1.21E+04

3.59E+03

1.10E+04

-

-

Methylparaben

DM

8.28E+02

3.48E+02

7.63E+02

8.95E+02

9.81E+02

Ethylparaben

DM

2.24E+03

8.25E+02

2.10E+03

2.39E+03

2.53E+03

*Abbreviation of 11-hydroxyprogesterone
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averages are within 5% from the unity. When minimum occupied areas are used, the
ratios are between -0.11 and 0.24 log units. The average value is increased by 10%. In
Figure 5.13b, the ratios Km/w/Km/w(adrug,exp.) were calculated by changing adrug term only
without adjusting the transfer free energy term. When the maximum occupied areas of
model drugs are employed, the predicted micelle/water partition coefficients are
decreased dramatically. The average drop in the ratios is -0.7 log unit corresponding to
80% decreases. If the minimum occupied areas of solutes are used, the predicted Km/w
values are increased with the average increment of 64%. For ±10% variations in adrug the
micelle/water partition coefficients are also significantly shifted: ~18% drop for
adrug=1.1adrug,exp. and ~22% increase for adrug=0.9adrug,exp.

Based on above analyses, if the correlations between two parameters, adrug and Gtrans are
considered, the predicted micelle/water partition coefficients are not sensitive to the
occupied areas of model drugs when those areas are within 10% of their experimental
values. On the other hand, if the chosen areas are far removed from the fitted areas, such
as the maximum occupied areas, the predictions result in significant deviations up to a
factor of 2 or 3 from the original calculations. If we ignore the correlations between the
interfacial areas occupied by model drugs and transfer free energies of the drugs and only
adjust the area term, the calculated Km/w values are much more sensitive than those with
consideration of the correlations: even ±10% variations in adrug term could produce ~
±20% changes in the micelle/water partition coefficients.

Recalling that the determinations of Gtrans and adrug, and the sensitivity of Km/w to these
two parameters the requirement for highly accurate experimental result of ~C is critical
to the success of the prediction of Km/w.
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Figure 5.13a,b, The ratio of calculated micelle/water partitioning coefficient (Km/w) using
varying parameter, adrug, and the micelle/water partitioning coefficient (Km/w,0) using
experimentally determined interfacial area occupied by drugs (adrug). Four groups of adrug
values were chosen: the maximum and minimum interfacial areas, ±10% variations from
adrug,exp. (a) Another parameter, Gtrans, was allowed to vary with changing adrug to best fit
the oil/water interface adsorption experiment of drugs (Fig. 5.3~5.5); (b) The parameter
Gtrans was fixed with changing adrug in the calculations of Km/w.
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5.3.5.

Effect of Salt on the Micelle/water Partitioning Coefficients

In section 3.3.2, the Km/w values of three model drugs, progesterone, diazepam and
methylparaben, in ionic micelle systems (SDS and DTAB) were observed to decrease in
the presence of 0.15N NaCl. The reduction of Km/w of model drugs in ionic micelles
could be explained by the changes in micelle structure due to the added salt. Literature
referneces (Hiemenz and Rajagopalan, 1997; Ueno and Asano, 1997) show the increase
of aggregation number of ionic micelles by addition of NaCl. From our NMR studies on
diffusivity of micelles in Chapter 7, the micelles show significant decreases in size.
According to our surface-localized model, the increasing Naggre with decreased r will
decrease the area per surfactant at micelle surface, A, and increase the surface pressure, .
These changes indicate there is less space on the micelle surface to solubilize drug
molecules. The large surface density of surfactant molecules makes the adsorption of
drug less favorable. Equations (A2.4) and (A2.14) clearly demonstrate that reducing A
and increasing  will result in smaller values for Km/w.

5.3.6.

Solubilization Isotherm Simulations - Moving Beyond the Dilute Solution

Condition
The above simulations were based on dilute condition of the solubilizates. On the other
hand, the solubilization capacity of a micelle system which was related to saturated
condition of the solute was more relevant in practical design of drug delivery system.
Indeed, the majority of measured micelle/water partition coefficients are carried out
under saturated conditions. In this section, the Km/w values at finite solute concentrations
will be studied. We extend the surface-localized model to finite solute concentrations.
The detailed derivations are shown in Appendix 2.2.

Unlike the dilute condition where

the final results of Km/w have a clear expression as Eq.(A2.13) and (A2.14), the calculated
Km/w at finite solute concentration involve a numerical solving of Eq. (A2.20) and (A2.21)
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for surface pressure, , at the micelle surface. The micelle/water partition coefficients are
calculated using Eq. (A2.22) and (A2.23).

There are limited experimental results of the solubilization isotherm for our interested
systems in literature. Goto and Endo reported the experimental Km/w values of three
parabens in SDS solutions as a function of drug concentration using gel filtration
technique (Goto and Endo, 1978). We applied our extended surface-localized model to
calculate the solubilization isotherms in these parabens-in-SDS systems in order to test
the accuracy of the model.

The results of the simulations of three parabens in SDS

solutions are shown in Figures 5.14~5.16, where the ratio of Km/w at finite drug
concentration (experimental) to that predicted by applying the dilute condition is plotted
as a function of mole fraction of drug in micelles. In general, the model successfully
predicts the overall trend of the micelle/water partitioning, but the deviations from the
model increase with drug concentration. The experimental slopes for three parabens
solubilized in SDS solutions were -1.77 (methylparaben), -1.84 (ethylparaben) and -1.87
(butylparaben) while the predicted slopes were -1.15 (methylparaben), -1.14
(ethylparaben) and -1.15 (butylparaben). The deviations of the predictions were between
35~39%. As has been experimentally observed in many other micelle solubilization
systems (Christian et al., 1986; Lee et al., 1990; Goto and Endo, 1978; Croy and Kwon,
2005), micelle/water partition coefficients tend to decrease with increasing concentration.
The drop of Km/w (experimental) with increasing drug concentration is likely mainly due
to the nature of surface adsorption of solutes.

As drug concentration in the system

increases, it is likely that the density of solutes on the oil/water interface would approach
a saturated state. Saturating the surface would be expected to lower the partitioning
coefficient between interface and bulk water at higher solute concentration. For example,
under saturated condition of solutes, the maximum mole ratios of drug to surfactant were
0.56 (methylparaben), 0.48 (ethylparaben) and 0.64 (butylparaben). The significant
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Figure 5.14, Experimental and predicted solubilization isotherms for methylparaben in
SDS micelles. Experimental data are from Goto and Endo (Goto and Endo, 1978).
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Figure 5.15, Experimental and predicted solubilization isotherms for ethylparaben in SDS
micelles. Experimental data are from Goto and Endo (Goto and Endo, 1978).
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Figure 5.16, Experimental and predicted solubilization isotherms for butylparaben in SDS
micelles. Experimental data are from Goto and Endo (Goto and Endo, 1978).
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change in the composition of the micelle brought about by the high fraction of solute
would induce an assembly that is far removed from that of a dilute solution. The
assumption used in the model that micelle size was not affected by the solubilization of
the drug would not be expected to be true given the dramatic changes in micelle structure.
The model sensitivity test in section 5.3.4 showed even a small change in micelle size
could produce significant changes in micelle/water partition coefficients. For instance,
the deviation of 1Å in radius of SDS micelles could result in 28% changes in K m/w for
methylparaben. The PGSE NMR studies in Chapter 7 will show there was no significant
change in micelle size in the presence of solutes, but the conclusion only held within the
experimental detection limit that was larger than 1Å.

Another assumption of the model

was the small changes in Laplace pressure, due to the presence of the solubilizates, were
not considered in the co-adsorption between drugs and surfactants at the micelle surface.
The assumption would hold at low drug concentration but would induce larger errors at
high drug concentration and would likely contribute to the deviations of the predictions
from experiments.

In addition to the parabens in SDS micelle systems, we also examined the micelle/water
partition coefficients of all 9 model drugs in three surfactant systems at saturated
condition.

The calculated Km/w values under dilute and saturated conditions as well as

experimental micelle/water partition coefficients are listed in Table 5.12 for comparison.
The ratios between Km/w (saturated) and Km/w (dilute) were calculated and shown in Table
5.12. The ratios represented the effect of finite concentration of solute on the
micelle/water partitioning.

Interestingly, the majority of the ratios were quite close to 1:

16 out of 25 ratios were greater than 0.85 and another 4 ratios were between 0.7 and 0.85.
For these systems, high drug concentration made little effect on the micelle/water
partitioning coefficients. The predicted Km/w using dilute condition provided good
estimations of the micelle/water partitioning at saturated drug concentrations. Only 5 out
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of 25 ratios had smaller values than 0.7: 0.49 for methylparaben in SDS micelles, 0.52 for
ethylparaben in SDS micelles, 0.32 for butylparaben in SDS micelles, 0.65 for
methylparaben in DTAB micelles and 0.67 for ethylparaben in DTAB micelles. The
influences of finite drug concentration on micelle/water partitioning were the greatest
when the three parabens were solubilized in SDS solutions. The experimental ratios of
Km/w between dilute and saturate conditions were 0.44 (methylparaben), 0.41
(ethylparaben) and 0.28 (butlyparaben) that were quite close to our predicted ratios.
Another two cases when finite solute concentration had significant effects on Km/w values
were methylparaben and ethylparaben solubilized in DTAB micelles. For the 5 cases
which had the lowest ratios, the corresponding solubilization capacities were the highest
among all 25 systems with the minimum of 0.47. The 4 systems that had the medium
ratios of Km/w(saturated)/Km/w(dilute) between 0.7 and 0.85 also had quite high
solubilization capacities that were between 0.22 and 0.42. The only exceptions that high
solubilization capacity resulted in low ratio of Km/w(saturated)/Km/w(dilute) were
methylparaben and ethylparaben in DM micelle systems. The solubilization capacities of
DM micelles were 0.42 (methylparaben) and 0.36 (ethylparaben) but the ratios were both
0.85. Compared to ionic surfactants SDS and DTAB, the solubilization in nonionic DM
micelles were less sensitive to the solute concentrations in micelles.

Figure 5.17 illustrates the comparisons between experimental and predicted micelle/water
partition coefficients at the saturated solute concentrations. The overall predictions were
in good agreements with experiments. Predicted Km/w did not deviate by more than a
factor of 2 from the experimental values. Most of the predictions (17 out of 25) were
within factor of 1.5 from the experiments. The R-square was 0.953. The results strongly
supported the applicability of the surface-localized model to micellar solubilization.
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Table 5.12, Calculated micelle/water partitioning coefficients under dilute condition
(shown early in section 5.3.3 Table 5.5) and non-dilute condition (saturated solution)
compared to experimental micelle/water partitioning coefficients (mainly under saturated
condition). The ratios of Km/w(saturated solution) and Km/w(dilute condition) are listed.
Km/w

Km/w

dilute

saturated

Km/w
Ratio

exp.

Progesterone

SDS

5.25E+05

3.83E+05

0.73

3.69E+05

Testosterone

SDS

7.33E+04

6.31E+04

0.86

1.14E+05

11OH-prog*

SDS

5.84E+04

4.58E+04

0.78

6.75E+04

Diazepam

SDS

9.84E+04

7.19E+04

0.73

8.93E+04

Prazepam

SDS

2.82E+05

2.50E+05

0.89

4.03E+05

Temazepam

SDS

3.68E+04

2.86E+04

0.78

4.70E+04
3.24E+03 (dilute)

Methylparaben

SDS

3.66E+03

1.78E+03

0.49

1.42E+03 (saturat.)
8.51E+03 (dilute)

Ethylparaben

SDS

8.82E+03

4.56E+03

0.52

3.48E+03 (saturat.)
7.24E+04 (dilute)

Butylparaben

SDS

9.62E+04

3.09E+04

0.32

2.04E+04 (saturat.)

Progesterone

DTAB

2.27E+05

1.94E+05

0.85

1.79E+05

Testosterone

DTAB

2.98E+04

2.79E+04

0.94

5.40E+04

11OH-prog*

DTAB

2.29E+04

2.06E+04

0.90

3.57E+04

Diazepam

DTAB

4.64E+04

3.93E+04

0.85

2.94E+04

Prazepam

DTAB

1.27E+05

1.19E+05

0.94

8.76E+04

Temazepam

DTAB

1.89E+04

1.64E+04

0.87

1.67E+04

Methylparaben

DTAB

1.84E+03

1.20E+03

0.65

1.73E+03

Ethylparaben

DTAB

4.57E+03

3.06E+03

0.67

4.28E+03

Progesterone

DM

1.50E+05

1.36E+05

0.91

9.49E+04

Testosterone

DM

1.75E+04

1.69E+04

0.97

3.09E+04

11OH-prog*

DM

1.43E+04

1.34E+04

0.94

1.32E+04

Diazepam

DM

2.72E+04

2.50E+04

0.92

2.10E+04

Prazepam

DM

8.24E+04

7.96E+04

0.97

6.51E+04

Temazepam

DM

1.21E+04

1.13E+04

0.93

9.63E+03

Methylparaben

DM

8.28E+02

7.05E+02

0.85

1.16E+03

Ethylparaben

DM

2.24E+03

1.91E+03

0.85

2.85E+03

*Abbreviation of 11-hydroxyprogesterone
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5.3.7.

Effect of Solutes on CMC of Micelles – Influence of Laplace Pressure

A very interesting phenomenon observed commonly during micelle studies is the
reduction of critical micelle concentration (CMC) upon solubilization of drug. Goto and
Endo systematically studied the CMC of SDS micelles as a function of aqueous
concentrations of three parabens (Goto and Endo, 1978).

In this section, we apply the

Laplace pressure effect to quantitatively predict the decline of CMC with increasing drug
concentrations. The detailed derivations of the model are shown in Appendix 2.3. The
development of the theory can be divided into 2 steps: the first step is the introduction of
solutes to micelle surface lowers the surface pressure and thus decreases the Laplace
pressure; the second step is the surfactant molecules, subject to Laplace pressure, will
have a lower transfer free energy from bulk water to micelle surface and thereby
decreasing the CMC.

Figure 5.18 compares the predicted and experimental CMCs of SDS micelles as a
function of aqueous concentrations of three parabens. The overall predictions are quite
good. The model successfully predictes the decreasing trend of CMC with increasing
drug concentration and also the slope of the CMC reduction with respective to drug
concentration. Under the condition of equal solute concentration, butylparaben produced
the greatest drop of CMC because that solute is the most surface active at oil/water
interface. According to Eq. (A2.25) and (A2.26), the greatest negative transfer free
energy of butylparaben (Gtrans=-31.4kJ/mol) could increase the surface pressure and
lower the Laplace pressure to the greatest extent, resulting in the greatest drop in the
CMC.

The successful predictions of the CMC~Conc. curves support the existence and
importance of the Laplace pressure in micelle systems. The predictions are based on two
assumptions: (1) the micelle size is not significantly affected by the addition of solutes;
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Figure 5.17, Comparison between experimental and predicted micelle/water partitioning
coefficients (Km/w) of 9 model drugs in 3 surfactant systems under saturated condition of
drugs.
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(2) The activity (free energy level) of surfactant at micelle surface is not changed with
increasing solute concentration. The second assumption is important because it will
change the monomer concentration of surfactant (CMC) and not the micelle structure as a
consequence of the change of transfer free energy from bulk water to micelle surface.

5.4.

CONCLUSION

A surface-localized thermodynamic model was successfully applied to predict the
micelle/water partitioning coefficients of 9 model drugs in 3 micelle systems. The
thermodynamic model was employed to calculate (1) the transfer free energies of model
drugs from aqueous solution to oil/water interface; (2) the occupied areas of drugs at the
oil/water interface. The greater the negative transfer free energy and the smaller the
occupied interfacial areas by the drug molecules, the greater the

micelle/water partition

coefficients. For three model surfactants, the larger surface pressure at micelle surface
correlated to lower solubilization capacity of the micelles. The successful predictions of
micelle/water partitioning coefficients using surface-localized model support the
following conclusions: (1) the model hydrophobic drugs are predominantly located at the
surface region of the micelles; (2) the co-adsorption to the micelle surface by drugs and
surfactants is the main mechanism of micellar solubilization; (3) the 2-D solution
adsorption model is successfully applied to the hydrocarbon-water interface system and
the relationship between drugs and surfactants is mainly pure competition without their
specific interactions; (4) Laplace pressure exhibits a significant effect on micelle/water
partitioning of the model drugs and can not be ignored.

The sensitivities of the predicted micelle/water partition coefficients to the chosen
parameters were tested. The Km/w values were sensitive to the radius of the micelles with
constant aggregation number of the micelles. Many parameter pairs were strongly
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Figure 5.18, Predicted and experimental CMCs of SDS as a function of drug
concentration in aqueous solutions. The experimental data are from Goto and Endo (Goto
and Endo, 1978).
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correlated with each other, for examples, aggregation number and radius of micelles,
interfacial area occupied by drug molecules and transfer free energy of drug substance
from water to oil/water interface. If the correlations of those parameter pairs were
considered, the predicted micelle/water partitioning coefficients were not sensitive to the
aggregation number of the micelles (50s~100 for SDS and DTAB, 113~130 for DM),
interfacial area occupied by water molecules (7.6~10Å²) and the interfacial area occupied
by drug molecules (<10% variation). The insensitivity of the predictions to those chosen
parameter reflected the robustness of the surface-localized model.

The model was extended to study some other micellar solubilization properties: salt effect,
solubilization isotherm, CMC depression effect by solutes. The addition of salts to the
surfactant solutions resulted in a decreased micelle/water partition coefficient for ionic
micelle systems. This phenomenon could be explained by increasing aggregation number
of micelles due to the screening of electrostatic forces between charged headgroups in the
presence of salt while the micelle size was decreased. The model clearly showed the
above changes could cause decrease in the micelle/water partition coefficients.

The surface-localized model was extended to finite solute concentration. The simulated
solubilization isotherms for parabens solubilized in SDS micelles were compared to
experiments from literature. The model successfully simulated the trend of Km/w~Cdrug
curves but could not predict the slope of the curves accurately. The micelle/water
partition coefficients of 9 model drugs in 3 micelle systems at saturated condition of
model drugs were calculated and the results were in good agreements with experimental
values.

The CMC of SDS micelles were observed to decrease with increasing concentration of
parabens. The Laplace pressure acting on surfactant molecules were considered in the
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thermodynamic model simulations. The quantitative predictions of CMC~Cdrug curves
coincided with experiments very well.

Copyright © Shaoxin Feng 2009
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Chapter 6

Molecular Simulation Studies on the Orientations of Model Drugs at Oil/water
Interface

6.1.

INTRODUCTION

To understand the solubilization mechanism of hydrophobic drugs in micelle system, the
location, orientation and amount of hydrophobic drugs solubilized in the lipid assembly
are important factors to be considered. The three factors are interdependent. For instance,
the maximum amount of drugs in micelles is dependent on the location and orientation of
the model drugs in micelles.

The location and amount of model hydrophobic drugs in micelle systems have been
extensively studied in last three chapters based on a framework of a thermodynamic
model. A surface-localized thermodynamic model considering the co-adsorption of drug
and surfactant molecules for micelle surface successfully predicted the micelle/water
partition coefficients.

Sensitivity analysis of the model illustrated that the areas

occupied by model drugs at micelle surface could influence the micelle/water partitioning
(Section 5.3.4.4). The larger occupied interfacial areas are correlated with less solubilized
drugs in micelles. For example, a 10% increase in the area could decrease the
micelle/water partition coefficient by 20% under assumption that other parameters, such
as G waterinterface , remain constant. The interfacial areas occupied by model drugs are
dependent on the size and orientation of the drugs. Since the size of a specific drug is
fixed, the orientation of the drug localized at the micelle surface would be important to
the solubilization capacity. Understanding the orientation of drug substances in micelles
may also be critical to the chemical stability of solubilized drugs because of the
anisotropic local environment that may protect chemically-vulnerable functional groups.
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So far, little is known about the orientation of model drugs at the micelle surface. In the
literature, NMR technique was employed to detect the intermolecular interactions as well
as microenvironment of different functional groups in order to infer the orientation of
solubilizates in micelles (Hawrylak and Marangoni, 1999; Heins et al., 2007; Gjerde et al.,
1998; Ueno and Asano, 1997; Nagaonkar and Bhagwat, 2006; Suratkar and Mahapatra,
2000;). These studies have advantages in probing selective regions of the solute molecule
in aqueous or oil phases. The methods do not give detailed information such as the angles
between the long axes of solutes with the oil/water interface. The angles would affect the
interfacial areas occupied by model drugs and the micelle/water partition coefficients.

In this chapter, the experimental interfacial areas occupied by model drugs from the
adsorption studies at dodecane/water interface (Section 5.3.1) were used to infer the
orientation of the drugs at oil/water interface. A molecular simulation method was
employed to calculate the possible cross-section areas of the drug molecules along any
defined directions. By matching the calculated areas with experimental values and
applying chemical intuition (considerations on hydrophilic/hydrophobic interactions and
surface energies), the orientations of the drug molecules at oil/water interface,
specifically the angles between the drug and interface, could be determined.

6.2.
6.2.1.

METHODS
Molecular Structures of Isolated Drug Molecules

There were three ways of obtaining three-dimensional molecular structures of single drug
molecule. The following methods were taken in order:
(1) If the crystal structures of model drugs were reported in literature and the complete
molecular structure information including the fractional coordinates of all atoms was
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available, the molecular structures of the single drug molecule were extracted from the
reported crystal structure data.

(2) If the crystal structures of model drugs were reported in literature and the partial
molecular structures including only the fractional coordinates of heavy atoms were
available, the partial molecular structures of the single drug molecule were extracted
from the reported crystal structure data and hydrogen atoms were added afterwards
employing Hyperchem® software (Hyperchem, 2001).

(3) If there was no reported crystal structure of model drugs that included the molecular
details, the molecular structure was built and optimized using quantum chemistry
software. In our studies, GaussView® software (Frisch et al., 2000) was employed to
build the molecule according to its chemical structure and Gaussian03® software (Frisch
et al., 2003) was used to optimize the structure based on minimum-energy principle. The
calculation technique used in structure optimization was Hartree-Fock method combined
with Pople‟s 6-31G** basis set.

6.2.2.

Defining the Boundary of Isolated Molecules

To calculate the cross-section area of a molecule, the boundary of the molecule was
defined as the “molecular shell”. In our studies, an isosurface of electron densities of the
molecule was used as the molecular boundary. The electronic structure of drug molecules
was calculated using Hartree-Fock method with 6-31G** basis set. The calculations were
carried out using Gaussian 2003 software. A three dimensional grid of electron densities
for the drug molecules was generated from the electronic structures described as wave
functions of electrons solved from Hartree-Fock equation. The resolutions of the grid
were 10 points/Å along all three directions.
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To define the molecular boundary, the isovalue of the isosurface of electron densities was
chosen so as to match the enclosed volume of the isosurface to experimental partial molar
volume of the drugs. The isovalue for electron densities was kept constant for all model
drugs. The generation of isosurface from the 3-D grid of electron densities and the
calculations of the enclosed volume by the isosurface were performed using self-written
computer program with C language.

6.2.3.

Calculation of Cross-section Areas along All Possible Directions

To make the calculation more convenient, the Cartesian coordinates of drug molecules
were fixed while the orientations of oil/water interface were varied. The normal of the
interface was used to describe the orientation of the plane and a pair of angles () was
sufficient to represent all possible directions of the normal. The vector of the normal with
angles () was (sincos, sinsin, cos) (0<<, 0<<2). Once the orientation of
the interface was defined, a series of planes parallel to the orientation would cut through
the body of the molecular shell. For each plane, the cross-section area was calculated
based on the intersection between the plane and the molecular shell. Among those
cross-section areas corresponding to the parallel planes, the maximum area was chosen
for the specific orientation. The above calculations were carried out for all possible
orientations chosen as follows:





i

2n

0

  


j


 2i

i0~n
for i  0
j  1 ~ 4i

(6.1)

for i  0

The orientations shown in above equation only covered half of a sphere. Because the
calculations had an inversion symmetry: the area calculated for orientation with normal
(x, y, z) was same with the area for orientation (-x, -y, -z). Therefore half sphere is
sufficient to represent all possible directions. The parameter n determined the resolution
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of the orientations that was approximately 90o/n. The larger n corresponded to higher
resolution. In our studies, a value of 18 was chosen for n with the resolution of the
orientations equal to 5o. The simulations were carried out using self-written C program.

6.2.4.

Visualizations of the Molecules, Isosurfaces of Electron Densities, and

Cutting Planes
The visualizations of the drug molecules, molecular shells, and the cutting planes that
represented the oil/water interface were realized using OpenDX® software (OpenDX). A
ball-and-stick model was used to show the molecular structure. Different atoms were
color coded and had different radii. The molecular shells that represented the molecular
boundaries were made half-transparent in order to illustrate the molecular structures
inside. The intersection between the molecular boundary and the cutting plane was
clearly demonstrated. The cutting plane was also mapped with electron densities. Areas
with red color had highest electron density while areas with blue color had lowest
electron density. The axes of 3-D Cartesian coordinates were shown beside the molecules
with the gridlines. The scales had a unit of Å.
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6.3.
6.3.1.
Of

RESULTS AND DISCUSSION
Molecular Structures of Model Drugs
the

model

compounds,

progesterone,

testosterone,

17-estradiol,

11-hydroxyprogesterone, diazepam, temazepam and methylparaben had reported crystal
structures that included complete molecular structures (Allen, 2002). The molecular
structures could be extracted from those reported structure data. Another three drugs,
oxazepam, prazepam and ethylparaben, had reported crystal structures that included
partial molecular structures that only had coordinates of heavy atoms (Allen, 2002; Lin,
1986). These molecular structures were completed by adding hydrogen atoms using
Hyperchem® software. Figure 6.1 uses prazepam as an example to illustrate the
molecular structure extracted from literature without hydrogen atoms, Fig. 6.1a, and
molecular structure with added hydrogen atoms using Hyperchem® program, Fig. 6.1b.
Butylparaben has no reported crystal structure containing detailed molecular structure.
The molecular structure of butylparaben was built according to its chemical structure
using GaussView® program. One advantage of using GaussView to draw molecular
structures was the program provided initial bond lengths and bond angles that were close
to true values so that the following structure optimization calculations were more
efficient. The molecular structure was optimized using Hartree-Fock/6-31G** method
and the calculations were carried out using Gaussian03® software. The optimized
structure of butylparaben is shown in Figure 6.2.

6.3.2.

Determination of Molecular Boundaries

The molecular boundary was defined using an isosurface of electron densities of the
molecules. The cut-off electron density, or the isovalue of the isosurface, was chosen so
as to match the enclosed volume by the isosurface to the experimental occupied
molecular volume. The experimental occupied volumes of model drugs were estimated
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a

b
Figure 6.1, (a) The molecular structure of prazepam extracted from reported crystal
structure (Allen, 2002) without coordinates of hydrogen atoms; (b) The molecular
structure in (a) was added with hydrogen atoms using Hyperchem® software.

158

Figure 6.2, The optimized molecular structure of butylparaben using Hartree-Fock
/6-31G** method with the aid of Gaussian03® program (Frisch et al., 2003).
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using the reported crystal structures and the results shown in Table 5.1. In Table 6.1, the
enclosed volumes by the isosurface of electron densities using different isovalues were
calculated and compared with experimental occupied molecular volumes. Using least
square fitting, the isovalue =0.00065e/bohr3 gave the best matches between calculations
and experiments. The comparisons between calculated and experimental occupied
volumes by isolated model drugs are shown in Figure 6.3. The predictions coincide well
with the experimental results.

6.3.3.

Determining Orientation of Model Drugs by Matching Calculated

Interfacial Areas Occupied by Model Drugs to Experimental Areas
The theoretical areas occupied by model drugs at oil/water interface could be calculated
as the cross-section areas of the molecular shells with a cutting plane representing the
oil/water interface. Since the actual orientations of the model drugs at oil/water interface
were unknown, exhaustive searches were carried out for all possible orientations. For
each orientation, a cross-section area could be calculated and compared to the
experimental value (see section 5.3.1). The matching between the calculations and
experiments could indicate the possible orientations of the drugs at oil/water interface.

In our simulations, a fixed molecule with changing cutting planes was more convenient in
calculating the cross-section areas than a fixed cutting plane with changing molecular
positions and orientations. From the computational point of view, the above two cases
were equivalent to each other.

The orientations of the cutting planes were described using two angles,  and (0<<,
0<<2). A total number of 685 “molecular slices” with the resolution of 5o were
considered to calculate the corresponding cross-section areas. In Table 6.2, the
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Table 6.1, The calculated occupied volumes of isolated molecules using different
isovalues of the isosurfaces of electron densities compared to experimental occupied
volumes for all model drugs.
The calculated occupied volumes of isolated molecules (Å³)

Model drugs
progesterone
testosterone
17 -estradiol
11OHprog*
diazepam
oxazepam
prazepam
temazepam
methylparaben
ethylparaben
butylparaben

3

using the following isovalue of electron density (e/bohr )
0.0005

0.00055

0.0006

0.00065

0.0007

0.0008

444.7
416.9
389.7
457.8
371.5
365.0
447.6
380.1
203.3
238.1
289.9

436.9
408.9
382.7
450.0
364.6
358.3
439.5
375.1
199.3
233.4
284.2

429.9
402.3
376.4
442.9
358.3
352.2
432.1
368.7
195.6
229.1
279.0

423.3
396.3
370.6
436.4
352.5
346.6
425.4
362.8
192.3
225.1
274.2

417.3
390.7
365.2
430.3
347.1
341.5
419.1
357.4
189.2
221.5
269.9

406.4
380.6
355.6
419.4
337.5
332.2
407.7
347.7
183.7
215.0
262.0

*Abbreviation of 11-hydroxyprogesterone
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Experimental
occupied
volume(Å³)

441.3
406.9
370.2
450.7
344.3
330.5
417.7
356.7
182.7
213.8
259.2

Figure 6.3, The comparisons between calculated and experimental occupied volumes by
isolated model drug molecules. The calculated occupied volumes were based on a cut-off
electron density of 0.00065e/bohr3.
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experimental areas are listed for comparisons. Figures 6.4~6.14 illustrate the orientations
of model drugs at the oil/water interface (shown as the blue plane in the graph) when they
are occupying maximum and minimum areas at the interface. Those calculated maximum
and minimum cross-section areas are shown in Table 6.2. There were significant
differences between the maximum and minimum areas with the ratio of a max/amin ranging
from 1.7 (prazepam) to 3.3 (butylparaben) suggesting that the molecules would not be
accurately described by simple spherical geometry.

When the data in Table 6.2 are examined, two trends are immediately apparent. All
molecules in a single class tend to exhibit similar orientations. Each class of model
solutes tends to exhibit characteristic orientation angles. For three benzodiazepines
(oxazepam is not included because of the lack of accurate experimental areas occupied by
oxazepam molecules), the experimental occupied areas by isolated molecules are not
significantly different from the theoretical minimum occupied areas. Thus, it is concluded
that benzodiazepines are likely orientated vertical to the oil/water interface. For three
parabens, the experimental occupied areas are significantly larger than the minimum
areas by 6~9Å² which suggests the long axes of paraben molecules deviate from the
vertical orientation and form angles with the normal of the oil/water interface.

The estimated angles deviated from the normal are shown in the last column of Table 6.2.
The angles were calculated between the long axis of the fixed molecule and all normals
of the cutting planes that could produce the calculated cross-section areas within 1Å²
from the experimental area. For the three parabens, the average angles are around 42 o.
When steroids were studied, the experimental occupied areas are significantly larger than
theoretical minimum areas by 18~25Å², corresponding to angle of about 54o between the
long axes of steroid molecules and the normal of the oil/water interface.
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a

b

Figure 6.4, The orientations of progesterone when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 104.4Å² and the minimum projected area is 39.6 Å². The
scales of axes have a unit of Å.

a

b

Figure 6.5, The orientations of testosterone when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 95.8Å² and the minimum projected area is 39.5Å². The
scales of axes have a unit of Å.
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a

b

Figure 6.6, The orientations of 11-hydroxyprogesterone when it occupies the maximum
(a) and minimum (b) areas at the oil-water interface which is illustrated using a blue color
plane. The maximum projected area is 104.8Å² and the minimum projected area is 40.2Å².
The scales of axes have a unit of Å.

a

b

Figure 6.7, The orientations of 17-estradiol when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 95.8Å² and the minimum projected area is 38.3Å². The
scales of axes have a unit of Å.
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a

b

Figure 6.8, The orientations of diazepam when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 86.2Å² and the minimum projected area is 42.7Å². The
scales of axes have a unit of Å.

a

b

Figure 6.9, The orientations of temazepam when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 84.9Å² and the minimum projected area is 45.5Å². The
scales of axes have a unit of Å.
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a

b

Figure 6.10, The orientations of prazepam when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 86.4Å² and the minimum projected area is 50.9Å². The
scales of axes have a unit of Å.

a

b

Figure 6.11, The orientations of oxazepam when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 83.7Å² and the minimum projected area is 44.8Å². The
scales of axes have a unit of Å.
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a

b

Figure 6.12, The orientations of methylparaben when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 62.0Å² and the minimum projected area is 24.5Å². The
scales of axes have a unit of Å.

a

b

Figure 6.13, The orientations of ethylparaben when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 70.6Å² and the minimum projected area is 25.6Å². The
scales of axes have a unit of Å.
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a

b

Figure 6.14, The orientations of butylparaben when it occupies the maximum (a) and
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane.
The maximum projected area is 82.9Å² and the minimum projected area is 25.4Å². The
scales of axes have a unit of Å.
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Table 6.2, The calculated maximum and minimum cross-section areas occupied by drug
molecules at oil/water interface, amax and amin, compared to the experimental
cross-section areas of molecules at oil/water interface, aexp, reported in Table 5.2 (section
5.3.1); the estimated angles between long axes of model drugs and the normal of the
oil/water interface and the calculated time-average interfacial areas occupied by drug
molecules when the molecules are permitted to rotate freely at oil/water interface, aaverage.
Drug
Progesterone
Testosterone
11prog*
Diazepam
Temazepam
Prazepam
Methylparaben
Ethylparaben
Butylparaben
17-estradiol
Oxazepam

amax(Å²)
104.4
95.8
104.8
86.2
84.9
86.4
62.0
70.6
82.9
95.8
83.7

amin(Å²)
39.6
39.5
40.2
42.7
45.5
50.9
24.5
25.6
25.4
38.3
44.8

aexp.(Å²)
58.0±4.4
59.8±4.9
64.8±1.9
46.2±4.7
41.3±3.7
54.0±5.7
31.9±4.0
31.8±4.6
34.1±1.2
57.4±105.3
42.1±17.5

*

Abbreviation for 11-hydroxyprogesterone
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Angles (o)
49.5±3.9
55.8±5.4
56.8±4.9
29.1±12.9
N/A
16.9±7.3
47.3±3.1
38.4±3.0
41.2±3.9
n.d.
n.d.

aaverage(Å²)
64.8
62.5
66.2
59.7
61.2
69.7
38.0
42.0
46.7
59.5
59.3

The estimated orientation angles could be rationalized by chemical intuition using the
distribution of hydrophilic functional groups in the molecule of interest. Figure 6.15
shows a schematic of orientations of 3 series of model drugs at oil/water interface.
Molecules of model drugs are illustrated using ellipsoids which have long and short axes.
The small circles in the figure represent hydrophilic functional groups. The determining
factor for the orientation of a molecule at oil/water interface is its free energy state; the
molecule will choose an orientation that has the minimum free energy. There are two
factors affecting the total free energy of a molecule at the oil/water interface. One
modulating factor is the occupied area of the molecule. The larger occupied area of the
molecule at oil/water interface, the larger the surface energy based on Eq. (A1.1). For
other factors being equal, the molecule tends to take the minimum surface area to lower
its surface energy. A second factor that influences the molecular orientation at oil/water
interface is the distribution of hydrophilic functional groups of the molecule.
Sequestering a polar (hydrophilic) functional group in a non-polar (hydrophobic)
environment can be rather costly in terms of free energy. Molecular orientations that
maximize the interactions of the polar functional groups with water tend to minimize the
free energy. The two orientation factors may or may not conflict with each other.
Obviously, when considered together, the effects of the two factors result in an
orientation that will result in a minimum system free energy. In our studied system,
benzodiazepines seem to have no conflict between the two factors. There are one or two
hydrophilic functional groups (hydroxyl or carbonyl group) in each molecule that are
adjacent to each other. As shown in Fig. 6.15a, the benzodiazepine molecules can take the
minimum occupied interfacial area and, at the same time, maintain the hydrophilic
functional groups in aqueous phase. For parabens, the two hydrophilic groups are far
from each other as shown in Fig. 6.15b. It is not possible for the molecule to occupy a
minimum surface area while simultaneously maintaining contact of the two hydrophilic
groups with water. It seems reasonable to expect that the molecule will rotate from the
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42o
°

54o
°
Water
Oil

Benzodiazepines

Parabens

Steroids

(a)
(b)
(c)
Figure 6.15, A schematic of orientations of three series of model drugs at oil/water
interface. The molecules of model drugs are illustrated using ellipsoids that have long and
short axes reflecting molecular shapes. The small circles represent the hydrophilic
functional groups.
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vertical orientation until the two hydrophilic groups are near/in the water phase. As a
consequence, the long axes of parabens form an angle (~42o) with the normal of the
oil/water interface. For steroids, the two hydrophilic groups are at opposite ends of long
axis of each molecule. Similar to parabens, the conflict between the two factors,
maintaining the minimum surface area and keeping hydrophilic groups in water, will
drive the molecules to deviate from the vertical orientation. Because the hydrophilic
groups are more distantly separated in steroid molecules compared to the paraben
molecules, the angles between long axes of drug molecules and the normal of oil/water
interface are larger for steroids (~54o) than those for parabens (~42o).

In the above analysis, we considered the solute to occupy an area of the interface while in
a static fixed orientation. In reality, the drug adsorption is a dynamic partitioning
phenomenon. As a consequence, the orientation of drug molecules at the oil/water
interface is unlikely fixed and would represent a time-average over different orientations.
Solubilization of drug in micelle systems is known to be a dynamic partitioning
phenomenon. The high exchange rate of molecules between the micelles and water
(103~108/s (Lindman and Wennerstrom, 1980)) suggests the estimated orientations are
time averages over possible orientations. The estimated angles between long axes of
drugs and the normal of oil/water interface, e.g. 42o for parabens and 54o for steroids, are
time average angles over their possible orientations. In the extreme case, the solute may
freely rotate within the plane of the surface. The last column of Table 6.2 presents the
average areas occupied by the solutes when allowed to freely rotate. When the average
occupied areas are compared to experimental values, the experimental areas occupied by
benzodiazepines and parabens are significantly smaller than the calculated average. For
steroids the experimental areas occupied are close to the overall average when permitted
to freely rotate. The results suggest steroids may have larger rotating degree of freedom at
oil/water interface as compared to benzodiazepines and parabens.
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The experimental studies on the occupied interfacial areas were carried out on a flat
dodecane/water interface (Section 5.3.1). When attempting to correlate these findings to
results at a micelle surface we must assume that the micelle surface curvature has no
effect on the occupied area.

In these studies, rigid molecular structures (extracted from crystal structure) were
employed, while, in solution state, the molecules had less restriction and could be flexible.
For our model drugs, steroids molecules are all rigid and benzodiazepines are mainly
rigid with a benzene ring at C5 position having limited rotating ranges due to the steric
hindrance. Parabens have flexible hydrocarbon chains but the determining factor of
occupied surface areas is the rigid bulky resonance structure of the molecules. Therefore,
the simplifications using rigid molecular structure will not introduce significant errors on
the calculations of the areas occupied by drugs at the oil/water interface.

6.4.

CONCLUSION

The orientations of model drugs at oil/water interface were estimated by comparing the
experimental occupied areas of model drugs to the theoretical areas when model drugs
were taking any possible orientations at oil/water interface. The theoretical occupied
interfacial areas were carried out using molecular simulation methods: (1) the molecular
boundary was defined using an isosurface of electron density; (2) the cross-section area
of the molecule cut by a plane representing the oil/water interface was used as the
occupied area corresponding to the specific orientation.

The orientations of model drugs at oil/water interface are different for different drug
series but are similar within one series of model drugs. All three benzodiazepines are
believed to take the vertical orientation at oil/water interface because the experimental
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occupied areas are not significantly different from theoretical minimum areas. For
parabens, the long axis of each drug molecule form an angle about 42o with the normal of
oil/water interface. For steroids, the angles between long axes of drug molecules and the
normal of oil/water interface aere about 54o.

The molecular orientations at oil/water interface are related to the distribution of
hydrophilic functional groups of model drugs. If the hydrophilic groups are congregated
at one end of molecular long axis, such as benzodiazepines, the molecules are likely
taking vertical orientations that occupied minimum areas while maintaining hydrophilic
groups in aqueous phase. If the hydrophilic groups are widely separated in the molecule,
such as parabens and steroids, the solute cannot take the minimum surface areas and, at
the same time, keep the hydrophilic groups in water. The long axes of those molecules
would form angles with the normal of oil/water interface to reach the minimum of total
free energy.

Copyright © Shaoxin Feng 2009
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Chapter 7
NMR Studies on Inter-molecular Interactions in Micelles and Micellar Diffusivity

7.1.

INTRODUCTION

Several spectroscopy-based methods, such as UV/vis, fluorescence, NMR, etc., have
been used to determine the location of solubilizates in micelles (Sabate et al., 2001;
Vermathen et al., 2000; Bromberg and Temchenko, 1999; Lebedeva et al., 2007; Ueno
and Asano, 1997; Hawrylak and Marangoni, 1999). The thermodynamic-model-based
approach of the present work has advantages in quantitative predictions of fractions of
drugs located in different regions of micelles and micelle/water partitioning coefficients
of model drugs. On the other hand, the method lacks detailed information of micellar
solubilization, such as locations of specific functional groups in micelles, because the
thermodynamic analysis treats one whole molecule as an elemental unit. The
spectroscopic

techniques

could

provide

qualitative

information

such

as

the

microenvironment of a functional group and explicit interactions between different
function groups.

In Chapters 3~5 we have employed the thermodynamic-model-based method to
determine the location of drugs in micelles and predict the partitioning of drugs between
micelles and water phase. In this chapter, we will use 2-D and PGSE NMR techniques to
study the microstructures of micelles solubilizing drugs. The inter-molecular interactions
between surfactants and drugs are expected to be determining factors in the locations and
orientations of drug molecules in micelles. For example, if the drugs were located at
micelle surface, interactions between drugs and headgroups of surfactants would be
expected. Specifically, the 2-D NMR techniques, including NOESY (Nuclear Overhauser
Effect SpectroscopY) and ROESY (Rotating-frame nuclear Overhauser Effect
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SpectroscopY), were employed to measure the interactions between surfactants and drugs
in micellar aggregates. PGSE NMR technique can provide information on the
translational diffusivities of particles which are correlated to the particle sizes. Here the
PGSE NMR technique was mainly employed to detect the changes of micelle size with
different drug concentrations and in the presence and absence of salts. The information of
micellar size was used to test the validity of some assumptions in the thermodynamic
model in Chapter 3~5. These studies provide complementary information on
solubilization mechanism of micelle systems.

7.2.

MATERIALS AND METHODS

7.2.1.

MATERIALS

Progesterone (>99%), diazepam, temazepam, methylparaben (>99%), ethylparaben
(>99%),

butylparaben

(>99%),

sodium

dodecyl

sulfate

(>99%),

dodecyltrimethylammonium bromide (>99%) and dodecyle -D-maltoside (>98%) were
obtained from Sigma-Aldrich (St. Louis, MO). 11-hydroxyprogesterone (>95%) was
from Janssen Chimica (New Brunswick, NJ). D2O (>99.9% isotopic purity) was
purchased from Sigma-Aldrich. Three millimeter NMR tubes with a 500MHz rating were
purchased from Norell (Landisville, NJ).

7.2.2.
7.2.2.1.

METHODS
2D NMR (NOESY and ROESY) Methods

NOESY (Nuclear Overhauser Effect SpectroscopY) and ROESY (Rotating-frame nuclear
Overhauser Effect SpectroscopY) were used to detect the inter-molecular interactions
when the spatial distance between two protons is shorter than 5Å. NOESY measures the
dipolar coupling between nuclear spins and is suitable for „small‟ (MW<1000) and „large‟
(MW>2000) molecules for which NOEs (nuclear Overhauser effect) are positive and
negative respectively, but may fail for mid-sized molecules (Claridge, 1999). ROESY
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observed transient NOEs in the rotating frame and is especially useful where the NOESY
cross-peak signals are weak because the NOEs are near the transition between positive
and negative. ROESY cross-peaks are always positive, but ROESY signal can also be
interfered by other effects, such as TOCSY (TOtal Correlation SpectroscopY) transfer
and COSY(COrelation SpectroscopY)-type cross-peak (Claridge, 1999).

Figure 7.1 shows the pulse sequences used in NOESY and ROESY experiments. The
sequence of NOESY consists of three 90o pulses. The evolution time, d2, would be
systematically incremented to provide chemical shift information along the 2nd dimension
(F1 domain). The mixing time, mix, is the duration for the spin-spin cross relaxation to
occur and is kept constant in the experiments. The ROESY sequence includes a 90o pulse
following by a varied evolution time, d2, and a fixed mixing time, max, when an
alternating-phase spin-lock is applied to reduce TOCSY transfer (Hwang, 1992).

NOESY experiments were performed on a Varian Inova 400MHz NMR spectrometer
(S/N S010883) equipped with a Highland Performa II gradient probe (S/N P003732). The
acquisition and processing of the spectra were carried out using VNMR 6.1c software
(Varian). D2O was used as solvent for all the NMR experiments. The mixing time in
NOESY measurements was 0.5~1.0s, and the relaxation delay, d1, was 6s. The
experiments were acquired with 16 scans and 1024 complex data points for each of the
200 evolution delay time (d2). The spectral width was 4060Hz.

ROESY experiments were carried out on a Varian VNMR 500MHz NMR spectrometer
(S/N 41312). The acquisition and processing of the spectra were carried out using
VNMRJ 2.2c software (Varian). The mixing time in ROESY measurement was 0.2~0.3s.
The relaxation delay, d1, was set to 3s and a homospoil gradient spoil sequence was
employed prior to the d1 delay to achieve a less oscillatory steady-state for 2-D
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90o

90o

d1

90o

mix

d2

Pulse sequence used in NOESY experiments
90o
180o

d1

180o n=mix/(4*slpw90)

d2

Pulse sequence used in ROESY experiments

Figure 7.1, The schematics of pulse sequences used in NOESY and ROESY experiments.
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experiment (Varian Instrumental Manual, 2001). The experiments were acquired with 32
scans and 2048 complex data points for each of the 224 evolution delay time (d2). The
spectral width was 5000Hz.

7.2.2.2.

2-D NMR Sample Preparations

Near-saturated concentrations of model drugs were employed in surfactant solutions with
D2O as solvent. The systems containing drugs and surfactant solutions were rotated at
room temperature for 2 days to ensure complete dissolution. For the 400 MHz NMR
instrument, about 0.75mL sample solutions were placed into 5mm NMR tubes. For the
500 MHz NMR instrument, about 0.25mL sample solutions were placed into 3mm NMR
tubes.

7.2.2.3.

PGSE NMR Method

Pulsed gradient spin echo (PGSE) NMR technique as a means of measuring diffusivity
was first developed by Stejskal and Tanner (Stejskal and Tanner, 1965) based on the
concept of nuclear spin echo brought by Hahn (Hahn, 1950) and Carr and Purcell (Carr
and Purcell, 1954). Two magnetic field gradient pulses are employed, and they are
essential for correlating the translational motion of nuclei to the NMR signal intensity.
There are two commonly used pulse sequences: nonstimulated and stimulated PGSE
pulse sequences, which are shown in Figure 7.2. Nonstimulated PGSE pulse sequence
uses a 90o pulse to start dephasing the magnetization followed by a 180o pulse to rephrase
the magnetization and realize an echoed signal. The stimulated pulse sequences utilize
three successive 90o pulses to bring about the same effect. In Figure 7.2, d0~d5 are
acquisition delays. The spin echo condition requires: d0=d3 and d2=d4.
Stimulated spin echoes are often employed in system which has a short T2 relaxation time
and a slow diffusivity. For the micelle system, the diffusivity of micelle is much slower
than that of monomer and the spin-spin coupling relaxation time (T2) of nuclei in micelle
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Nonstimulated PGSE NMR sequence
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g
d5

d2

d3



d4

Stimulated PGSE NMR sequence

Figure 7.2, Schematics of nonstimulated and stimulated PGSE NMR sequences used in
diffusivity measurements. The shaded bars represent the magnetic field gradient (along z
direction) pulses with duration, , and intensity, g.
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is also much shorter than that of monomer due to the molecular motional restriction in
micelles.

For stimulated PGSE experiment, the equation used to determine the diffusivity can be
written as:





I  I 0 exp  D 2 g 2 2    3

(7.1)

where I and I0 are the measured NMR signal intensities in the presence and absence of
magnetic field gradient; D is the diffusivity;  is the gyromagnetic ratio (which is equal to
2.67515x108s-1T-1 for proton);  and g are the duration and intensity of the magnetic field
gradient pulse along z direction;  is the diffusion time between two magnetic field
gradients in the pulse sequence which is equal to   d 2  pw90  d 5  pw90  d 3 (see
Figure 7.2; pw90 is the length of a 90o pulse). In the experiment,  and  are kept
constant. By changing gradient strength, g, a series of signal intensity I are measured.
Since the ln(I/I0) and g2 have good linear relationship, the slope is used to calculate the
diffusion coefficient D.

The diffusivity measurements were carried out on a Varian Inova 400MHz Fourier
Transform NMR spectrometer (S/N S010883) equipped with a Highland Performa II
gradiet probe (S/N P003732). Thin-walled 3mm glass sample tubes were used in order to
keep the sample within the linear region of the gradient coil. Compared to 5mm tube, the
3mm sample tube could also shorten the time to reach thermal equilibrium and inhibit the
thermal convection that could affect the measured diffusivity (Antalek, 2002). The
temperature of the measurements was controlled at 27.0±0.1oC. The samples were
equilibrated inside the NMR probe for at least 15 minutes prior to the data collection. The
trapezoidal gradient shape was utilized instead of the standard rectangular gradient in
order to minimize the effects of eddy currents on diffusivity measurements (Price and
Kuchel, 1991).
182

The instrument was calibrated using a standard solution containing 15mg/mL SDS in
D2O. The literature values of the diffusivities of dodecyl sulfate at 15mg/mL
concentration are 0.976x10-10m2/s at 25oC (Landman et al., 1984) and 1.70x10-10m2/s at
45oC (Miller et al., 1994). The interpolated diffusion coefficient at 27oC based on
Arrhenius relationship was 1.05x10-10m2/s. After the calibration our measured diffusivity
of the standard was (1.05±0.01)x10-10m2/s. The diffusivity of the standard was measured
both before and after each set of experiments. The intraday deviation of the diffusivities
of standards was less than 1%. The advantage of using 15mg/mL SDS as the standard
solution was the diffusivity value of the standard was close to the diffusivity of the
samples while conventional standards, such as D2O or dioxane, had values which were
one order of magnitude higher than that of samples.

In our experiments, a value of 200ms was used for the delay time d5 which was the
dominant term for the diffusion time, . Delay time d2(=d4) was 10~20ms and d0(=d3)
was 0.4ms. Pre-sequence time delay d1 should be 5 times greater than T1 of species of
interest so as to permit the magnetizations to return to their equilibrium positions. A delay
time of 5s was chosen for d1. The length of 90o pulse, pw90, ranged from 15.3 to 16.0s
when the transmitter power (tpwr) was set to 57 dB. The duration of the magnetic field
gradient pulses, , was set to 5ms, and the strength of the gradient pulses, g, was varied
from 5 to 27 Gauss/cm in 10 steps in most cases. The squares of gradient strengths, g2,
were chosen to be equally spaced between the minimum and maximum values. The
minimum field gradient strength was set to 5 Gauss/cm instead of zero due to the poor
performance at gradient strengths near zero, specifically significant phase distortion of
spectra. The maximum gradient strength was varied between 22 and 30 Gauss/cm based
on the gradient strength needed to cause an attenuation of NMR signal by about 90%. A
trapezoidal shape of magnetic field gradient pulse was employed: a gradient ramp with
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duration of 0.2ms was applied at the beginning and end of each gradient pulse in order to
minimize the eddy current effect on signal fluctuation. Other parameters and their
corresponding values included a sweep width of 6000 Hz, 16384 points for Fourier
transform and 8~64 transients depending on the signal strength.

There were multiple NMR bands associated to each molecule, the drug or surfactant, in
the system. Each band could be used to detect the diffusivity of the corresponding
molecule. To improve the accuracy of the measurements, three bands were chosen for
each molecule to detect the diffusivity separately. Since the measurement of each sample
was repeated three times, the final determined diffusivity was an average of 3×3=9
measurements. The chosen NMR bands in diffusivity determinations for model drug and
surfactant molecules are listed in Table 7.1. The chemical shifts of SDS, DTAB and
butylparaben were in good agreements with the reported values in D2O media (Hawrylak
and Marangoni,1999; Suratkar and Mahapatra, 2000; Panicker, 2008).

7.2.2.4.

PGSE NMR Sample Preparations

A known amount of model drugs was dissolved into surfactant solutions with D2O as
solvent to make near-saturated solutions of the drugs. The drug-surfactant solution
systems were rotated for 2 days to ensure complete dissolution of the solid drugs. To
prepare solutions with lower drug concentrations, the above samples were diluted 1.5~3
times with blank surfactant solutions (with same surfactant concentration). When salts
were present, NaCl was weighed and added into surfactant solutions to make 0.15N
concentration of NaCl. About 0.25mL sample solutions were place into 3mm NMR tube
for diffusivity measurements.
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Table 7.1, List of NMR bands of model drugs and surfactants used in diffusivity
measurements.
Drug/Surfactant

Chemical shifts of NMR bands used
in diffusivity measurements (ppm)

Progesterone

5.8, 2.2, 0.7

Diazepam

7.5, 7.2, 3.5

Methylparaben

7.9, 6.9, 3.9

Butylparaben

7.9, 6.9, 1.0

SDS

4.1, 1.3, 0.9

DTAB

3.2, 1.3, 0.9

DM

3.5~3.9, 1.3, 0.9
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7.3

RESULTS AND DISCUSSION

7.3.1.
7.3.1.1.

Two-dimensional NMR
2-D NMR for Steroids in Micelles

NOESY and ROESY NMR techniques were used as a means to study the locus of
solubilization of model drugs in micelles. Figure 7.3 shows the ROESY spectrum for
3.5mg/mL 11-hydroxyprogesterone in 15mg/mL SDS solutions. The corresponding 1-D
spectrum is shown at both the top and left sides of the 2-D spectrum. There are several
peaks identified as belonging to the steroid, such as 0.7, 2.0~2.7, 5.7ppm; one
characteristic peak belonging to SDS, 0.9ppm; and at least three overlapped peaks having
contributions from both the surfactant and drug, such as 1.3, 1.7, 4.0ppm. Many
cross-peaks are present corresponding to short distance (<5Å) between two hydrogen
atoms. Unfortunately, all the cross-peaks could be explained by intra-molecular
interactions (surfactant-surfactant or drug-drug) and no evidence of inter-molecular
interactions between surfactant and drug molecules was observed. Shown in Figure 7.4 is
the ROESY spectrum for 1.9mg/mL 11-hydroxyprogesterone in 20mg/mL DTAB
solutions. Based on the 1-D spectrum, the peaks at 0.7, 2.0~2.7, 4.0, 5.7ppm are
exclusively assigned to the drug; the peaks at 0.9, 3.2, 3.4ppm are assigned to DTAB and
the peaks at 1.3, 1.8ppm are assigned to both the drug and surfactant due to the overlaps.
Similar to 11-hydroxyprogesterone-SDS systems, all observed cross-peaks correspond
to intra-molecular interactions and no inter-molecular interaction between drug and
surfactant molecules is evident. These results do not imply that the surfactant fails to
solubilize the drug. The data in Section 3.3.1 clearly does illustrate the power of SDS to
solubilize 11-hydroxyprogesterone.

The ROESY experiments were carried out on 11-hydroxyprogesterone (0.5mg/mL) in
20mg/mL DM solutions. The results are not shown. No cross-peak corresponding to
inter-molecular interactions between drug and surfactant was observed. It is partly due to
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Figure 7.3, ROESY of 3.5mg/mL 11-hydroxyprogesterone in 15mg/mL SDS.

Figure 7.4, ROESY of 1.9mg/mL 11-hydroxyprogesterone in 20mg/mL DTAB
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the low drug concentration compared to the concentration of surfactant. As a result, the
intra-molecular interactions of drug molecules may not be sufficiently detectable and
only the cross-peaks between protons of surfactant molecules were observed.

Both ROESY and NOESY techniques were applied to 15mg/mL SDS solutions
containing 2.6mg/mL progesterone with the results not shown here. The mixing time for
ROESY experiment was 0.2s while the mixing time for NOESY experiments varied from
0.2 to 1.0s. But in all the 2-D spectra, no cross-peak related to inter-molecular
interactions between drug and surfactant was seen.

In all the studied steroid-in-micelle systems, no evidence of interactions between steroid
and surfactant molecules was observed. The possible reasons include: (1) In some
systems, there are broad overlaps between characteristic peaks of the drug and surfactant.
For example, in 11-hydroxyprogesterone/SDS systems, there is only one peak
exclusively assigned to surfactant (0.9ppm), which corresponds to the protons at the
terminal methyl group of alkyl tail of SDS. As a consequence of 0.9ppm being the sole
unambiguous peak, the outlined NMR methods will only detect an interaction between
drug and the end of hydrophobic tail of SDS molecules. (2) The qualities of 2-D spectra
were poor due to a significant t1-noise and the signal/noise ratio was significantly
lowered. (3) The rotational movement of drug molecules in micelles can be sufficiently
rapid that the distance between two protons of drug and surfactant cannot remain below
5Å on the NMR timescale. In Chapter 6 it was speculated that the steroids have larger
degree of freedom at oil/water interface compared to benzodiazepines and parabens. This
factor may contribute to the difficulties of detecting interactions between drugs and
surfactants for SDS-steroid systems.
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7.3.1.2.

2-D NMR for Parabens in Micelles

Figure 7.5 shows the ROESY spectrum of 4.9mg/mL methylparaben in 15mg/mL SDS
solutions. The NMR bands at 0.9, 1.2, 1.6 and 4.0ppm are assigned to the methyl group,
hydrocarbon chain (including 9 carbons adjacent to methyl group), -protons and
-protons of the SDS. Methylparaben has characteristic peaks at 3.8ppm (methyl group),
6.9 and 7.9ppm (aromatic ring). The following cross-peaks corresponding to
inter-molecular interactions between the drug and surfactant were observed: 0.9↔3.8ppm,
1.2↔3.8/6.9/7.9ppm, 1.6↔7.9ppm, 4.0↔7.9ppm (labeled by arrows in Fig. 7.5). A
schematic representation, Figure 7.6, demonstrates how the interactions could be used to
determine the location and orientation of drug molecules in micelles. The short distance
between aromatic ring of methylparaben and - and -protons of SDS indicates the
location of the aromatic ring in the vicinity of the head groups of the surfactant, and
therefore the micelle surface. The interactions between methyl group of methylparaben
and the terminal methyl group of the hydrophobic tail of SDS suggests the methyl group
of methylparaben is pointing towards the micelle core. From the configuration derived
from the inter-molecular interactions, the hydroxyl group of methylparaben must be
pointing to the aqueous environment. To prove the observed interactions happened in the
micelles but not in the solution state, such as from dimer complexes, the 2-D NMR
spectrum was measured at surfactant concentration lower than the CMC. The spectrum of
1.0mg/mL methylparaben in 1.0mg/mL SDS solutions shows only cross-peaks
corresponding to intra-molecular interactions and no cross-peak between the drug and
surfactant (the spectrum is not shown).

Figure 7.7 shows the ROESY spectrum of 6.7mg/mL methylparaben in 20mg/mL DTAB
solutions. There is no overlap between NMR bands of methylparaben and those of DTAB.
The characteristic peaks of DTAB include 0.9ppm (methyl group at the end of
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Figure 7.5, ROESY of 4.9mg/mL methylparaben in 15mg/mL SDS. The interested
cross-peaks are labeled using arrows.

Figure 7.6, A schematic of inter-molecular interactions between methylparaben and SDS
molecules detected by ROESY experiments (Fig. 7.5).
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the hydrocarbon tail), 1.1~1.2ppm (hydrocarbon chain consisting of 9 carbons adjacent to
methyl group), 1.6ppm (-protons), 3.2ppm (methyl groups at the head group), and
3.8ppm (-protons). The following cross-peaks between functional groups of
methylparaben and DTAB were observed: 0.9↔3.8ppm, 1.1~1.2↔3.8/6.9/7.9ppm,
3.2↔6.9/7.9ppm (labeled using arrows in Fig. 7.7). Figure 7.8 is a schematic
representation illustrating the specific interactions between methylparaben and DTAB in
micelles. The aromatic ring of the drug is close to the head group of DTAB molecules
while the methyl group of methylparaben is close to the end of hydrophobic tail of the
surfactant. These observations are consistent with the conclusion that the aromatic ring
and hydroxyl group of methylparaben are located at micelle surface while the methyl
group of the drug points towards the micelle core.

Shown in Figure 7.9 is the NOESY spectrum of 3.7mg/mL methylparaben in 20mg/mL
DM solutions. DM has characteristic bands at 0.9ppm (methyl group of the hydrophobic
tail), 1.3ppm (hydrocarbon chain including 9 carbons adjacent to terminal methyl group),
1.6ppm (-protons), 3.3~3.9, 4.3 and 5.3ppm (head group). Obviously, the broad band,
3.3~3.9ppm, of the head group overlaps with the sharp peak (3.8ppm) corresponding to
the methyl group of methylparaben. No conclusive information can be obtained for
interactions with the methyl group of methylparaben. The cross-peaks between
6.9/7.9ppm and 0.9/1.3/1.6/3.3~3.9ppm were observed which indicate the interactions
between the aromatic ring of methylparaben and both the head group and hydrocarbon
chain (including the terminal methyl group) of the surfactant. A schematic figure
demonstrating the inter-molecular interactions is shown in Figure 7.10. These results
suggest the drug and surfactant molecules may have more compact packing in DM
micelles compared to that in ionic micelles. The ROESY experiments were carried out on
the same system (methylparaben/DM system, results are not shown). No cross-peaks
between the drug and surfactant were seen. This lack of response may be because the
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Figure 7.7, ROESY of 6.7mg/mL methylparaben in 20mg/mL DTAB. The interested
cross-peaks are labeled using arrows.

Figure 7.8, A schematic of inter-molecular interactions between methylparaben and
DTAB molecules detected by ROESY experiments (Fig. 7.7).
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Figure 7.9, NOESY of 3.7mg/mL methylparaben in 20mg/mL DM. The interested
cross-peaks are labeled using arrows.

Figure 7.10, A schematic of inter-molecular interactions between methylparaben and DM
molecules detected by NOESY experiments (Fig. 7.9).
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cross-peak was significantly weakened by the much shorter spin-spin relaxation time
(T2=0.01~0.04s) for protons in DM micelles compared to the mixing time used in
ROESY experiments (tmix=0.3s).

Figure 7.11 is the ROESY spectrum of 3.7mg/mL ethylparaben in 15mg/mL SDS
solutions. Ethylparaben has characteristic bands at 7.8 and 6.9ppm (aromatic ring),
4.3ppm (-CH2- group), and 1.3ppm (methyl group). Compared to NMR bands of SDS,
4.0, 1.6, 1.2 and 0.8ppm, the methyl group band of the drug (1.3ppm) is very close to the
peak of the hydrocarbon chain of SDS (1.2ppm) and is near the methyl group band of
SDS (0.8ppm). When a small cross-peak (such as inter-molecular interactions) arises
where two bands exhibit close chemical shifts, the signal is often difficult to be
distinguished because of the t1-noise (along y-axis of Fig. 7.11) in a region close to the
diagonal peaks of the 2-D spectrum. Therefore the interaction between methyl group of
ethylparaben and alkyl chain of SDS is difficult to detect. On the other hand, from the
off-diagonal cross-peaks, the following interactions between the drug and surfactant
could be observed: the aromatic ring of ethylparaben with the alkyl chain of SDS
(7.8/6.9ppm↔1.2ppm); the aromatic ring of the drug with the -protons of SDS
(7.8/6.9ppm↔4.0ppm). A schematic representation of the detected inter-molecular
interactions between ethylparaben and SDS molecules is shown in Fig. 7.12. The results
indicate the aromatic ring of ethylparaben is located between the head group and alkyl
chain of the surfactant. The orientation of the model drug cannot be determined from the
ROESY experiment.

Shown in Figure 7.13 is the ROESY spectrum of 5.8mg/mL ethylparaben in 20mg/mL
DTAB solutions. Inter-molecular interactions included: the aromatic ring of ethylparaben
with the hydrocarbon chain of DTAB (7.8/6.9ppm↔1.2ppm); the aromatic ring of the
drug with the methyl groups in head group of DTAB (7.8/6.9ppm↔3.1ppm). The
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Figure 7.11, ROESY of 3.7mg/mL ethylparaben in 15mg/mL SDS. The interested
cross-peaks are labeled using arrows.

Figure 7.12, A schematic of inter-molecular interactions between ethylparaben and SDS
molecules detected by ROESY experiments (Fig. 7.11).
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Figure 7.13, ROESY of 5.8mg/mL ethylparaben in 20mg/mL DTAB. The interested
cross-peaks are labeled using arrows.

Figure 7.14, A schematic of inter-molecular interactions between ethylparaben and DTAB
molecules detected by ROESY experiments (Fig. 7.13).
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inter-molecular interactions are demonstrated in Figure 7.14.

The aromatic ring of

ethylparaben is close to both the head group and alkyl chain of the surfactant molecule
which suggest the aromatic ring of the drug is near the surface of the DTAB micelles.
Similar to that observed in ethylparaben/SDS system the 2-D NMR technique could not
detect significant interaction between the methyl group of ethylparaben and the
hydrophobic tail of DTAB. No conclusions concerning molecular orientation could be
made.

Figure 7.15 is the ROESY spectrum of 5.0mg/mL butylparaben in 15mg/mL SDS
solutions. Butylparaben has characteristic peaks at 7.8 & 6.9ppm (aromatic ring), 4.2ppm
(-protons), 1.7ppm (-protons), 1.4ppm (-protons), and 0.9ppm (methyl group). The
short spacing between the NMR bands of alkyl chain of butylparaben and the peaks of
alkyl chain of SDS (4.0, 1.6, 1.2 and 0.8ppm) prevents unambiguous identification of
interactions between alkyl chains of the drug and surfactant. On the other hand the
cross-peaks between the aromatic ring of butylparaben (7.8/6.9ppm) and the alkyl chain
(1.2ppm) or -protons (4.0ppm) of SDS were observed. The corresponding interactions
are illustrated in Figure 7.16 which suggests the aromatic ring of butylparaben is located
between the head group and alkyl chain of the surfactant and therefore is in the vicinity of
the micelle surface.

For all three parabens, the aromatic rings of the drug are shown to be close to micelle
surface. When methylparaben is solubilized in ionic surfactant systems (SDS and DTAB),
the methyl group of the drug is spatially close to the terminal methyl group of
hydrophobic tail of the surfactant. The orientation of model solute could be determined:
methyl group of methylparaben penetrats into the micelle core and the hydroxyl group of
methylparaben must be on the micelle surface contacting water molecules. The location
of methyl groups of ethylparaben and butylparaben in micelle could not be defined so
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Figure 7.15, ROESY of 5.0mg/mL butylparaben in 15mg/mL SDS. The interested
cross-peaks are labeled using arrows.

Figure 7.16, A schematic of inter-molecular interactions between butylparaben and SDS
molecules detected by ROESY experiments (Fig. 7.15).
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easily because the corresponding NMR peaks are close to the peaks of hydrophobic tail
of surfactants. A weak cross-peak between two NMR bands that are near to each other in
chemical shift is usually overwhelmed by the t1 noise in the 2-D NMR spectrum. In
nonionic surfactant system, the interactions between the aromatic rings of methylparaben
and all characteristic peaks of DM were observed. It may be due to the compact
molecular packing in DM micelle.

7.3.1.3.

2-D NMR for Benzodiazepines in Micelles

Figure 7.17 shows the ROESY spectrum of 3.8mg/mL diazepam in 15mg/mL SDS
solutions. The NMR bands assigned to diazepam have 7.6ppm (-8H, -9H), 7.5/7.4ppm
(benzene ring connected to C-5), 7.1ppm (-6H), 4.6/3.8ppm (-CH2-), and 3.4ppm (-CH3).
As marked with arrows in the figure, the observed cross-peaks between the drug and
surfactant include 7.5↔1.2ppm, 7.5↔4.0ppm, 7.4↔1.2ppm, and 7.1↔1.2ppm. The
corresponding intermolecular interactions are illustrated in Figure 7.18. The benzene ring
connected to C-5 of diazepam is close to both the -protons and alkyl chain of SDS
molecule. The proton at C-6 position of diazepam is near the alkyl chain of SDS
molecule in the micelles. These interactions indicate that part of diazepam molecule, e.g.
the benzene ring at C-5, is near the head group of surfactant and therefore close to the
micelle surface.

Shown in Figure 7.19 is the ROESY spectrum of 4.4mg/mL temazepam in 15mg/mL
SDS. The characteristic peaks for temazepam have 7.6ppm (-8H, -9H), 7.5/7.4ppm
(benzene ring connected to C-5), 7.1ppm (-6H), 3.4ppm (-CH3 ). The observed
cross-peaks are: 7.5↔1.2ppm, 7.5↔3.9ppm, 7.4↔1.2ppm, 7.4↔3.9ppm and
7.1↔1.2ppm (labeled using arrows in Fig. 7.19). The corresponding intermolecular
interactions between temazepam and SDS molecules are shown in Figure 7.20. The
benzene ring at C-5 position of temazepam is close to both the -protons and alkyl chain
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Figure 7.17, ROESY of 3.8mg/mL diazepam in 15mg/mL SDS. The interested
cross-peaks are labeled using arrows.

6
5

Figure 7.18, A schematic of inter-molecular interactions between diazepam and SDS
molecules detected by ROESY experiments (Fig. 7.17).
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Figure 7.19, ROESY of 4.4mg/mL temazepam in 15mg/mL SDS. The interested
cross-peaks are labeled using arrows.

6
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Figure 7.20, A schematic of inter-molecular interactions between temazepam and SDS
molecules detected by ROESY experiments (Fig. 7.19).
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of surfactant. The proton at C-6 position of temazepam is near alkyl chain of SDS
molecule. These drug-surfactant interactions suggest part of temazepam molecules is
close to the micelle surface, e.g. the benzene ring at C-5 position.

Figure 7.21 shows the ROESY spectrum of 1.6mg/mL temazepam in 20mg/mL DTAB
solutions. The detected inter-molecular interactions include: the benzene ring at C-5
position of temazepam with the alkyl chain of DTAB (7.6/7.5↔1.3ppm); the benzene
ring at C-5 of temazepam with the methyl groups at head group of DTAB (7.6↔3.1ppm);
the proton at C-6 of temazepam with the alkyl chain of DTAB (7.2↔1.3ppm). Figure
7.22 shows the schematic representation of inter-molecular interactions between the drug
and surfactant molecules. The benzene ring at C-5 of temazepam is near micelle surface
due to the short distance between the benzene ring and head group of DTAB. The
measured intermolecular interactions are not sufficient to determine the orientation of
temazepam in the micelles.

ROESY spectrum of 0.7mg/mL temazepam in 20mg/mL DM solutions was measured
with the results not shown here. No cross-peak corresponding to inter-molecular
interaction was observed. The relatively low concentration of drug compared to the
surfactant concentration and the short spin-spin relaxation time (T2) of DM compared to
the mixing time are two reasons for the failure of detecting inter-molecular interactions in
the system.

In conclusion, when benzodiazepines are solubilized in ionic surfactant systems (SDS
and DTAB), 2-D NMR method can detect the interactions between the benzene ring at
C-5 position of benzodiazepines and both the head groups (-protons of SDS or methyl
groups at head group of DTAB) and alkyl chain of surfactant molecules. The results
indicate the benzene ring at C-5 of the drug molecules are in the vicinity of the micelle
202

Figure 7.21, ROESY of 1.6mg/mL temazepam in 20mg/mL DTAB. The interested
cross-peaks are labeled using arrows.

6
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Figure 7.22, A schematic of inter-molecular interactions between temazepam and DTAB
molecules detected by ROESY experiments (Fig. 7.21).
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surface. Since some other functional groups of benzodiazepines, e.g. carbonyl and/or
hydroxyl groups, are more hydrophilic than the benzene ring, it is very likely those
hydrophilic groups are located at the micelle surface and contact with water molecules.

7.3.2.

Pulse Gradient Spin-Echo (PGSE) NMR

PGSE NMR technique was employed to measure the diffusivity of drug or surfactant
molecule in solutions. The diffusivity was correlated to particle size through
Stokes-Einstein relation assuming the particle had a spherical shape:
D

k BT
6 r

(7.2)

where D is the diffusivity; kB is the Boltzmann‟s constant (1.38×10-23 J/K);  is the
viscosity of media; and r is the radius of the particle. Fortunately, the model micelles had
a spherical shape (Yalkowski and Zografi, 1972) which satisfied the requirement of
Stokes-Einstein relation. Since kB, T and  are all constant or near constant in our study,
the micelle size could be detected by measuring the diffusivity of the micelle.

For both the drug and surfactant, the measured diffusivities are comprised of two
components, monomers and micelles. The total diffusivity could be expressed as:
Dtotal  f monomer Dmonomer  (1  f monomer ) Dmicelle

(7.3)

where Dtotal, Dmonomer, Dmicelle are measured diffusivity, diffusivity of the monomer and
diffusivity of the micelle, respectively; fmonomer is the mole fraction of the drug or
surfactant in monomer state in solutions. Only under conditions fmonomer<<1 and
fmonomerDmonomer<<Dtotal, the measured total diffusivity would reflect the diffusivity of
micelle.

The micelle size was measured as a function of drug concentration in order to detect the
extent to which the micelle size may change when drugs were solubilized.
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7.3.2.1.

Drugs Solubilized in SDS Micelles

Progesterone, diazepam and butylparaben were chosen as representatives of the three
model drug series. The concentration of SDS was fixed at 15mg/mL. The measured
diffusivities of drug molecules as a function of drug concentration are shown in Figure
7.23. Rearranging Eq. (7.3), the diffusivity of the micelle can be expressed as:
Dmicelle 

Dtotal  f monomer Dmonomer
1  f monomer

(7.4)

The diffusivity of progesterone monomer in D2O has been reported as (5.68±0.07)×10-6
cm2/s (Land, 2005). The diffusivity of the diazepam or butylparaben monomer was
estimated based on approximate relationship:
13

Ddrug

 V progesterone 

 D progesterone 
 V

drug



(7.5)

where Ddrug and Dprogestereone are the diffusivities of the drug and progesterone monomers
in D2O; Vprogesterone and Vdrug are molar volumes of the drug and progesterone. The molar
volumes of the model drugs could be obtained from Table 5.1. The validity of Eq.(7.5)
was tested by comparing the calculated diffusivity of methylparaben in D2O (7.6×10-6
cm2/s) to that of the measured value (7.4×10-6 cm2/s). Applying Eq. (7.5), the diffusivities
of diazepam and butylparaben monomers in D2O were 6.2×10-6 and 6.8×10-6 cm2/s,
respectively.

The mole fraction of drug monomers as a function of total drug concentration could be
estimated from the solubilization results in Chapter 3 (Table 3.2~3.4 and Fig. 3.14, 3.17
and 3.20). The fmonomer values are 0.0027 for progesterone, 0.010 for diazepam and 0.033
for butylparaben. Substituting the values of Dmonomer and fmonomer into Eq. (7.4), the
measured diffusivities of SDS micelles are 6.8, 6.6 and 6.5×10-7 cm2/s when progesterone,
diazepam and butylparaben were used as the solubilizates. Using the average value of the
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diffusivities, 6.6×10-7 cm2/s, and viscosity of D2O at 27oC (1.05cP) (Cho et al., 1999) in
Eq. (7.2), the radius of SDS micelle is determined to be 32Å.

As shown in Fig. 7.23, for all three model drugs, the diffusivities of micelle exhibit no
statistically significant changes in radius with varying drug concentration, indicating the
micelle size remains constant even when solubilizing drugs. The results support the
co-adsorption model of the drug and surfactant at micelle surface where micelle size
remains constant.

In Figure 7.23, the effect of added electrolyte on the micelle size is also presented. In the
presence of 0.15M NaCl in 15mg/mL SDS solutions, the total diffusivities of
progesterone and diazepam are significantly larger than the diffusivities in the absence of
salt. The mole fractions of drug monomers could be determined from the solubilization
results in Chapter 3 (Table 3.5, Fig. 3.24). The fmonomer values are 0.0040 for progesterone
and 0.012 for diazepam. Eq. (7.4) was employed to determine the diffusivities of SDS
micelles to be 7.7×10-7 (progesterone as solute) and 7.3×10-7 cm2/s (diazepam as solute).
Using Eq. (7.2), the micelle size is estimated to be 28Å, a value slightly smaller than the
32Å found in the absence of NaCl.

In may also be noted in Figure 7.23 that in the presence of 0.15M NaCl, the micelle size
is not significantly changed with increasing drug concentration.

7.3.2.2.

Drugs Solubilized in DTAB Micelles

Progesterone, diazepam and butylparaben were solubilized in 20mg/mL DTAB solutions.
The diffusivities of drug molecules were measured as a function of drug concentration
with results shown in Figure 7.24 and 7.25. Based on early studies on solubilization of
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Figure 7.23, Diffusivities of progesterone, diazepam and butylparaben as a function of
drug concentration in 15mg/mL SDS solutions in the absence and presence of 0.15M
NaCl.

Figure 7.24, Diffusivities of progesterone and diazepam as a function of drug
concentration in 20mg/mL DTAB solutions in the absence and presence of 0.15M NaCl.
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Figure 7.25, Diffusivities of butylparaben as a function of drug concentration in
20mg/mL DTAB solutions.
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progesterone and diazepam in DTAB solutions (Table 3.2~3.3, Fig. 3.15 and 3.18), the
mole fractions of drug monomers, fmonomer, are 0.0055 for progesterone and 0.033 for
diazepam. The calculated diffusivities of DTAB micelles from Eq. (7.4) are 7.7×10-7
cm2/s (progesterone as solute) and 7.9×10-7 cm2/s (diazepam as solute). The
hydrodynamic radius of DTAB micelle is calculated from Eq. (7.2) to be 27Å.

From Fig. 7.24, with increasing concentration of progesterone, the micelle size of DTAB
was observed to decrease slightly, but significantly, due to the increase in diffusivity of
the micelle. The student‟s t-test gives a two-tailed p-value of <0.01 (0.007) between the
diffusivities at low (0.47mg/mL) and high (1.42mg/mL) concentrations of progesterone
(using unequal variances because the measured diffusivity of a substance has a larger
standard deviation at lower concentration of the substance). For diazepam, the radius of
DTAB micelle has no significant change with increasing drug concentration. Both of the
results suggested the solubilized drug may replace surfactant molecules during the
solubilization process to keep micelle size constant or even decrease micelle size.

In our early solubilization studies (Chap. 3), it was observed that additon of butylparaben
to DTAB solution could make the solutions cloudy indicating the disturbance of DTAB
micelle structures. Here we investigated the size of newly formed assemblies by
measuring the corresponding diffusivity. Figure 7.25 shows the diffusivity of
butylparaben is dramatically decreased with increasing drug concentration in the DTAB
solutions. When the concentration of butylparaben is increased from 2mg/mL to 6mg/mL,
the diffusivity of butylparaben is decreased by 43%. The corresponding micelle size and
micelle volume would increase by approximately 43% and 190%, respectively. The
significant grow of micelle size may have resulted in phase transition of the system and
the cloudy appearance of butylparaben in DTAB mixture.
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The effect of added electrolyte on DTAB micelle size is shown in Fig. 7.24. In the
presence of 0.15M NaCl in 20mg/mL DTAB solutions, the diffusivities of progesterone
and diazepam were measured as a function of drug concentration. To estimate the
contribution of drug monomers to total measured diffusivity, the mole fraction, fmonomer,
was determined using the early solubilization results in the presence of salt (Table 3.5 and
Fig. 3.25). The mole fraction of progesterone monomers is 0.0061 and the mole fraction
of diazepam monomers is 0.032. The diffusivities of DTAB micelles are calculated from
Eq. (7.4) to be 9.2×10-7 cm2/s (progesterone as solute) and 8.4×10-7 cm2/s (diazepam as
solute). Using the average value of micelle diffusivities in Eq. (7.2), the estimated
hydrodynamic radius of the DTAB micelle in the presence of 0.15M NaCl is 24Å which
is smaller than the radius of the DTAB micelle in the absence of NaCl (27Å).

7.3.2.3.

Drugs Solubilized in DM Micelles

Figure 7.26 shows the diffusivities of dodecyl -D-maltoside (20mg/mL) as a function of
concentration of model drugs, progesterone and diazepam. Due to the low solubilization
capacity of DM micelles, the concentration of solubilized drugs is much lower than the
surfactant concentration, resulting in weak NMR signals. The diffusivity measurements
of drug molecules using those weak NMR signals exhibited large relative error (>10%)
and were not used in micellar size determination. As an alternative, diffusivity of the DM
micelle was determined by employing DM-associated NMR signals.

To estimate the diffusivity of the DM micelle using Eq. (7.4), the diffusivity of DM
monomers was required. It may be inappropriate to extrapolate the diffusivity of DM
monomer from the diffusion coefficient of progesterone using Eq. (7.5) because DM has
a long chain structure while the structure of progesterone is bulky. The structural
similarity between DM and SDS molecules enabled us to estimate the diffusivity of DM
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Figure 7.26, Diffusivities of DM as a function of drug concentration in 20mg/mL DM
solutions in the absence and presence of 0.15M NaCl. Two model drugs, progesterone
and diazepam, were used.
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monomer based on diffusion coefficient of dodecyl sulfate monomer. The measured
Dmonomer of dodecyl sulfate ion is 4.6×10-6 cm2/s at SDS concentration below the CMC.
The McGowan volumes of dodecyl sulfate and DM are calculated to be 361 and
651Å³/molecule (McGowan, 1978), respectively. Employing Eq.(7.5), the estimated
diffusivity of DM monomer is 3.8×10-6 cm2/s. consequently, the diffusivity of DM
micelle in the absence of drug is 6.0×10-7 cm2/s. The hydrodynamic radius of DM micelle
is calculated from Stokes-Einstein relation to be 35Å.

From Fig. 7.26, the diffusivity of micelles is significantly decreased in the presence of
either progesterone or diazepam. When drug concentrations are raised to 0.5mg/mL for
progesterone and 0.6mg/mL for diazepam, the diffusivities of DM micelles are decreased
by 18% and 15%, respectively, that corresponds to increases of the micelle size by 18%
(progesterone as solute) and 15% (diazepam as solute). The volume changes of DM
micelles due to the solubilization of model drugs would be more dramatic: 64%
(progesterone) and 52% (diazepam) increases. Assuming the drugs were simply added to
DM micelles, the volumes of the micelles should be increased by only ~2.5% for
progesterone and ~3% for diazepam. The measured volume changes of DM micelles are
significantly larger than those based on the simple addition model, suggesting the
aggregation number of DM micelle must be increased dramatically even in the presence
of small amount of solubilized drug molecules.

The effect of adding 0.15M NaCl on the measured diffusivities of DM molecule as a
function of concentration of model drugs, progesterone and diazepam, is shown also in
Figure 7.26. In the absence of drug, the diffusivity of DM molecule in the presence of
salts is not significantly different from that in the absence of salts, suggesting the micelle
size does not change with added salts. The additions of 0.6mg/mL progesterone and
0.8mg/mL diazepam result in a decrease in the diffusivities of DM by 31% and 29%,
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respectively. Similar to drug in DM micelle systems in the absence of salt, the micelle
volumes are dramatically increased by 125% (progesterone as solute) and 115%
(diazepam as solute) when solubilizing <4% (w/w) model drugs in micelles. Under these
conditions, the aggregation number of DM micelle must be increased significantly with
increasing drug concentration. Our early studies in Section 5.3.4.2 used the
surface-localized thermodynamic model to demonstrate the solubilizations were not very
sensitive to the aggregation number of DM micelles.

7.3.2.4.

Support for Competition of the Drug and Surfactant at the Micelle

Surface
In the interfacial tension experiments in the bulk state outlined in Chapter 4, competition
between the drugs and surfactants for the dodecane/water clearly occurred.

It is

interesting to speculate whether the co-adsorption of drug and surfactant in the micelle
might be described as a competition for micelle interface.

If we hypothesize that the

drugs are competing with surfactants at the micelle surface, the micelle size must not
increase upon drug solubilization.

Under the condition of constant micelle size, the

drug molecule could replace surfactant molecule at micelle surface instead of simply
adding to the micelle. The studies in Sections 7.3.2.1 and 7.3.2.2 showed the radii of SDS
and DTAB micelles are not significantly increased with the increasing concentration of
solubilizates, e.g. progesterone and diazepam, both in the absence and presence of 0.15N
NaCl. In the case of progesterone in DTAB system (in the absence of NaCl), the micelles
size is even significantly decreased with increasing drug concentration. These results
would be consistent with the hypothesis that the added drugs to micelles may be
replacing surfactant molecules due to the limited surface area of a micelle. Additional
work would be necessary before a definitive conclusion of competition over
co-adsorption could be drawn.
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7.3.2.5.

Possible Self-Association of Drug Molecules

Previously, we alluded to the assumption that the drug molecules do not self-associate in
bulk solution. To test this assumption, we measured the diffusivities of the drug as a
function of drug concentration. The results are shown in Figure 7.27. If the drug could
self-associate at a certain drug concentration, the diffusivity of methylparaben as a
function of drug concentration would exhibit a breakpoint connecting a constant
diffusivity region and a descending curve with increasing drug concentration. The results
in Figure 7.27 show that the diffusivity of methylparaben is independent of the drug
concentration up to the aqueous solubility. The absolute diffusivity value of
methylparaben could also rule out the formation of dimer or oligomer because the
diffusivity of dimer or oligomer should be lower than 6.0×10-6 cm2/s according to Eq.
(7.5). The measured diffusivity is, in fact, higher at 7.3±0.1×10-6 cm2/s. Based on above
analyses it may be concluded that methylparaben does not self-associate in aqueous
solutions.

7.4.

CONCLUSION

The two-dimensional NMR techniques including ROESY and NOESY were employed to
probe the inter-molecular interactions between the drug and surfactant molecules in the
micelles. In steroids/surfactants systems, the overlaps of NMR bands between solute
molecules and hydrocarbon chains of surfactants (not including terminal methyl group)
hindered the possible intermolecular interactions.

When parabens were solubilized in SDS and DTAB micelles, the interactions between
aromatic rings of parabens and alkyl chains of surfactants as well as -protons of SDS or
methyl groups at head group of DTAB were clearly detected which indicated the aromatic
rings of parabens were close to micelle surface. For methylparaben in SDS and DTAB
systems, the methyl groups of the drug was found to be spatially close to the terminal
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Figure 7.27, Diffusion coefficients of methylparaben in D2O as a function of drug
concentration.
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methyl groups of alkyl chains of surfactants. Then the orientation of methylparaben in
SDS/DTAB micelles was determined: the phenol group was likely located at micelle
surface and the methyl group penetrated inside the micelles. For ethylparaben and
butylparaben solubilized in SDS and DTAB micelle systems, the methyl groups of the
drugs had chemical shifts close to that of methyl group in alkyl chain of surfactant which
made the detection of corresponding cross-peaks difficult due to the big t1-noise. In
methylparaben/DM system, the interactions between aromatic ring of the drug and many
NMR bands of DM including head group, hydrocarbon chain and even the terminal
methyl group of hydrophobic tail of DM. The nonspecific interactions may be due to the
compact molecular packing in the nonionic micelles.

In benzodiazepine/surfactant systems, the interactions between benzene ring at C-5
position of benzodiazepines and both alkyl chain and head group (-prontons in SDS or
methyl groups at N-1 position of DTAB) of ionic surfactants were observed which
suggested part of benzodiazepine molecule was located in the vicinity of the micelle
surface. When benzodiazepines were solubilized in DM micelles, the relatively low
solubilization capacity of the nonionic micelles resulted in a drug concentration much
less than surfactant concentration. Therefore the cross-peaks between drug and surfactant,
whose intensities were proportional to drug and surfactant concentrations, were too weak
to be detected.

In all drug/surfactant systems where inter-molecular interactions were detected, there
were some evidences that show part of solubilized drug was close to micelle surface. This
finding supported our micellar surface solubilization picture based on the thermodynamic
analyses in Chapter 3~5.

216

The PGSE NMR method was utilized to measure the diffusivity and size of the micelles
in the presence of different drugs. The sizes of SDS micelles had no statistically
significant change with increasing concentration of progesterone, diazepam or
butylparaben. The phenomena are consistent with the hypothesis that added drug
molecules may replace surfactant molecules in micelles to keep the micelle size constant
in agreement with the existence of drug-surfactant competition for micelle surface. The
sizes of DTAB micelles were either slightly decreased or unchanged with increasing
concentration of progesterone or diazepam which also supported the co-adsorption of the
drug and surfactant at the micelle surface. When butylparaben was added to DTAB
solutions, the micelle size was significantly increased by up to 43%. The cloudy
appearance of the solutions suggests a broad distribution of micelle sizes. For nonionic
DM micelles, the solubilization of small amount of hydrophobic drug resulted in
significant increase in micelle size and aggregation number.

The salt effect on micelle size was studied. The hydrodynamic radii of SDS and DTAB
micelles were decreased in the presence of 0.15M NaCl while the hydrodynamic radii of
DM micelles were not affected by salts. The sizes of SDS and DTAB micelles showed no
significant change with increasing concentration of progesterone or diazepam in the
presence of salts. The results indicate the co-adsorption of the drug and surfactant at
micelle surface would happen even in the presence of salts. On the other hand, the sizes
of DM micelles were significantly increased with added progesterone or diazepam in the
presence of salts. It may be due to the decrease in Laplace pressure by the solubilized
drug at micelle surface that let the surfactant move to micelle surface more easily.

Copyright © Shaoxin Feng 2009
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Chapter 8
Conclusions and Future Work

In summary, the following experimental results have been obtained:



For three series of model drugs in three micelle systems, the measured micelle/water
partitioning coefficients were much larger than hydrocarbon/water partitioning
coefficients, which indicated the core region of micelle was insufficient to solubilize
the model hydrophobic drugs.



Hydrocarbon/water interfacial tension could be significantly decreased in the
presence of hydrophobic drugs, while the model drugs exhibited little or no surface
activity at oil/air or water/air interface. The hydrophobic drugs could compete with
surfactant molecules for the oil/water interface and the competition could be
quantitatively simulated using thermodynamic model.



A surface-localized thermodynamic model that considered the surfactant-drug
co-adsorption at the micelle surface was successfully applied to predict the
micelle/water partitioning coefficients of three series of model drugs in three micelle
systems. The critical parameters in calculating micelle/water partitioning included
the radii of micelles, surface activities of model drugs at oil/water interface
( G waterinterface ) and surface pressure at the micelle surface.



The surface-localized thermodynamic model successfully explained the salt effect on
micellar solubilization, drug concentration dependency for micelle/water partitioning
(solubilization isotherm), and surfactant CMC depression by solutes.



Molecular simulations combined with experiments on drug adsorption at oil/water
interface were employed to determine the orientation of drug at oil/water interface.
The molecular orientations were strongly dependent on the distribution of
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hydrophilic functional groups of model drugs.


2-D NMR (ROESY and NOESY) technique was able to detect some drug-surfactant
interactions but also had limitations when strong overlaps of NMR peaks or low drug
loading occurred.



The measured diffusivities of micelles using PGSE NMR method showed
insensitivity of micelle size (for ionic surfactants) to the solute concentration, which
supported the drug-surfactant co-adsorption in micelles.

The overall goal of this dissertation is to probe the mechanism of drug solubilization in
micelle systems. The work presented here provides a starting point for future studies that
are laid out as followings:



The surface-localized model could be extended to more complex mixed-micelle
systems that are physiologically relevant, e.g. phospholipids/bile salts mixtures. The
competitions between hydrophobic drugs and two surfactants for oil/water interface
are expected.



The surface adsorption of model drugs at oil/water interface could mimic biological
membrane/water partitioning. Therefore, the permeability of drug through biological
membrane may be correlated to the surface activities of the drug at
hydrocarbon/water interface.



The present work is mainly dealing with surfactants that have small headgroups. The
micelle surface (oil/water interface) is the dominant locations for drugs. In practical
applications, many nonionic surfactants have much larger headgroups that usually
contain PEGylated chains, e.g. Tween80, VitaminE TPGS, CremophorEL, Solutol,
etc. These bulky headgroups will introduce at least one more location for drug
solubilization. A model that considers multi-locations will be proposed to predict the
drug solubilization.
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The progress on the mechanistic understanding and quantitative predictions on drug
solubilization in micelle systems will provide a guideline for selecting solubilizing
ingredients and speed up the drug formulation process.

Copyright © Shaoxin Feng 2009
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APPENDICES

Appendix 1.

Liquid-liquid Interfacial Adsorption by Two-dimensional Solution

Model
Based on 2-D solution model, the chemical potential of a component of the interface can
be expressed according to Butler‟s equation (Butler, 1932):

 is   is , 0  RT ln xis f i s     ai

(A1.1)

where i is the chemical potential of component i, which could be water, drugs or
surfactants; superscript s stands for surface; superscript 0 stands for standard state; x is
the mole fraction based concentration; f is the activity coefficient;  is the interfacial
tension; and a is the partial molar interfacial area occupied by a molecule of component i.
In the bulk phase the chemical potential could be written as:

 il   il , 0  RT ln xil f i l 

(A1.2)

where superscript l stands for bulk liquid. When the interface and bulk phase reach
equilibrium the chemical potentials will be same:

 is   il

(A1.3)

In the absence of surface active species, the following relationship holds for solvent
water:
s ,0
l ,0
 water
  water
  0 a water

(A1.4)

where 0 is the interfacial tension in the absence of surface active agents and awater is the
interfacial area occupied by a water molecule.

If the activity coefficients at the interface, f i s , are assumed to be unity for all molecules
and f i l are assumed to be unity for neutral molecules, the above equations yield
following relationships:
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s
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xwater
 xwater
exp  water   exp  water 
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 Gwaterinterface, drug
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xdrug
 xdrug
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x surfact

(A1.5a)
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(A1.5b)

 l
 G waterinterface, surfact 
 a

 exp  surfact  for nonionic surfactant
 x surfact exp 
RT
RT 





 G waterinterface, surfact 
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 l
l
 
 exp  surfact  for ionic surfactant
x
f
exp
surfact
surfact

RT


 2 RT 

(A1.5c)

where subscripts “water”, “drug” and “surfact” represent water, drug and surfactant;
G waterinterface

is

transfer

free

energy

from

bulk

water

to

interface

Gwaterinterface,i  is,0  il ,0   0 ai ;  is the surface pressure defined as interfacial tension
difference between in the absence and presence of surfactant:    0   . In Eq.(A1.5a),
l
l
l
the mole fraction of bulk water, x water
, is chosen as 1 because xsurfact
are both
, xdrug

assumed to be much less than 1.

The total mole fractions of components occupying the surface will be equal to 1:
s
s
s

 x water  xdrug  x surfact  1
 s
s
s

 x water  xdrug  2 x surfact  1

(for nonionic surfactant)
(for ionic surfactant)

(A1.6)

The Eq.(A1.5a)~(A1.5c) are substituted into the appropriate equation (A1.6) in order to
solve for surface pressure . The final equation will have one of the following forms
under selected conditions:

1) Only one type of ionic surfactant, e.g. SDS or DTAB, is present, Eq. (A1.6) becomes:

 Gwaterinterface, surfact
 a

l
l
exp  water   2 x surfact
f surfact
exp 
RT 
RT
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 a
 exp  surfact

 2 RT


  1 (A1.7)


2) Only one kind of nonionic surfactant or neutral drug is present, Eq. (A1.6) becomes:

 Gwaterinterface, i
 a

exp  water   xil exp 
RT 
RT




 a 
 exp  i   1
 RT 


(A1.8)

where subscript i could be surfactant or drug.

3) Both ionic surfactant and neutral drug are present, Eq. (A1.6) becomes:


 a
 exp  surfact

 2 RT

 a 
 exp  drug   1

 RT 

 Gwaterinterface, surfact
 a

l
l
exp  water   2 x surfact
f surfact
exp 
RT 
RT


x

l
drug

 Gwaterinterface, drug
exp 
RT






(A1.9)

4) Both nonionic surfactant and neutral drug are present, Eq. (A1.6) becomes:


 a

 exp  surfact 
RT 



 a 
 exp  drug   1

 RT 

 Gwaterinterface, surfact
 a

l
exp  water   x surfact
exp 
RT 
RT


 G waterinterface, drug
l
 x drug
exp 
RT


(A1.10)

The oil/water surface tension in the presence of one or two surface active components
could be calculated by    0  

using the surface pressure solved from Eq.

(A1.7)~(A1.10).

Another important property of surface adsorption is the surface pressure as a function of
interfacial area per surfactant molecule, known as the -A relationship. For ionic
surfactant in the absence of drug, according to 2-D solution model, the interfacial area per
surfactant (A) can be calculated as follows:
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A

s
s
a water x water
 a surfact x surfact
s
x surfact

 a surfact  a water

s
x water
s
x surfact

(A1.11)

s
s
s
s
Rearranging Eq. (A1.6), xwater
 2xsurfact
 1, to xsurfact
 (1  xwater
) 2 . Substituting the
s
expression for xsurfact
in Eq. (A1.5a) to Eq. (A1.11) the equivalent form of -A

relationship is obtained:
A  a surfact  a water

 a surfact

 a surfact

s
2 x water
s
1  x water

 a

2 exp  water 
RT 

 a water
 a

1  exp  water 
RT 

a water
2
 a

exp water   1
 RT 

(A1.12)

The above equation could be transformed to - relationship:



2a water
RT 
ln 1 

a water 
A  a surfact






(A1.13)

For nonionic surfactant in the absence of drug, the -A relationship is derived based on
same principle:
A  a surfact 



a water
 a

exp water   1
 RT 

a water
RT 
ln 1 

a water 
A  a surfact

(A1.14)






(A1.15)
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Appendix 2.

Surface-localized Thermodynamic Model

In Mukerjee‟s two-state model, solubility of drugs in the micelle system was expressed as
a sum of contributions from two locations (Gumkowski, 1986).

K m / w  K m / w,core  K m / w, surface
 K h / w exp[ PV RT ] 

Af
Xw

(A2.1)


Af 

 K h / w exp[ PV RT ]1 
X
core


where Km/w and Kh/w are micelle/water and hydrocarbon/water partitioning coefficients of
drugs based on mole fraction; Xw and Xcore are mole fraction-based concentrations of drug
in aqueous phase and micellar core; P is Laplace pressure which is equal to 2/r for
spherical micelle ( is interfacial tension on micelle surface and r is radius of the micelle);
V is partial molar volume of drug; f is relative adsorption potential of the drug to account
for the effect of headgroups on adsorption;  is surface excess of the drug in
hydrocarbon/water interface and is defined by the Gibbs isotherm:


1 
RT  ln C

(A2.2)

A is micelle/water interfacial area per surfactant molecule and could be estimated by:

A  4r

2

(A2.3)

N aggr

where r is the radius of micelles and Naggr is the aggregation number.

In the surface-localized model, the micelle/water partitioning coefficient could be
expressed as:
K m / w  K m / w,core  K m / w, surface
 K h / w exp[  PV RT ] 


Af
exp[  PV RT ]
Xw

Af
exp[  PV RT ]
Xw
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(A2.4)

The intermediate step, the 2nd line of Eq. (A2.4), is equivalent to Mukerjee‟s two-state
model, Eq. (A2.1). An assumption used in the model is the micelle surface is subjected to
Laplace pressure. The assumption was implicitly employed in Mukerjee‟s two-state
model but was not clearly stated. In our studied systems, the contributions of the micellar
core to solubilization were assumed to be negligible and the micelle/water partitioning
coefficient was expressed using the solubilization by micellar surface only. See Chapter 3
for experimental evidence to support this assumption.

A2.1.

Dilute Solute Condition

The term Xw in Eq. (5.4) could be expressed by rearranging the Gibbs isotherm as:

1

1 
1 



Xw
X w RT ln X w
RT X w RT X w

(A2.5)

At infinite dilution of drug, the Eq. (A1.8) for neutral drug adsorbed at liquid-liquid
l
interface can be simplified using   0, xdrug
 X w  0

1

 Gwaterinterface, drug 
  a water
  1
 X w exp 
RT
RT





 Gwaterinterface, drug 

RT


exp 
X w a water
RT



(A2.6)

Substituting above equation to (A2.5), the term Xw is expressed in terms of free energy
of transfer:

 Gwaterinterface, drug 

1 
1


exp

X w RT X w a water
RT



(A2.7)

Relative adsorption potential f is defined as surface density of drugs in the presence of
surfactants divided by surface density of drugs in the absence of surfactants:
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f 


 (in the presenceof surfactant)
 drug

 drug (in the absenceof surfactant)

(A2.8)

s
   drug
   surfact

( water
) x drug
(in the presenceof surfactant)

( water   drug )

s
x drug
(in the absenceof surfactant)

where  and   are the surface density at dodecane/water interface in the absence and
presence of surfactants; x s is the mole fraction at the interface.

The mole fractions of the various components at the surface are related to the mole
fractions in bulk liquid by Eq. (A1.5a, b, c). Using the equation set combined with
  0 ) and relationship Eq. (A1.6), the first term of
infinite dilution condition (  drug ,  drug

Eq. (A2.8) could be simplified for nonionic surfactants:

   drug
   surfact

( water
)
( water   drug )






   surfact

( water
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 water
s
s
1 ( x water
a water  x surfact
a surfact )

1 a water
s
x water
a water

a water
s
 (1  x water
)a surfact
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exp  water a water
RT 


a water

 a
 1  exp  water
RT




 a surfact


(A2.9)

Applying the equations (A1.5b), the second term in Eq. (A2.8) becomes:

 Gwaterinterface, drug 
    a drug 
l
 exp  0

x drug
exp 
x ( w/ surfactant)
RT
RT





s
x drug ( w/o surfactant)
 Gwaterinterface, drug 
    0 a drug 
l
 exp  0

x drug
exp 
RT
RT




s
drug

  0   a drug
 exp 
RT
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(A2.10)

Substituting the equations (A2.9) and (A2.10) into Eq. (A2.8), the relative adsorption
potential becomes:

f 

 a drug
exp 

 a

 a

 RT
a water exp  water   a surfact 1  exp  water 
RT 
RT 



a water


 (A2.11)


Eq. (A2.11) is valid for nonionic surfactant. For ionic surfactant, such as SDS and DTAB,
the relative adsorption potential could be written as:

f 

a water
 a
 a surfact
a water exp  water  
RT 
2


 a drug
exp 

 a water 
 RT
1  exp  RT 





 (A2.12)


Substituting Eq. (A1.14)/(A1.12) and Eq. (A2.11)/(A2.12) into Eq. (A2.4), the
micelle/water partitioning coefficient could be calculated as follows:
For nonionic surfactants:

Km/ w 

Af
exp[ PV RT ]
Xw


 G waterinterface, drug  
a water
1

exp
 a surfact 
a water
RT
 a


exp water

 RT





 
  1
 
 a drug
a water

exp 

 a

 a

 RT
a water exp  water   a surfact 1  exp  water 
RT 
RT 



 G waterinterface, drug 
 a 
PV 
 exp  drug  exp 
exp 

RT
RT 
 RT 





 a water 
1  exp  RT 
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PV 
 exp
 RT 


(A2.13)

For ionic surfactants:

 Gwaterinterface, drug 
 a
 exp  drug
2 exp 
RT


 RT


 a water 
1  exp  RT 




Km/ w


PV 
 exp 

 RT 


(A2.14)

The Eq. (A2.13) and (A2.14) are the operational equations employed to predict
micelle/water partitioning coefficients.

A2.2.

Non-dilute Solute Condition

When concentration of solute is finite, the definition of micelle/water partition coefficient
is:

Km/ w

s

x drug

s
 xx
surfact  x drug


l
x drug






(A2.15)

Eq. (A1.5a, b, c) are modified to be applied to highly curved micelle surface:

 a

 a

s
l
xwater
 xwater
exp  water   exp  water 
RT 
RT 



 interface,drug
 Gwater
s
l
xdrug
 xdrug
exp 
RT


s
x surfact


 a
 exp  drug

 RT

(A2.16a)





(A2.16b)

 interface,surfact 
 l
 G water
 a

 exp  surfact  for nonionic surfactant
 x surfact exp 
RT
RT 





 interface,surfact 
 G water
 a

 l
l

 exp  surfact  for ionic surfactant
 x surfact f surfact exp 
RT


 2 RT 

(A2.16c)

Eq. (A2.16a, b, c) have the same forms with Eq. (A1.5a, b, c) with the differences in the
free energies of transfer from water to interface for drugs and surfactants. The

G water
interface represents the transfer free energy from bulk water to highly curved
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micelle surface. Because the drugs are subjected to Laplace pressure at micelle surface,
the transfer free energy for drug is expressed as:
 interface,drug  G waterinterface,drug  PV
G water

(A2.17)

Since the PV term is positive, the free energy of transfer from water to micelle surface,

G water
interface,drug , has less negative value than that for flat surface. Therefore, the drug is

less surface active at micelle surface compared to flat oil/water interface.


For ionic surfactant, the G water
interfacesurfact can be determined using pure surfactant

system in the absence of drugs. An equation similar to Eq. (A1.7) is obtained by
substituting Eq. (A2.16a) and (A2.16c) into Eq. (A1.6):

 interface, surfact
 Gwater
 a

l
l
exp  water   2 x surfact
f surfact
exp 
RT 
RT




 a
 exp  surfact

 2 RT


  1


(A2.18)

The surface pressure, , at the micelle surface can be estimated according to Section 5.3.2.
l
The monomer concentration in bulk water, xsurfact
, is equal to CMC. Activity coefficient
l
can be calculated using Eq. (4.3) and interfacial areas occupied by water and
f surfact

surfactants are shown in Section 4.3.3.2. The only unknown parameter is

G water
interface,surfact which could be determined by solving Eq. (A2.18).


Using same principle, the G water
interface,surfact term for nonionic surfactant can be

calculated using the following equation:

 interface, surfact
 Gwater
 a
 l
exp  water   x surfact
exp 
RT 
RT
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 exp  surfact
RT




  1


(A2.19)

When both ionic surfactant and neutral drug are present, the equations (A2.16a, b, c) are
substituted into Eq. (1.6):

 interface, surfact 
 Gwater
 a
 a

l
l
 exp  surfact
exp  water   2 x surfact
f surfact
exp 
RT 
RT



 2 RT
 interface,drug 
 Gwater
 a 
l
 exp  drug   1
 x drug
exp 
RT


 RT 





(A2.20)

When both nonionic surfactant and neutral drug are present, the following equation is
obtained by substituting Eq. (A2.16a, b, c) into Eq. (1.6):

 interface,surfact 
 G water
 a

 a

l
 exp  surfact 
exp  water   x surfact
exp 
RT 
RT
RT 




 interface,drug 
 Gwater
 a 
l
 exp  drug   1
 x drug
exp 
RT


 RT 

(A2.21)

In Eq. (A2.20) or (A2.21), there is only one unknown parameter, the surface pressure ().
The equation is numerically solved for the surface pressure.

Now all the parameters in Eq. (2.16a, b, c) are known, the micelle/water partition
coefficient is calculated by substituting Eq. (2.16b, c) into Eq. (2.15):

231

For ionic surfactant:
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(A2.22)
For nonionic surfactant:
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RT 
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exp 
RT 
RT
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(A2.23)

The assumptions used for above derivations include:
(1) The solute and surfactant are ideally competing with each other for the micelle
surface in the absence of specific interactions between the solute and surfactant
molecules.
(2) The radius of micelles is not changed with addition of solutes to micelles.
(3) The transfer free energy of solute molecule from water to micelle surface is
independent of solute concentration.
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A2.3.

The Effect of Finite Solute Concentration on CMC of Surfactants Using

Laplace Pressure Concept
The CMC of micelle would be a function of the transfer free energy of surfactant
molecule from bulk water to micelle surface. The following relationship holds:

 interface  Gwater
 interface,0 
 Gwater
CMC

 exp
CMC0
RT



(A2.24)

where CMC and CMC0 are the critical micelle concentrations in the presence and absence


of solutes; G water
interface and G waterinterface,0 are the transfer free energies of the

surfactant from water to micelle surface in the presence and absence of solute.

The change in the transfer free energy is mainly due to the change in Laplace pressure
acting on surfactant molecule.

  Gtrans
 ,0  Gwaterinterface  PV   Gwaterinterface  P 0V 
Gtrans
V (A2.25)
 2( 0   ) 2( 0 0 ) 
 P  P0 V  

V  2   0 
r
r
r


where P and P0 are the Laplace pressures in the micelles in the presence and absence of
solute;  0 is the surface pressure at micelle surface in the absence of solute with the
values for the model surfactants shown in Table 5.4;  is the surface pressure at micelle
surface in the presence of model drugs and can be calculated in Section A2.2.

Substituting Eq. (A2.25) into Eq. (A2.24), the ratio CMC/CMC0 is expressed as:
CMC
 2  V 
 exp  

CMC 0
 r  RT 

(A2.26)

Because of the usage of results in Section A2.2, the three assumptions used in that section
are applied to the current question. There is one more assumption that the surfactant
molecules are subject to Laplace pressure.
Copyright © Shaoxin Feng 2009
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